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Heterocyclic structures are critical components of an extensive collection of chemotherapeutic 
agents, either in service or under development, for treating numerous human illnesses. As a 
result, reaction technologies for heterocycle construction, in the context of both target- and 
diversity-oriented synthesis, enjoy a particularly prominent role in medicinal chemistry. 
Amongst all the C-C bond forming reactions, the classic Diels-Alder cycloaddition remains one 
of the most powerful transformations in organic chemistry especially for the formation of 
heterocyclic structures. Herein, we report a new methodology based on inverse electron demand 
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Diels-Alder reaction utilizing reactive “N-alkenyl iminium ion” and a suitable dienophile for the 
stereoselective synthesis of substituted piperidine derivatives. In presence of a suitable Lewis 
acid, the “N-alkenyl iminium ion” is generated from the respective enamine-aminal derivative in 
situ and undergoes Diels-Alder reaction with a dienophile producing a highly substituted N-
heterocycle (piperidine derivative) in one step. 
An efficient transition metal catalyzed isomerization technique for the synthesis of a new 
enamine-aminal synthon from respective N-allylamine derivatives has been developed. Cationic 
Ir-(COE) complex, a potential catalyst for ICR chemistry, was used for the isomerization of tosyl 
protected N-allylamine derivatives to synthesize N-tosyl-alkenyl iminium ion precursor in high 
geometrical selectivity and quantitative yield whereas carbamate (or amide) protected N-
allylamine derivatives were isomerized with good E/Z ratio using Grubbs II.  
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1.0  DEVELOPMENT OF DIASTEREOSELECTIVE INTERMOLECULAR HETERO 
DIELS-ALDER REACTION: SYNTHESIS OF N-HETEROCYCLES 
1.1 DIASTEREOSELECTIVE SYNTHESIS OF PIPERIDINES 
1.1.1 Hetero Diels-Alder Reaction in Synthesis of Substituted Piperidines 
Nitrogen-containing heterocycles (N-heterocycles) form an important part of the 
chemotherapeutic world.1 Specifically, piperidines are found as common building blocks in large 
numbers of naturally/unnaturally occurring biologically active molecule2 making them attractive 
targets for synthesis. The hetero-Diels-Alder cycloaddition3
                                                 
1 For selected reviews, see: (a) Sondhi, S. M.; Singhal, N.; Johar, M.; Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 
2002, 9, 1045-1074. (b) Newton, R. F. PharmaChem 2003, 2, 44-45. (c) Whitehouse, M. W. Curr. Med. Chem. 
2005, 12, 2931-2942. 
 reaction is one of the most useful 
transformations for the synthesis of piperidines as it allows formation of the cyclic structures 
with high degrees of substitutions in a highly stereoselective fashion. For the synthesis of 
2 For recent reviews, see: (a) Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron 2003, 59, 
2953. (b) Daly, J. W. J. Med. Chem. 2003, 46, 445. (c) Buffat, M. G. P. Tetrahedron 2004, 60, 1701. (d) Harrity, J. 
P. A.; Provoost, O. Org. Biomol. Chem. 2005, 3, 1349. (e) Escolano, C.; Amat, M.; Bosch, J. Chem. Eur. J. 2006, 
12, 8198. (f) Sun, Z.;Yu, S.; Ding, Z.; Ma, D. J. Am. Chem. Soc. 2007, 129, 9300-9301. 
3 For comprehensive reviews on asymmetric DA reaction see (a) Corey, E. J. Angew. Chem., Int. Ed. 2002, 41, 
1650-1667. (b) Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem., Int. Ed. 2002, 
41, 1668-1698. For an excellent introduction to heterodienophiles, see: (c) S. M. Weinreb in Comprehensive 
Organic Synthesis, Vol. 5 (Ed.: B. M. Trost, I. Flemming, L. A. Paquette), Pergamon, Oxford, 1991, chap. 4.2, pp. 
401-449. For an overview of heterodiene Diels-Alder partners, see: (d) D. L. Boger in Comprehensive Organic 
Synthesis, Vol. 5 (Eds.: B. M. Trost, I. Flemming, L. A. Paquette), Pergamon, Oxford, 1991, chap. 4.3, pp. 451-512. 
For related overviews, see (e) Boger, D. L.; Weinreb, S. M. Hetero Diels-Alder Methodology in Organic Synthesis; 
Academic Press: San Diego, 1987; Chapter 1. (f) Boger, D. L. Chem. Rev. 1986, 86, 781-793. 
 
 2 
piperidines, various possible combinations between dienes and dienophiles in hetero-Diels-Alder 
reactions are listed in Figure 1, showing both neutral (A, B and C) and ionic models (D) where 
either diene (A, B and D) or dienophile (C) is bearing the hetero atom. The resulting cycloadduct 
(piperidine) may be obtained from electron rich dienes (HOMO) and electron deficient 
dienophiles (LUMO) or vice versa (also known as Inverse-Electron-Demand cycloaddition).  
 
N
N
N
N
N
N
N N
Z
Z = Protecting Group
Z
(A)
(B)
(C)
(D)
 
Figure 1. Various models for hetro Diels-Alder reaction 
 
The model A is the most prevalent in the literature for the synthesis of piperidine 
derivatives. A few examples of asymmetric synthesis of piperidines utilizing model A are 
discussed. Boger and co-workers popularized N-sulfonyl-1-aza-1,3-dienes (1) as the 4π 
component in diastereoselective hetero-Diels-Alder reactions to access piperidine skeletons 
(Scheme 1).4
 
 When an optically active enol ether 2 was treated with N-sulfonyl-1-aza-1,3-diene 
(1), the respective cycloadduct 3 was obtained in high yield and high selectivity. Their studies 
showed that the reactions exhibited high endo selectivity and regiospecificity. 
                                                 
4 Clark, R. C.; Pfeiffer, S. S.; Boger, D. L. J. Am. Chem. Soc. 2006, 128, 2587-2593. 
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Scheme 1. Synthesis of substituted piperidines using chiral enol ether 
NH
O
ON
CO2Et
SO2Ph
N
SO2Ph
CO2Et
O
NH
O
CCl4
rt, 0.5M, 48h
+
> 98% conversion
d.r. 96:2:2
1 2 3  
 
Carretero and co-workers reported 5
 
 a chiral Lewis acid mediated catalytic and 
asymmetric cycloaddition protocol for the synthesis of enantiopure piperidine derivatives from 
N-sulfonyl-1-aza-1,3-dienes  and simple vinyl ethers (Scheme 2). By choosing N-(8-quinolyl)-
sulfonyl group in N-sulfonyl-1-aza-1,3-diene (4), both the reactivity and selectivity were 
improved dramatically. Kanemasa’s chiral ligand, DBFOX-Ph, was found to provide the highest 
enantioselectivity. 
Scheme 2. Lewis acid catalyzed substituted piperidine synthesis 
N
Ph
SO2Ar
O N N O
Ph Ph
DBFOX-Ph =
Ar = 8-quinolyl
OC3H7Ph
+
NPh
SO2Ar
Ph
OC3H7
10 mol% Ni(ClO4)2•6H2O
10 mol% DBFOX-Ph
CH2Cl2
rt
66%, 91% ee
endo/exo = 98:2
4 5
 
 
                                                 
5 Esquivias, J.; Arrayas, R. G.; Carretero, J. C. J. Am. Chem. Soc. 2007, 129, 1480-1481. 
 4 
Heterocyclic chiral triazolium carbene catalyst 6 was used by Bode and co-workers6
 
 in 
the context of N-hereto Diels-Alder reactions using N-sulfonyl-1-aza-1,3-dienes and α,β-
unsaturated aldehydes (Scheme 3). The triazolium carbene catalyst reacts with the aldehyde to 
generate a highly reactive dienophile that takes part in the Diels-Alder reaction producing highly 
enantioselective dihydropyridinone product 7. This bears the significance that the organocatalyst 
mediated process can also be utilized in asymmetric preparations of piperidine derivatives. 
Scheme 3. Chiral carbene catalyzed substituted piperidine synthesis 
N
SO2Ar
Ph
O
N
Ph
SO2Ar
Ar = 4-MeOPh
+
H
O
CO2Et CO2Et
90%, 
ee = 99%
10 mol% 6
10 mol% DIPEA
10:1 Toluene/THF, rt
O
N
N
N
Mes
Cl6 =
7
 
 
Aside from model A, the literature is also enriched with traditional hetero Diels-Alder 
cycloaddition models B and C7
                                                 
6 He, M.; Struble, J. R.; Bode J. W. J. Am. Chem. Soc. 2006, 128, 8418–8420. 
, but the ionic model D is known to a much lesser extent.  The 
models A and B involve neutral imine moieties 8 and 9 as the diene partner, whereas in model D, 
the diene partner is the alkenyl-iminium ion 10 (Figure 2). Surprisingly, these types of alkenyl-
iminium ion dienes (10) are rarely known in the literature due to the fact that they are highly 
7 (a) i) For a review of Diels-Alder reactions with heteroaromatic compounds see: Needleman, S. B.; Kuo, M. C. C. 
Chem. Rev. 1962, 62, 405-431. ii) For a recent review of Diels-Alder reactions of aza dienes see: Boger, D. L. 
Tetrahedron 1983, 39, 2869-2939. (b) For examples of the use of 1-aza diene Diels-Alder cycloaddition readions in 
synthesis see: i) Cheng, Y. S.; Fowler, F. W.; Lupo, A. T. J. Am. Chem. Soc. 1981, 103, 2090-2091. ii) Cheng, Y. S.; 
Lupo, A. T.; Fowler, F. W. Ibid. 1983, 105, 7696-7703. (c) i) Sainte, F.; Serckx-Poncin, B.; Hesbain-Frisque, A. M.; 
Ghosez, L. J. Am. Chem. Soc. 1982, 104, 1428-1430. ii) Aue, D. H.; Thomas, D. J. Org. Chem. 1975, 40, 1349-
1351. 
 5 
reactive, and there is no easy way to generate them. However, considering the potential of 
alkenyl-iminium ion as a diene in the construction of highly substituted piperidine skeletons 
attracted us to pursue a detailed study of their preparations, reactivity, and application towards 
the synthesis of substituted piperidine derivatives.  
 
N
R
N
R
ZN
R
Z
1-azabutadiene 2-azabutadiene alkenyl-iminium ion
8 9 10
 
Figure 2. Aza dienes used in hetro-Diels-Alder reactions 
 
1.1.2 Iminium Ion Intermediates in C-C Bond Forming Reactions 
Iminium ions8
                                                 
8 Royer, J.; Bonin, M.; Micoulin, L. Chem. Rev. 2004, 104, 2311-2352. 
 are well known electrophilic intermediates, often used for C-C bond formation 
reactions for synthesizing cyclic and as well as acyclic nitrogen-containing structures. These 
intermediates are used widely in cyclization processes and exemplified by many famous 
reactions such as the Mannich reaction. Iminium ion mediated cyclization protocols offer many 
advantages over other methods. For example, iminium ions, in general, are very reactive 
intermediates and so a wide variety of nucleophiles can be used and they can easily be generated 
from available methods. The reactivity of the respective iminium ion depends on the substitution 
present at both C and N atom and on the associated counter ion (Figure 3). The presence of 
 6 
electron withdrawing group either at C or N enhances the electrophilicity, hence its reactivity. 
Acyl groups are often used as the protecting group on the N atom. The intramolecular addition 
of nucleophiles to in situ generated iminium ions is common in the literature. Several pathways 
have been used for generating these ions and among them, α-fragmentation methods, 
acylation/alkylation of imines and condensations with secondary amines are the most useful. The 
α-fragmentation method involved mainly the use of Lewis acids but electrochemical oxidation or 
metal catalyzed C-H activation (where LG = H) have also been employed. Among the Lewis 
acids, TiCl4, SnCl4, BF3·OEt2 and TMSOTf are used most frequently.  
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R2R3
R4
N
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R2R3
R4
R1, R2 = H,
             alkyl, aryl
R3 = Acyl, Tosyl, COOR, CONR2, 
        NR2,  Alkyl, H
N
R1R2
R3 R4
N
R4R3
R1R2
LG
LG = Leaving GroupIminium Ion
N
R2R1
R3
N
H
R4 R3
Condensation
α-Fragmentation
Alkylation
or 
Acylation
Fragmentation by:
a) Lewis acid
b) C-H activation
c) Electrochemical oxidation
 
Figure 3. Iminium ions: General features 
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The chemistry associated with “N-acyl iminium”8 and “N-alkyl iminium” ion 
intermediates 9 are well recognized in the chemical literature and are profoundly rich. These 
intermediates are normally generated by ionizing N,O-acetals using stoichiometric amount a of 
Lewis acid. Significant research efforts have been directed towards the development of suitable 
catalytic conditions so as to avoid the use of a full equivalent of the Lewis acid (Scheme 4). 
Recently, Rutjes10 (eq 1.1) showed that 2 mol% Sn(OTf)2 efficiently induced cyclization of aryl 
containing allylic N,O-acetal 11 to produce the substituted tetrahydroisoquinoline 12 in 79% 
yield. On a similar line, Kobayashi11
 
 reported Lewis acid catalyzed ring-opening of N,O-acetals 
possessing an exocyclic nitrogen atom to achieve acyclic structures. Benzyl (tetrahydropyran-2-
yl) carbamate 13 formed the acyclic N-acyl iminium ion with 20 mol% TMSOTf, and was 
subsequently trapped with the reactive enolsilyl ether 14 to produce the ring-opened alcohol 15 
in 90% yield (eq 1.2).  
Scheme 4. Iminium ion mediated transformations catalyzed by Lewis acids 
N
N
Ns
BnO
2 mol% Sn(OTf)2
Ns
OMe
79%
OMe
(1.1)
11 12  
                                                 
9 For reviews on N-acyl iminium ions, see (a) Speckamp, W. N.; Moolenaar, M. J. Tetrahedron 2000, 56, 3817-
3856. (b) Bloch, R. Chem. Rev. 1998, 98, 1407-1438.   
10 Kinderman, S. S.; Wekking, M. M. T.; van Maarseveen, J. H.; Schoemaker, H. E.; Hiemstra, H.; Rutjes, F. P. J. T. 
J. Org. Chem. 2005, 70, 5519-5527. 
11 Sugiura, M.; Hagio, H.; Hirabayashi, R.; Kobayashi, S. J. Am. Chem. Soc. 2001, 123, 12510-12517. 
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In another experiment, Doyle 12
 
 showed that the Rh-based catalyst, dirhodium 
caprolactamate (16), in the presence of methanol and hydrogen peroxide activates the α C-H 
bond of N,N-dimethyl aniline 17 and generated the respective N-alkyl iminium ion in situ, which 
was further intercepted by a reactive nucleophile, 2-triisopropoxysilylfuran (18) to produce the 
acyclic oxidative product 19 at 60 °C (Scheme 5). 
Scheme 5. Transition metal catalyzed iminium ion formation 
N
CH2
CH3
O OTIPS N
CH3
O
O
tBuOOH,
+
60 °C, 95%
MeOH,
1 mol%
Rh
ON
RhH
1917 18
16
 
 
Catalytic and asymmetric reactions utilizing iminium ion intermediates are still 
challenging and not well known in the literature. Recently, ingenious work in the Jacobsen 
group13
                                                 
12 Catino, A. J.; Nichols, J. M.; Nettles, B. J.; Doyle, M. P. J. Am. Chem. Soc. 2006, 128, 5648-5649. 
 has led to the identification of the thiourea based organo-catalyst 20 as the best catalyst 
to obtain highly enantioselective Pictet-Spengler reaction. Tryptamine derived imine formed 
from 21 and the aldehyde, produced the N-acyl iminium ion intermediate 22 in presence of an 
13 Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558-10559. 
 9 
acylating reagent like acylchloride, and the catalyst, which subsequently underwent 
intramolecular attack producing the enantiorich Nβ-acyl-tetrahydro-β-carboline derivative 23 
(Scheme 6).  
 
Scheme 6. Organocatalyzed cyclization via iminium ion formation 
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Gellman14
 
 in 2006 reported a highly enantioselective methodology for aminomethylation 
of aldehydes under organo-catalysis utilizing N-alkyl iminium ion intermediate, and this 
methodology could further be extended to produce β2-amino acids. Less reactive N,N-dibenzyl-
methylene iminium ion (24) was generated from aminal 25 under the reaction conditions, which 
got intercepted by reactive enamine 26 derived from the aldehyde 27 and organo-catalyst 
complex 28. The selectivity of the nucleophilic addition to the iminium ion was rationalized 
from the sterics present on the catalyst (Scheme 7). 
                                                 
14 Chi, Y.; Gellman, S. H. J. Am. Chem. Soc. 2006, 128, 6804-6805. 
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Scheme 7. Bronsted acid mediated iminium ion formation followed by alkylation 
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It was evident that both Lewis and Bronsted acids were equally effective for the 
generation of iminium ions, and wide variety of nucleophiles could be applied to form the C-C 
bond. Strategically, both Lewis and Bronsted acid mediated cyclization processes would be 
valuable in the context of our approach towards the synthesis of substituted piperidines.    
1.1.3 Alkenyl Iminium Ion as Diene in Hetero Diels-Alder Reaction 
The existence of the “N-alkenyl iminium ion” (29) in the literature is not well known, but its 
related analogs derived from N-acyl iminium ion (30) are known (Figure 4). These intermediates 
are primarily involved in C-C bond construction and frequently utilized to introduce α-
substitution to an amine. They also are well known in cyclization reactions for the formation of 
N-heterocycles. The lesser known part of N-acyl iminium ions is their ability to behave as diene 
partner in Diels-Alder cycloaddition reactions. Under certain conditions, the respective electron 
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deficient 4π system of N-acyl iminium ions can be exploited as diene partner in Diels-Alder 
reaction15
 
 with variety of electron rich alkenes producing stereoselective N-heterocycles. 
N
Z
R2
R1
N
Z
R2
R1
OMe
Fragmentation
N-alkenyl iminium ion Enamine-aminal
N
R
R1
R2 O
N-acyl iminium ion
Vs
30 29
 
Figure 4. 4π systems of N-acyl and N-alkenyl iminium ion 
 
Schmidt16 in the late sixties used the electron deficient 4π system obtained from the N-
acyl iminium ion 30 as a diene partner (Scheme 8), and using various dienophiles, was 
successfully able to form corresponding cycloadducts (eq 1.3). In presence of stoichiometric 
SnCl4, the N-acyl iminium ion was produced from N-(chloromethyl)benzamide 31, and the 
respective diene intermediate underwent [4+2] type cycloaddition with trans-β-methylstyrene 
(32) yielding the respective oxazine 33 in 91% yield (eq 1.4). Few years later, Borsotti 17 
obtained similar results by utilizing a similar concept and was able to obtain cycloadduct 36 
upon treating an olefin 34 with a solution of paraformaldehyde, nitrile 35, and sulfuric acid (eq 
1.5). In 2003, Yoshida18
                                                 
15 For a review of N-acyl imines in Diels-Alder reactions: Weinreb, S. M.; Scola, P. M. Chem. Rev. 1989, 89, 1525-
1534 and references therein. 
 reported the irreversible generation of N-acyl iminium ion pool (38) by 
means electrochemical oxidation of 37 (to avoid Lewis acid) and obtained cycloadducts 39 with 
various dienophiles such as alkenes and alkynes (eq 1.6).  
16 Schmidt, R. R. Angew. Chem., Int. Ed. 1969, 8, 312. 
17 Giordano, C.; Ribaldone, G.; Borosotti, G. Synthesis 1971, 92-95. 
18 Suga, S.; Nagaki, A.; Tsutsui, Y.; Yoshida, J. Org. Lett. 2003, 5, 945-947. 
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Scheme 8. Examples of N-acyl iminium ion in cycloaddition reactions 
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Relatively stable acridizinium salts have been known in the literature for a long time 
(Scheme 9). The electron deficient 4π system of acridizinium 4019 underwent cycloaddition with 
a variety of dienophiles to produce bicyclic pyridinium salt 41 (eq 1.7). In 1985, Shono 20
                                                 
19 Bradsher, C. K.; Solomons, T. W. G. J. Am. Chem. Soc. 1958, 80, 933-934. 
 
reported a new [3+3] type annulation to form piperidine skeletons using α,α⁄-dimethoxylated 
amide 43 and allyltrimethylsilane in presence of excess TiCl4. One of the aminals of 43 was 
20 Shono, T.; Matsumura, Y.; Uchida, K.; Kobayashi, H. J. Org. Chem. 1985, 50, 3243-3245. 
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ionized first with TiCl4 to produce an N-acyl iminium ion, which was subsequently trapped with 
allyltrimethylsilane to produce the homoallylic derivative via a stable β-silyl cation. Finally, 
under the reaction conditions, another iminium ion was generated, which underwent 
intramolecular cyclization with the homoallylic double bond, yielding the desired [3+3] 
cycloadduct 44 (eq 1.8). 
 
Scheme 9. Iminium ion as diene in cycloaddition reactions 
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R
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Based on the work of Povarov and Orahovats, 21  the aniline derived aldimine 45 in 
presence of BF3·OEt2 underwent cycloaddition with electron rich dienophile (eq. 1.9) (Scheme 
10). Upon activation by BF3·OEt2, imine 45 generated an N-alkenyl iminium ion which 
underwent cycloaddition with enol ether and produced the tetrahydroquinoline derivative 46. 
Mariano22
                                                 
21 (a) i) Povarov, L. S.; Mikhailov, B. M. Izu. Akad. Nauk SSSR, Ser. Khim. 1964, 2221. ii) Povarov, L. S., Grigos, 
V. I.; Karakhanov, R. A.; Mikhailov, B. M. Ibid. 1964, 179; 1963, 2039. (b) Trifonov, L. S.; Orahovats, A. S. 
Heterocycles 1984, 22, 355. 
 reported a similar result utilizing the same concept. Instead of aldimine 45, inactivated 
2-aza 1,3-diene 47 was synthesized and treated with BF3·OEt2 (eq. 1.10). Lewis acid activation of 
22 Cheng, Y.; Ho, E.; Mariano, P. S.; Ammon, H. L. J. Org. Chem. 1985, 50, 5678-5686. 
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imine produced the N-alkenyl iminium ion, which upon cycloaddition with electron rich 
dienophiles, like vinyl ether, produced the respective cycloadduct 48. The methodology 
described above proves that N-alkenyl iminium ion generation is possible under suitable Lewis 
acidic conditions, and they can be used as Diels-Alder reaction partners. 
 
Scheme 10. Aza diene in cycloaddition reactions 
N
Me
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Akiyama and co workers 23
 
 reported a metal free cyclization protocol for 
tetrahydroquinoline derivatives synthesis. In the reaction protocol, chiral Bronsted acid (49) was 
used to produce the cycloadduct from azabutadiene and electron rich pyran. Overall, the reaction 
was cis stereoselective and exhibited high enantioselectivity (Scheme 11).  
Scheme 11. Bronsted acid catalyzed tetrahydroquinoline synthesis 
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23 Akiyama, T.; Morita, H.; Fuchibe, K. J. Am. Chem. Soc. 2006, 128, 13070-13071. 
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Based on these literature evidences, we are confident that the respective N-alkenyl 
iminium ions, similarly, can also be engaged in cycloaddition reactions. They are less known in 
the literature because of the fact that azabutadiene synthesis is not well known. The only useful 
azabutadiene that can be generated easily is phenyl aldimine. 
1.1.4 N-Tosyl Iminium Ion in C-C Bond Forming Reaction 
N-Tosyl iminium ions mediated C-C bond forming reaction24 strategies have received much less 
attention than the corresponding N-acyliminium ion mediated reactions. Limited synthesis of the 
respective aminals precursor prevents its use in C-C bond forming reactions. N-Tosyl iminium 
ion possesses similar characteristic properties as the N-acyliminium ion does, and in general, 
they are more reactive intermediate (Scheme 12). For example, Somafi and co-worker reported25 
the utility of such N-tosyl iminium ion in their methodology demonstrating by the synthesis of 
the powerful neurotoxin alkaloid (+)-Anatoxin-a via cyclic N-tosyl iminium ion intermediate (eq 
1.11). In their tetrahydroisoquinolines synthesis methodology, Kaufman and co-workers26
  
 used 
cyclic N-tosyl iminium ion to introduce substitution at 3-position and synthesized a simplified 
analog of novel β-adrenergic receptor antagonist MY336-a (eq 1.12).  
                                                 
24 (a) Ahman, J.; Somafi, P. J. Chem. Soc. Perkin Trans.1 1994, 8, 1079-1082. (b) Sisko, J.; Henry, J. R.; Weinreb, 
S. M. J. Org. Chem. 1993, 58, 4945-4951. (c) Shono, T.; Matsumura, Y.; Katoh, S.; Takeuchi, K.; Sasaki, K.; 
Kamada, T.; Shimizu, R. J. Am. Chem. Soc. 1990, 112, 2368-2372. 
25 Ahman, J.; Somafi, P.Tetrahedron 1992, 48, 9537-9544. 
26 Ponzo, V. L.;  Kaufman, T. S. Synlett  1995, 11,  1149-1150.  
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Scheme 12. N-Tosyl iminium ion mediated cyclization 
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1.2 ALKENYL IMINIUM ION: REACTION DEVELOPMENT 
1.2.1 N-Alkenyl Iminium Ion in Diels-Alder Reaction: A New Strategy for Piperidine 
Synthesis 
Diels-Alder cycloadditions remain the standard by which most annulation methodologies are 
measured. The array of investigations devoted to developing new variants of the traditional 
Diels-Alder reaction attests to the critical role these cycloadditions continue to play in synthesis 
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activities.3 Indeed, identifying Diels-Alder variants that are not extensively developed, or at least 
well investigated, is a challenging task. As discussed earlier, N-acyl iminium ions participate in a 
wide variety of transformations that have inspired remarkable creativity in methods development 
and synthesis enterprises. One family of these reactive intermediates that has received relatively 
little attention is N-alkenyl iminium ions 29 (Figure 5). We were, however, intrigued in the 
potential of N-alkenyl iminium ions 29 to function as diene and, simultaneously, cognizant of the 
limited information concerning these species’ reactivity patterns. Cycloadditions with 29 as 
diene offered intriguing possibilities for tandem reaction development considering that these 
[4+2] cycloadditions would generate a new tetrahydropyridinium ion 51 suitable for further 
functionalization by nucleophilic addition. Therefore, we have envisioned that N-alkenyl 
iminium ion diene (29) would enable the stereoselective synthesis of fully-substituted piperidines 
52 in Diels-Alder cycloadditions via a three component cycloaddition process. In the first step, 
the electron deficient diene 29 would undergo cycloaddition with dienophile 50 resulting in a 
new cyclic tetrahydropyridinium ion 51; subsequent trapping of this intermediate with a suitable 
nucleophile would produce the fully substituted piperidine 52. These cycloadditions offer the 
potential for constructing four new C−C bonds and five new stereocenters in a single step. 
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Figure 5. Strategy towards new Diels-Alder variant 
 
The N-alkenyl iminium ion 29 can be obtained by ionization of an enamine-aminal 
derivative 53 under Lewis acid or Bronsted acid conditions (Figure 6). The respective enamine-
aminal derivative 53 can in turn be synthesized by isomerization of a simple N-allylamine 
derivative 54. We believed that the installing the aminal part in the enamine-aminal synthon 
could be done by direct alkylation using commercially available reagents like MOMCl or α-
chloro nitrile. Having an electron withdrawing protecting group (Z) on the nitrogen atom would 
stabilize both of the aminal and enamine motifs and would provide us a practical and easy way 
of making such synthons. Upon ionization of the enamine-aminal 53 by a suitable Lewis acid, a 
highly electron deficient diene 29 would be produced.  
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Figure 6. Strategy towards N-alkenyl iminium ion generation 
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1.3 CYCLOADDITION WITH ALLYLTRIMETHYLSILANE 
1.3.1 Initial Reaction Conditions Optimization 
To test our hypothesis, the N-tosyl enamine-aminal derivative, 55, was synthesized by two high 
yielding steps from commercially available allylamine. N-Tosyl enamine (55) possessed OMe as 
a leaving group and Ts as a protecting group. As a result, strong Lewis acids such as TiCl4 and 
BF3·OEt2 were considered for its ionization at low temperature and −78 °C was chosen as the 
initial operating reaction temperature considering the fact that the resulting electron deficient 
diene (56) might not be stable at higher temperatures.  To exploit the resulting 4π system for 
[4+2] type addition, the electron rich dienophile, ethylvinyl ether, was used. A solution of 55 in 
dichloromethane was added to TiCl4 (1.1 equiv) solution in dichloromethane at −78 °C followed 
by addition of ethylvinyl ether (10 equiv) (Figure 7). The progress of the reaction was monitored 
by TLC. Complete decomposition of the starting material 55 was observed. Similar observations 
were made when BF3·OEt2 was used as the Lewis acid at room temperature. At −78 °C, no 
reaction was observed with BF3·OEt2. In the reactions with TiCl4 at −78 °C and BF3·OEt2 at 
room temperature, extensive polymerization of the ethylvinyl ether was observed suggesting that 
the dienophile was not stable under these strong Lewis acid conditions. We then switched to 
milder Lewis acids such as ZnCl2 and MgBr2·OEt2, which failed to provide any reaction even at 
ambient temperature. This preliminary screening of the Lewis acids suggested that the aminal 55 
was inactive with various Lewis acids at lower temperatures except TiCl4 and therefore, led us to 
stay with the TiCl4/ −78 °C condition. 
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Figure 7. Preliminary reaction conditions development for the [4+2] cyclization reaction 
 
At this point, to validate the cycloaddition process, a search for a suitable dienophile that 
could survive under the reaction condition (TiCl4/ −78 °C) was made  and allyltrimethylsilane 
was chosen. Allyltrimethylsilane is extensively used in nucleophilic addition reactions due to its 
reactivity and stability under strong Lewis acid such as TiCl4.27
                                                 
27 Brocherieux-Lanoy, S.; Dhimane, H. ; Poupon, J-C. ; Vanucci, C.; Lhommet, G.  J. Chem. Soc., Perkin Trans. 1 
1997, 2163-2165. 
 Apart from being an electron-
rich dienophile, allyltrimethylsilane would also offer an ancillary advantage of being the 
nucleophile with which the tetrahydropyridinium ion intermediate would be trapped. Treating 55 
with TiCl4 (1.1 equiv) at −78 °C in presence of allyltrimethylsilane (5 equiv) provided the 
cycloadduct 58 (89% yield). This preliminary finding demonstrated well that the Lewis acid 
activated the leaving group (in this case OMe) generating an N-alkenyl iminium ion 56, which 
then proceeded for the [4+2] cycloaddition resulting in the tetrahydropyridinium ion intermediate 
57. Finally, the tetrahydropyridinium ion 57 was trapped with excess allyltrimethylsilane present 
in the reaction system yielding the product 58 in 89% yield and as a 2:1 mixture of diastereomers 
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(determined fron 1H NMR) (Scheme 14). The structure of the major diastereomer (as drawn in 
scheme 13) was deduced based on stereochemical proofs of cycloadditions performed later 
which suggested that the [4+2] cycloaddition itself was highly selective. The origin of the 2:1 dr 
in this case was the less selective addition of the nucleophile onto the tetrahydropyridinium ion 
58. 
  
Scheme 13. Cycloaddition with allyltrimethylsilane via N-alkenyl iminium ion 
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1.3.2 Attempted Cyclization with Other Electron Rich Dienophiles 
Due to the failure in getting cycloadducts from ethylvinyl ether and 55, a different approach 
using a mild Lewis acid catalyst that would liberate the diene under the reaction conditions (and 
would not destroy the dienophile) was considered. It was realized that by making the enamine-
aminal substrate more reactive, relatively milder Lewis acid could be used to generate the N-
alkenyl iminium ion. The reactivity of the enamine 55 could be enhanced by changing the 
protecting group from tosyl to carbamate (-COOR) or acyl (-COR) and also by changing the 
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leaving group to –OAc or Cl−. A carbamate (or acyl) moiety at the nitrogen would provide 
enough stability to the enamine, and at the same time, would make the nitrogen lone pair 
available to facilitate ionization. This might help to obtain ionization easily with relatively 
weaker Lewis acids.  Hence, protecting group modified substrates 59 (methoxycarbamate 
protecting group) and 60 (benzyloxycarbamate protecting group) were synthesized and subjected 
to cycloaddition reaction with various vinylether type dienophiles as shown in figure 8. 
However, no reactivity was observed at −78 °C using TiCl4, Ti(iOPr)2Cl2 or  BF3·OEt2 as Lewis 
acids. At a low temperature (−78 °C), the catalysts were inactive, but upon increasing the 
temperature, polymerization was seen.  The lack of reactivity of these carbamate protected 
dienes at −78 °C may be attributed to the carbonyl groups in the protecting groups which bind to 
the Lewis acids making them less reactive. 
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Figure 8. Cycloaddition with electronically rich dienophiles 
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Knowing that TiCl4 was ineffective for the ionization of substrate 59 at −78 °C, a screen 
of higher temperatures was needed. Since vinyl ether type dienophiles underwent polymerization 
at higher temperatures, we switched to allyltrimethylsilane. To test the reactivity of the 
carbamate protected substrates in the cycloaddition, the carbamate 59 was subjected to excess 
allyltrimethylsilane and TiCl4 at −78 °C and after 16 h, the starting material was recovered 
(Figure 9). In the next run, the reaction temperature was raised to −30 °C but again no 
conversion was observed. In a different reaction, we added TiCl4, carbamate 59, and 
allyltrimethylsilane at −78 °C, and then, the reaction temperature was increased gradually to 
room temperature. In this case, the desired cycloadduct 61 was obtained, but the yield (37%) and 
diastereoselection (1:1 d.r., determined fron 1H NMR) both were poor. Thus the carbamate 
protected substrate 59 was found to be reactive only at room temperature in presence of TiCl4, 
therefore less reactive than the tosyl-protected substrate 55.  
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Figure 9. Cycloaddition with carbamate protected enamine derivative 59 
 
Reaction temperature, as high as room temperature for our cycloaddition reaction, was 
not desirable, as the intermediate tetrahydropyridinium ion would undergo facile deprotonation 
leading to the eliminated product at such temperatures. In order to enhance the reactivity of the 
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substrate to achieve reaction at lower temperature, the carbamate protected enamine-aminal 
derivative 62 with a better leaving group (OAc) was synthesized. Assuming that the binding of 
TiCl4 to the carbonyl moiety was responsible for the low reactivity at low temperatures (< room 
temperature), we also looked for other weaker Lewis acid. SnCl4 is often used for the ionization 
of N,O-acetals and most of these SnCl4 mediated ionizations are done at 0 °C.16  Thus, enamine 
59 was treated with SnCl4 (1.1 equiv) and β-methylstyrene (63) at 0 °C, and the eliminated 
cycloadduct 64 was obtained in good yield (67%, 4.4:1 d.r., determined fron 1H NMR) (Table 1). 
Carbamate 62 was then subjected to similar reaction conditions (1.1 equiv SnCl4, 0 °C) but the 
isolated yield was low (25%). The reaction with enamine 62 was much faster (starting material 
was disappeared after 1 h) than the reaction with enamine 59, and it is because the OAc group is 
a better leaving group than OMe. The easy formation of N-alkenyl iminium ion from enamine 62 
leads to the product along with decomposition.  
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Upon analyzing the product 64, it was concluded that SnCl4 ionized the aminal to form 
the N-alkenyl iminium ion 65, which immediately underwent cycloaddition and produced the 
cyclic iminium ion intermediate 66 (Figure 10). This intermediate being relatively unstable at the 
higher temperature (0 °C), underwent quick deprotonation to produce the respective cycloadduct 
64 and none of the product 67 derived from nucleophile addition was observed. The 6:1 
diastereoselection suggested that the cycloaddition proceeded via both synchronous and non-
synchronous pathways via intermediates 68, 69 or stable benzylic cation 70. The preceding 
results clearly demonstrated that the carbamate protected system offered no advantage in terms 
of reactivity or diastereoselectivity and so we continued our investigations with the tosyl 
protected enamine-aminal 55. 
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Figure 10. A plausible mechanism of cycloadduct 64 
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1.4 CONCLUSION 
A new strategy for the substituted piperidine derivatives synthesis in a three component coupling 
reaction manifold has been demonstrated. The Lewis acid mediated successful generation of new 
N-tosyl diene intermediate has been described, and subsequently, their engagement in 
cycloaddition process has been evaluated. N-tosyl enamine-aminal diene precursor showed 
higher reactivity over the carbamate protected diene precursors.  
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2.0  DIASTEREOSELECTIVE N-HETEROCYCLIC SCAFFOLD SYNTHESIS 
2.1 CYCLOADDITION WITH ENAMINE DIENOPHILES 
2.1.1 Initial Observation: A Competitive Dimerization Reaction 
So far allyltrimethylsilane has been engaged with the diene 56 as both the dienophile and 
nucleophile. The utility of this new diene in conjunction with other dienophiles has yet to be 
proved, but it is clear the N-alkenyl iminium ion expresses sufficient reactivity to engage 
electronically activated olefins as dienophiles in [4+2] cycloadditions. The resulting 
tetrahydropyridinium ion intermediate after the initial cycloaddition is also active and can be 
intercepted with various nucleophiles. In order to explore the reactivity of the diene toward other 
reaction partners, activated, unactivated, and neutral types of olefins were evaluated next. The 
enamine-aminal 55 was utilized for these studies, and the activation was done with TiCl4 at −78 
°C. It has been shown earlier that electron rich dienophiles such as vinyl ethers are prone to 
polymerization under the TiCl4 conditions and so we were careful in choosing of electronically 
rich dienophiles. In our initial reaction, vinyl acetate was chosen as the dienophile partner and 
allyltrimethylsilane as the nucleophile (Scheme 14). Since vinyl acetate is not as reactive as 
allyltrimethylsilane, the nucleophile (allyltrimethylsilane) would have to be added at the end of 
the reaction to capture the cyclic intermediate formed after cycloaddition. A solution of vinyl 
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acetate was added to a solution of enamine 55 and TiCl4 at −78 °C, and after disappearance of the 
starting material on TLC (3 h), a solution of excess allyltrimethylsilane was added. However, 
after isolation and characterization of the product, we were surprised to obtain the dimer 71 
instead of the expected cycloadduct 72 in 85% yield. Thus in this reaction the enamine acted 
both as the diene and the dienophile partners and underwent cycloaddition reaction resulting in 
tetrahydropryridinium ion 73 instead of 74 which afforeded the dimer 71 after treating with 
allyltrimethylsilane. This suggested that vinyl acetate was less reactive than the enamine-aminal 
55 itself as the dienophile. The deactivation of vinyl acetate could be due to its binding with the 
Lewis acid. 
 
Scheme 14. An unexpected dimerization reaction 
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Knowing that the starting material could serve both as diene and dienophile, in the 
following reaction, we did not add any dienophile (Scheme 15). After disappearance of 55 
(monitored by TLC), the resulting reaction mixture was quenched with two different 
nucleophiles, 1) allyltrimethylsilane and 2) DIBAL-H. In both cases, the respective dimers 71 
and 75 were obtained in good yields (85 and 62% respectively). Trapping with 
allyltrimethylsilane produced the dimer 71 with similar yields (85%) as obtained in scheme 14, 
implying that vinyl acetate did not have any influence in the reaction. When DIBAL-H was used, 
the major product 75 was isolated in 62% yield but the diastereoselection obtained from this 
reaction was excellent (determined from 1H NMR), producing a single diastereomer. The 
observation of a single diastereomer in case of the DIBAL-H reaction suggested two things. 
Firstly, the cycloaddition itself resulting in the tetrahydropyridinium intermediate 73 is highly 
stereoselective and secondly, the 4:1 diastereomer ratio obtained in case of the 
allytrimethylsilane reaction (determined from 1H NMR) is caused by the less stereoselective 
addition of the nucleophile on to 73. In order to determine the nature of stereoselectivity in the 
cycloaddition reaction, the dimer 71 which was a white crystalline solid, was submitted to X-ray 
crystallography (Figure 11). From its X-ray crystallographic structure, it was confirmed that the 
cycloaddition proceeded with endo selectivity. The intermediate 73 was formed from the 
cycloaddition reaction of 55 with 56 via the endo-transition state 76. The subsequent 
nucleophilic addition of allyltrimethylsilane to the intermediate tetrahydropyridinium ion 73 
proceeded selectively from one side of the cyclic iminium ion intermediate favoring the chair 
like transition state 77 to afford a 4:1 mixture of diastereomers.  
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Scheme 15. Cycloaddition with electron rich dienophile (enamine 55)  
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Figure 11. X-ray structure of dimer 71 and transition states  
 
2.1.2 Reaction Scope with Enamine Dienophiles 
Based on the results of the dimerization reaction, it was clear that enamines could serve as 
effective dienophile partners in the cycloaddition reaction with the diene 56.  Enamines such as 
N-tosyl-indole 7828 and N-tosyl-2,3-dihydro-pyrrole 7929
                                                 
28 Wagger, J.; Svete, J.; Stanovnik, B.  Synthesis 2008, 9, 1436-1442.   
 are known in the literature and can be 
easily be prepared. [4+2] cycloaddition of diene 56 with such enamine types of dienophiles 
would allow construction of different complex piperidine structures very rapidly.  Therefore, 
enamines 78, 79 and (E)-N-methyl-N-(prop-1-enyl)-p-toluenesulfonamide (80) were chosen as 
dienophile partners in our subsequent cycloaddition reactions with 56. The enamine dienophiles 
were subjected to the standard reaction conditions (TiCl4, –78 °C) with enamine-aminal 55, and 
the resulting tetrahydropyridinium ion intermediates were treated with either base such as 
triethylamine or nucleophiles such as ketene acetal 81 or DIBAL-H (Table 2). It was found that 
these enamine dienophiles were indeed reactive under the reaction conditions, as they formed the 
respective cycloadducts 82a-d and suppressed the dimerization reaction.  The eliminated 
29 Fustero, S.; Sanchez-Rosello, M.; Jimenez, D.; Sanz-Cervera, J. F.; Del Pozo, C.; Acena, J. L. J. Org. Chem. 
2006, 71, 2706-2714.   
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products 82a and 82b resulting via triethylamine promoted abstraction of C3-H, were obtained as 
single diastereomers with good yield (79% and 76% respectively). When the resulting 
tetrahydropyridinium ion from N-tosyl-indole cycloaddition was reduced with DIBAL-H, a 1:1 
mixture of diastereomers (determined from 1H NMR) 82c was isolated (71%). The 1:1 
diastereoselectivity could be explained by considering the fact that the cycloaddition reaction 
was following an ionic pathway rather than a concerted pathway. When enamine 80 was used as 
the dienophile, the respective tetrahydropyridinium ion was formed which underwent 
nucleophilic addition with 80 itself to provide the product 82d (43%, d.r. >97:3) after quenching 
with ketene acetal 81. Thus the enamine 80 was found to be the most reactive among all of these 
enamine dienophiles. The above results suggest that enamine dienophiles are good dienophile 
partners in cycloaddition reactions with 56.  
 33 
Table 2. Reaction scopes: Synthesis of priperidine derivatives 
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d.r. were determined from 1H NMR  
2.1.3 C1-Substituted Piperidine Synthesis 
Substitution at the C1 position of enamine-aminal derivatives would provide access to azadienes 
possessing substitution at both terminal carbons. This substitution would allow us to construct 
fully substituted piperidine derivatives. Also from the reaction perspective, the substitution at the 
C1 position would change the reactivity of the resulting diene as the substitution would stabilize 
the incipient carbocation. For the same reason, milder Lewis acids could be effective for their 
generation. Considering these facts and the current progress in the enamine-aminal synthesis 
strategy, a C1-substituted N-alkoxymethyl enamine 83 was synthesized (discussed in Chapter 4). 
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Upon treating with Lewis acid, ionization of racemic 83 was obtained generating the anticipated 
mixture of (Z,E)- and (E,E)-dienes 84 and 85, respectively (Scheme 16). In situ cycloaddition of 
the more reactive (Z,E)-diene 84 with enamine 80 afforded the tetrasubstituted piperidine 86 with 
high endo-selectivity (44%, 97:3 d.r. as d.r. determined from 1H NMR) after quenching with 
triethylamine whereas the more stable (E,E)-diene 85 remained untouched and was recovered (eq 
2.1). Instead of dienophile 80, when more reactive dienophile allyltrimethylsilane was used, both 
of the (Z,E)- and (E,E)-dienes reacted with similar reactivity resulting in the cycloadduct 87 with 
10:18 diasteomeric ratio (determined from 1H NMR) (eq 2.2). Thus we have successfully added 
a degree of substitution to the cycloadducts by introducing a substitution at the C1 position. The 
introduction of the C1 substituent in the diene resulted in less reactive dienes 84 and 85 
compared to 56 in the cycloaddition with enamine dienophile 80. However allyltrimethylsilane 
was reactive enough to engage both dienes 84 and 85 in the cycloaddition reaction.  
 
Scheme 16. Cycloaddition with C1-substituted enamine-aminal 
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N
Me
Et
Ts
TMS
TMS
87 (61%)
10:18 d.r.
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83
+
TiCl4
(1.1 equiv)
CH2Cl2 
−78 °C
(2.2)
 
2.2 CYCLOADDITION WITH NEUTRAL AND UNACTIVATED OLEFINS 
2.2.1 Reaction with Cyclohexene: Reaction Condition Development 
The N-alkenyl iminium ion 56 has so far been found to engage in cycloadditions with electron 
rich dienophiles even at very low temperatures (–78 °C). Encouraged by these results, the 
reactivity of N-alkenyl iminium ion 56 was next evaluated with electronically neutral and 
unactivated olefins as dienophiles in the [4 + 2] cycloaddition reaction sequence to see if the 
electron-deficient nature of this diene would allow it to express sufficient reactivity in such 
cases. In this regard, cyclohexene (2.5 equiv) was subjected to the previously developed reaction 
conditions (TiCl4, –78 °C) (Table 3). The reaction required a longer time (> 24 h) to complete 
(monitoring by TLC). Upon seeing the disappearance of the starting material on TLC, excess 
allyltrimethylsilane was added and the reaction was quenched with a saturated solution of 
NaHCO3 after 3 h. The desired cycloadduct from cyclohexene, 88 (the perhydroisoquinoline 
derivative), as well as the dimer, 71, were isolated (88:71 = 2:1). Considering that non-reactive 
cyclohexene would not compete with the relatively reactive enamine 55, a complete dimerization 
was expected. However, due to the extremely electron-deficient nature of the diene, reaction with 
cyclohexene was possible leading to formation of cycloadducts 71 and 88 in a 2:1 ratio. The 
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poorer reactivity of cyclohexene in comparison with electron-rich enamine dienophile (from the 
starting material itself) caused the poor yield of cyclohexene cycloadduct 88 (15%). For 
improving the reaction reactivity towards the desired pathway to generate more of the 
cycloadduct 88 we hypothesisized that increasing the quantity of cyclohexene in the reaction 
mixture, and decreasing the active concentraton of the enamine via slow addition of the enamine 
precursor might enhance the yield of the desired product 88. Indeed, using 10 equivalents 
cyclohexene provided 48% of the desired product 88 and 20% of the dimer 71 after column 
purification. In the next experiment, a solution of enamine 55 was added slowly over a period of 
3-4 hours to a mixture of cyclohexene with TiCl4, a further enhancement in the yield of 88 (up to 
54%, isolated yield) was obtained. The poorer reactivity of cyclohexene resulted in extended 
reaction times (36 hours at −78 °C). We assumed that a relatively higher temperature would 
enhance the rate of the cycloaddition step, and then the overall reaction time could be lowered. 
However the effect of an increase in temperature on the stability of the intermediate 
tetrahydropyridinium ion 89 was not known. In order to know upto what temperature the 
intermediate 89 was stable, a few control reactions at different temperatures were performed, and 
the products were analyzed (Table 4). It was observed that the tetrahydropyridinium ion 
intermediate was stable at −50 °C, and the reaction showed better reactivity as it took six-eight 
hours to complete providing 88 in a slightly better yield of 59%. Upon increasing the reaction 
temperature to −30 °C, deprotonation of the C3-H occurred and the eliminated product 90 was 
isolated as the only product (yield not determined). Therefore the optimized condition for the 
cycloaddition reaction was found to be the slow addition of the diene precursor over three hours 
to cyclohexene (10 equiv) and TiCl4 (1.1 equiv) in dichloromethane at −78 °C, followed by 
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warm up to −50 °C and stirring for six-eight hours, followed by nucleophile addition, and stirring 
for one-three hours. The results are tabulated below. 
 
Table 3. Reaction with cyclohexene: Standard condition development 
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Table 4. Reaction with cyclohexene: Temperature scans 
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H
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2.2.2 Reaction with Cyclohexene: Synthesis of Structurally Diverse N-Heterocycles 
For the generation of structurally diverse piperidine derivatives, we proceeded to explore the 
scope of the cycloaddition reaction of diene 56 with cyclohexene with various nucleophiles, 
using the optimized reaction conditions [slow addition of 55 over three hours to a mixture of 
cyclohexene (10 equiv) and TiCl4 (1.1 equiv) at −78 °C, then stirred at −50 °C for twelve hours]. 
Upon intercepting the cycloadduct 89 with different nucleophiles, the reaction delivered the 
 39 
perhydroisoquinoline derivatives 88 (59%), 91a (54%), 91b (57%), and 91c (53%) as single 
diastereomers (Table 5). From X-ray crystallographic analysis of the crystalline cycloadduct 88, 
it was concluded that the reaction proceeded via an exo transition state 92, presumably due to the 
seric bulk of the cyclohexene ring (Figure 12). The intermediate 89 when treated with 
allyltrimethylsilane, underwent selective nucleophilic attack from the top less hindered convex 
face of the cyclic intermediate affording excellent diastereoselection (d.r. = 30:1).   
 
Table 5. Representative examples of synthesized piperidines with cyclohexene 
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Figure 12. X-ray structure and transition state 
 
Instead of treating with nucleophiles, the tetrahydropyridinium ion intermediate (93) was 
treated with base (Et3N) to afford the [n.4.0] bicyclic heterocycles (Table 6). The amine-
mediated deprotonation was used as an alternative method for further derivation of the 
cycloadducts providing an avenue to introduce diversity to the final structures. Cyclohexene and 
cyclooctene were employed as dienophiles in the reaction with 56 and the respective 
cycloadducts, 90 (53%) and 94 (69%), were isolated as single diastereomers. The results 
obtained from the cycloadditions between enamine 55 and neutral olefins where the non-reactive 
dienophiles underwent cycloaddition suggested that the N-alkenyl iminium ion is reactive with 
any type of dienophile, provided that the dienophile is stable under the reaction conditions. Upon 
establishing the reactivity towards neutral olefin dienophiles, simple O-allylic and N-allylic 
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olefins (electronically deactivated olefins) were evaluated next (Scheme 17). When subjected to 
excess 56 under the standard reaction conditions, decomposition of 55 was observed.  
 
Table 6. Representative example of [n.4.0] bicyclic heterocycles 
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Scheme 17. Cycloaddition with electronically unactivated dienophiles 
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2.2.3 Trapping Tetrahydropyridinium Ion with Isonitriles 
As mentioned above, the tetrahydropyridinium ion intermediate 89 was trapped with various 
reactive nucleophiles to introduce substitution at C2 position of the resulting piperidine such as 
88. Till this point, we did not evaluate the reactivity of the tetrahydropyridinium ion intermediate 
89 with moderately reactive nuclophile. In this regard, we considered isonitriles (Figure 13) 
which were nucleophilic in nature, and we envisioned that these reagents might provide enough 
reactivity to trap the tetrahydropyridinium ion intermediate 89. The addition of isonitriles would 
introduce diversity at C2 position by forming an amide type bond in the final cycloadducts.  
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Figure 13. Isonitrile as nucleophile  
 
Isonitriles are useful reagents in organic synthesis especially in several multicomponent 
processes, such as the Passerini 30  and Ugi 31
                                                 
30 (a) Andreana, P. R.; Liu, C. C.; Schreiber, S. L. Org. Lett. 2004, 6, 4231-4233.  (b) Andrade, C. K. Z.; Takada, S. 
C. S.; Suarez, P. A. Z.; Alves, M. B. Synlett.  2006, 1539-1541. 
 reactions. They are the active participant in 
31 (a) Kaim, L. E.; Grimaud, L.; Oble, J. Angew. Chem., Int. Ed., 2005, 44, 7961-7964. (b) Tanaka, Y.; Hasui, T.; 
Suginome, M. Org. Lett. 2007, 9, 4407-4410. 
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combinatorial and library syntheses of many methodologies. 32  Some of the isonitriles are 
commercially available, but they can also be easily prepared from readily available materials. 
We studied the addition of isonitriles as nucleophiles in the cycloaddition reaction of 56 with 
cyclohexene [slow addition of 55 over three hours to a mixture of cyclohexene (10 equiv) and 
TiCl4 (1.1 equiv) at −78 °C, then stirred at −50 °C for twelve hours], and the 
tetrahydropyridinium ion intermediate 89 was intercepted with different isonitriles (95a-c) 
(Table 7). When tert-butylisonitrile (95a) was used, the corresponding cycloadduct was formed 
but the tertiary butyl group was found to be unstable under the reaction conditions affording 91a 
(52% yield, single diastereomer) as the sole product. This result suggested that intermediate 89 
was sufficiently reactive to undergo addition of moderate nucleophiles such as 95a. When 95b 
was used as the nucleophile, a complex mixture of products was isolated but it was evident from 
the crude 1H NMR that product 96b had been formed. Column purification followed by 
crystallization afforded analytically pure sample in 36% yield and as a single diastereomer. It 
was understood that 95b was sufficiently reactive to trap 89, but the work up led to formation of 
several other byproducts (unindentified). To solve this problem, the work up protocol was 
standardized where byproduct formation was minimized. It was highly possible that the aromatic 
substitution present in 95b caused the isonitrile to be susceptible to work up conditions resulting 
in decomposition. Optically pure isonitrile 95c was synthesized following literature protocol33
 
 
and subjected to the reaction conditions which afforded the respective cycloadducts 96c (50%, 
1:1 d.r.) suggesting highly selective addition at C2 center.    
                                                 
32 (a) For review: Zhu, J. Eur. J. Org. chem. 2003, 1133-1144. (b) Kennedy, A. L.; Fryer, A. M.; Josey, J. A. Org. 
Lett. 2002, 4, 1167-1170. 
33 (a) Obrecht, R.; Herrmann, R.; Ugi, I. Synthesis 1985, 4, 400-402.  (b) Zhu, J.; Wu, X.; Danishefsky, S. J. 
Tetrahedron Letters 2009, 50, 577-579.  
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Table 7. Trapping the tetrahydropyridinium ion intermediate with isonitriles 
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d.r. > 97:3
d.r. > 97:3
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2.2.4 Reactivity of the N-Alkenyl Iminium Ion Diene 
The current progress in enamine-aminal synthesis enabled us to have four different N-alkenyl 
iminium ion dienes, 56, 97, 84/85 and 98 which contained substitutions at either or both ends of 
the structure (Scheme 18). In order to determine and compare the reactivity of these dienes as 
cycloadition partners, the respective diene precursors were subjected to cycloaddition reactions 
with cyclohexene. The diene 56 provided the cycloadduct 90 in 53% yield and as a single 
diastereomer but the diene 97 with no substitution at either C1 and C3 provided 99 in 18% yield 
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and as a single diastereomer. Diene 84/85 was completely unreactive towards cyclohexene, and 
upon quenching the reaction, the eliminated product (E)-N,N-di-(prop-1-enyl)-p-
toluenesulfonamide34
                                                 
34 Terada, Y.; Arisawa, M.; Nishida, A. Angew. Chem., Int. Ed. 2004, 43, 4063-4067. 
 100 was obtained. The diene 98 provided the respective cycloadduct 101 
(56% and > 97:3 d.r.) after the resulting tetrahydropyridinium ion intermediate was trapped by 
adding excess allyltrimethylsilane. The poor yield of cycloadduct (18%) from diene 97 and 
cyclohexene suggested that 97 was highly reactive in comparison to dienes 56 or 98, 
preferentially decomposing at a faster rate than undergoing cycloaddition reaction. Dienes 56 
and 98, possessing substituents at C3, showed similar reactivities whereas diene 84/85 
possessing substituents at both C1 and C3 was not sufficiently reactive and did not give any 
cycloadduct with cyclohexene. Therefore it could be concluded that substitution at C3 only was 
optimum for obtaining successful cycloaddition reaction with cyclohexene.  
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Scheme 18. Reactivity comparison of the dienes 
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2.2.5 Strategy to Remove Tosyl Protecting Group 
In the context of our methodology, however, to make the piperidine derivatives useful, it was 
necessary to remove the tosyl group from the final piperidine structures. So far, the tosyl 
protected enamine-aminal 55, provided better reactivity and was used throughout this 
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methodology as opposed to other carbamate protected enamine-aminals. Removal of the tosyl 
protecting group is usually carried out under harsh reductive conditions35 using either sodium-
naphthalenide or sodium-liquid ammonia, but some base mediated methods are known for the 
indole derived substrates.36
 
 As the utility of tosyl protected enamine-aminal 55 was well 
established in the synthesis of complex piperidines, efforts were made to find a different sulfonyl 
protecting group, which would provide similar reactivity and selectivity. The protecting group 
should offer a mild condition of its removal, which should be suitable for the piperidine 
derivatives. The group should be compatible with an isomerization reaction providing high yield 
and chemoselectivity.  Considering all of these facts, we proceeded with both tert-butyl and 
thiophene containing sulfonyl groups (Figure 14). Both of the groups are known, can easily be 
removed, and are expected to not change reactivity greatly. Finally, we decided to synthesize 
thiophenesulfonyl (thienyl, Th) protected enamine-aminal 102 instead of the tert-butylsulfonyl 
protected enamine-aminal 103 because the latter might not be stable under the cycloaddition 
conditions. 
N
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OMe
S
O
O
N
Me
S
OMeO
O
Me
Ts = tosyl Th = thienyl
vs
55 102
N
Me
S
OMeO
O
tert-butyl
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Figure 14. Tosyl vs thienyl protected enamine-aminal 
 
                                                 
35 (a) Moussa, Z.; Romo, D. Synlett 2006, 19, 3294-3298. (b) Gold, E. H.; Babad, E. J. Org. Chem. 1972, 37, 2208-
2210. 
36 Bajwa, J. S.; Chen, G-P.; Prasad, K.; Repic, O.; Blacklock, T. J. Tetrahedron Lett. 2006, 47, 6425-6427. 
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The diene precursor 102 was synthesized from commercially available thienyl-2-sulfonyl 
chloride following the same method as for the synthesis of 55 (details about their preparations 
are discussed in chapter 4). The reactivity pattern of the resulting dienophiles derived from 55 
and 102 were supposed to be similar. Based on this assumption, 102 was subjected to the 
standard reaction conditions developed for reactive [slow addition of 102 over three hours to a 
mixture of allyltrimethylsilane (5 equiv) and TiCl4 (1.1 equiv) at −78 °C] and non reactive 
dienophiles [slow addition of 102 over three hours to a mixture of cyclohexene (10 equiv) and 
TiCl4 (1.1 equiv) at −78 °C, then stirred at −50 °C for twelve hours]. The resulting 
tetrahydropyridinium ion intermediates (104) were subsequently trapped with nucleophiles, and 
a few illustrative examples are shown in table 8. As expected, when treated with 
allyltrimethylsilane, the thienyl derived diene was found to be reactive and the respective 
cycloadduct 105a was isolated (78%) as a 1:1 mixture of diastereomers at C2 center (determined 
from 1H NMR). Cycloaddition with cyclohexene resulted in hydroisoquinoline products 105b 
(49%, single diastereomer) and 105c (52%, single diastereomer). The diastereoselectivity and 
yields were comparable to tosyl-diene derived products which suggested that both of the dienes 
possessed similar reactivity.   
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Table 8. Synthesis of thienyl-2-sulfonyl (Th) protected piperidines 
N
Me
D
N
Th
+
Th
OMe
D
Me
N
Th
H
H
Me
N
Bn
N
Th
H
H
Me
N
Th
Me TMS
Nu N
Th
D
Me
Nu
102 104 105
105a (78%)  105b (49%) 105c (52%)
Nu:
product:
allylTMS allylTMS N-benzyl Indole
(d.r. 1:1) (d.r. >97:3 (d.r. >97:3)
TiCl4
(1.1 equiv)
CH2Cl2 
−78 °C
then −50 °C
dienophile: allylTMS cyclohexene cyclohexene
d.r. were determined from 1H NMR  
2.2.6 Removal of Thienyl Protecting Group and Derivatization of the Deprotected 
Piperidine 
After establishing the utility of the thiophene-2-sulfonyl protecting group in cycloaddition 
reactions, we focused our attention towards its removal and further derivatization of the resulting 
piperidines. It is known in the literature37
                                                 
37 (a) Salvador Gonzalez, A.; Gomez Arrayas, R.; Rodriguez Rivero, M.; Carretero, J. C. Org. Lett. 2008, 10, 4335-
4337. (b) Morimoto, H.; Lu, G.; Aoyama, N.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2007, 129, 9588-
9589.   
 that the thienyl group can be cleaved reductively under 
mild condition using magnesium in methanol. For the desulfonylation reaction, the thienyl 
derived cycloadduct 105a was subjected to magnesium-methanol condition at room temperature 
and the respective desulfonylated piperidine 106a was isolated in 91% yield after two hours 
(Scheme 19). The indole derived cycloadduct 105c was subjected next to the deprotection 
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conditions and the respective desulfonylated product 106b was isolated in good yield (94.5%). 
The piperidine 106b was subjected to further derivatization and subsequently was alkylated with 
chlorocaetyl chloride to afford 107 in good yield (83%). Further cyclization of 107 would lead to 
the complex spirocycle 108 (similar process is known in the literature38
 
). Thus the removal of 
thienyl protecting group was easily achieved. Further derivatization at the N center would be 
possible and this would provide another degree of diversity in the piperidine structure.       
Scheme 19. Reductive desulfonylation and further derivatization 
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38 (a) Banwell, M. G.; Lupton, D. W.; Willis, A. C. Aus. J. Chem. 2005, 58, 722-737. (b) Banwell, M. G.; Lupton, D. 
W. Org. & Biomol. Chem. 2005, 3, 213-215.     
 51 
2.3 CONCLUSION 
The reactivity of N-tosyl diene intermediate with various olefins, such as electronically activated, 
neutral, and unactivated, has been evaluated. Finally, utilizing this reactive diene in a 
multicomponent cycloaddition reaction sequence, an efficient access to structurally diverse and 
stereochemically rich piperidine derivatives have been demonstrated. The diene was found to be 
highly reactive and reacted with even the neutral dienophile cyclohexene. Further 
functionalization of the cyclic tetrahydropyridinium ion either by different nucleophiles or by 
amine-mediated deprotonation strategies adds another degree of diversity to the final products.  
These attributes are expected to render this methodology generally useful in both target-directed 
and diversity-oriented synthetic activities. 
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3.0  DEVELOPMENT OF A CATALYTIC AND ASYMMETRIC REACTION 
The direct production of enantioriched synthons by asymmetric catalysis is becoming a popular 
research strategy. Over the last two decades, chemists have discovered many asymmetric 
reactions to deliver enantiopure synthons by developing catalytic methods using either chiral 
Lewis acids or Bronsted acids. Towards this goal, we started to address those unsolved problems 
that we faced during our reaction development, and we focused our attention towards finding a 
catalytic and asymmetric method. We have observed a few facts during our reaction 
development using achiral Lewis acids catalysis and concluded that they are crucial in terms of 
finding a good catalytic and asymmetric method (Figure 15). Firstly, we realized that the N-
protecting group and the leaving group of the diene should be complementary to each other so 
that the most reactive diene precursor could be prepared. The leaving group should not be too 
labile so that problems during the isolation and/or handing of the substrate could be avoided. On 
the other hand, it should be labile enough for the ionization to take place. Also the protecting 
group should not hold the nitrogen lone pair too strongly so that it requires a strong Lewis acid. 
Therefore, both the protecting group on N and the leaving group will determine the strength of 
Lewis acid required for successful ionization. Secondly, we observed that low temperature was 
needed in order to stabilize the tetrahydropyran intermediate to avoid significant decomposition. 
Finally, the dienophile should be reactive enough to react with the diene at low temperature and 
should be stable in presence of the Lewis acid.  
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Figure 15. Evaluation of a catalytic and asymmetric reaction 
 
Considering all of these facts, we started to design our reaction for a successful 
asymmetric method (Figure 16). We considered three possible strategies through which we could 
introduce asymmetric components to our reaction for the synthesis of enantioriched piperidines: 
1) Using chiral dienophiles: The easiest and simplest way would be using simple chiral 
dienophiles, which are known in the literature and can easily be made while keeping 
the other parameters same. 
2) Using chiral diene: Chiral N-protecting groups are known and by using them, a chiral 
component can be introduced to the reaction. 
3) Using chiral ligand modified Lewis acid complex: Instead of using chiral auxiliary 
based approaches (1 and 2), a reagent controlled approach would be more attractive. 
The best and most desired way of introducing chirality would be using a chiral ligand 
modified Lewis acid complex.  
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Figure 16. Introduction of chirality to the reaction via various components 
3.1 REACTION DEVELOPMENT WITH CHIRAL AUXILIARIES 
3.1.1 Reaction Development with Chiral Dienophiles 
There are several chiral dienophiles often used in cycloaddition processes. For example, many 
diastereoselective Diels-Alder reactions were developed using enol ethers bearing chiral 
auxiliaries. Recently Boger and co-workers39 reported an asymmetric variant of the 1-azadiene 
Diels-Alder reaction with high diastereoselectivity. Dujardin, Denmark, and many others40
                                                 
39 Clark, R. C.; Pfeiffer, S. S.; Boger, D. L. J. Am. Chem. Soc., 2006, 128, 2587–2593. 
 have 
successfully used different chiral enol ethers and showed that high diastereoselectivities could be 
40 (a) Dujardin, G.; Rossignol, S.; Brown, E. Tetrahedron Lett. 1996, 37, 4007. (b) Dujardin, G.; Rossignol, S.; 
Brown, E. Synthesis 1998, 763. (c) Gong, J.; Bonfand, E.; Brown, E.; Dujardin, G.; Michelet, V.; Geneˆt, J. 
Tetrahedron Lett. 2003, 44, 2141. (d) Gaulon, C.; Dhal, R.; Chapin, T.; Maisonneuve, V.; Dujardin, G. J. Org. 
Chem. 2003, 68, 4338. (e) Gizecki, P.; Dhal, R.; Poulard, C.; Gosselin, P.; Dujardin, G. J. Org. Chem. 2004, 37, 
4007. (f) Review: Denmark, S. E.; Thorarensen, A. Chem. Rev. 1996, 96, 137. (g) Pettus, T. R. R.; Selenski, C. J. 
Org. Chem. 2004, 69, 9196. (g) Gizecki,P.; Dhal, R.; Toupet, L.; Dujardin, G.  Org. Lett., 2000, 2, 585–588. 
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obtained. Representative examples of chiral auxiliary bearing dienophiles are shown in Figure 
17. 
D*
=
O
Ph
Me O
Me
MeMe
O
NH
O
O
O
O
MeMe
 
Figure 17. Commonly used vinyl ether derived chiral auxiliaries in Diels-Alder reactions 
 
Initially, we thought that similar optically active enol ethers would be examined in our 
reaction methodology, but as mentioned previously, vinyl enol ethers were not compatible with 
titanium tetrachloride. Therefore we decided to use chiral silane based dienophiles rather than the 
chiral enol ethers. Several methods for the preparation of allylsilane derivatives are known in the 
literature. Racemic allylsilanes 109 41 , 110, and 111 42
                                                 
41 Hosomi, A.; Hashimoto, H.; Sakurai, H. J. Org. Chem., 1978, 43, 2551-2552.  
 were prepared according to known 
literature methods. Upon subjecting allylsilane 110 to the cycloaddition reaction with enamine 
55, the desired cycloadduct was not obtained (Scheme 20). Both the starting material and the 
allylsilanes disappeared leading to unindentified side-products. Similar observation was made 
with allylsilanes 109 and 111. We concluded that the use of strong Lewis acid should be avoided, 
and hence, newer types of diene precursors were needed where efficient ionization could be 
achieved with milder Lewis acids. 
42 Beresis, R. T.; Solomon, J. S.; Yang, M. G.; Jain, N. F.; Panek, J. S. Org. Synth.  1998, 75, 78-88.  
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Scheme 20. Cycloaddition: Attempts with racemic silanes 
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3.1.2 Reaction Development with tert-Butanesulfinyl Group  
We envisioned that an optically active sulfinyl group, such as tert-butanesulfinyl group, could 
serve the purpose of both protecting group and chiral auxiliary at the same time (Figure 18). The 
optically active sulfinyl moiety is recognized as an efficient chiral auxiliary and often used as a 
nitrogen protecting group. High diastereoselectivities have been observed in reactions of chiral 
tert-butanesulfinyl-protected imines with various nucleophiles.43 The N-sulfinyl group is readily 
cleaved from the addition products to provide amine hydrochlorides, and wide varieties of amine 
containing compounds have been prepared using this chemistry44
 
. In this methodology, by using 
such sulfinyl derived chiral protecting group, chirality could be introduced in the diene 
precursor. Thus we decided to synthesize enamine-aminal 112 from tert-butanesulfonamide 113. 
                                                 
43 Fernandez, I.; Khiar, N. Chem. Rev., 2003, 103, 3651–3706. 
44 (a) Ellman, J. A.; Owens, T. D.; Tang, T. P. Acc. Chem. Res., 2002, 35, 984–995. (b) Kochi, T.; Tang, T. P.; 
Ellman, J. A. J. Am. Chem. Soc., 2002, 124, 6518–6519. 
 57 
S
N
OMe
Me
S
NH2
S
N
O OMe
Me
O
Me
sulfone
sulfoxide 
(tert-butanesulfinyl)
OO
vs
55 112
113
 
Figure 18. tert-Butanesulfinyl motif an effective chiral protecting group 
 
The tert-butanesulfinamide 113 was prepared by following the procedure developed by 
Ellman and co-workers.45 Subsequent allylation of 113 was screened under several mild basic 
conditions including K2CO3/CAN or Cs2CO3/CAN conditions at elevated temperatures and 
NaH/DMF conditions at ambient temperature (Scheme 21). The NaH/DMF condition was found 
to be the most reliable, yielding the desired product in moderate yield (53%). However, to 
expedite the synthesis of required enamine-aminal 112, a racemic tert-butanesulfinyl chloride 
114 was prepared quickly by following a known literature procedure46
  
 and upon treating with 
excess allylamine, N-allyl-tert-butanesulfinamide (115) was synthesized (92%). Having 
sufficient 115 in hand, the second alkylation reaction was performed with MOM-chloride and 
NaH, affording N-allylaminal 116 with good yield (70%). 
                                                 
45 Weix, D. J.; Ellman, J. A.; Wang, X.; Curran, D. P. Org. Synth. 2005, 82, 157-165. 
46 (a) Gontcharov, A. V.; Liu, H.; Sharpless, K. B. Org. Lett., 1999, 1, 783-786. (b) Netscher, T.; Prinzbach, H.  
Synthesis, 1987, 8,  683-688. 
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Scheme 21. Synthesis of N-allyl-tert-butanesulfinylaminal 
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In order to synthesize the enamine-aminal 112, isomerization of 116 was required next. 
The cationic iridium condition (Ir2(COE)2Cl2, PCy3, NaBPh4, 40 ºC) developed in our group47 
was applied first, but only a partial conversion (<10%) was obtained (Scheme 22). Prolonging 
the reaction time at 40 ºC or raising the temperature to 80 ºC did not improve the conversion. It 
was also noticed that the conversion in the reaction was not reproducible. Isomerization reactions 
with other transitions metal catalyzed conditions, e.g. Rh(I) or Ru(I), were screened, but none of 
them led to product. In a control reaction, N-allyl-tert-butanesulfinamide (115) was subjected to 
isomerization with iridium catalyzed condition and a complete conversion to the corresponding 
isomerized product 117 was achieved providing the E isomer only. It was thought that the 
enamine-aminal 112 could also be prepared from 117 via alkylation with MOMCl. However, 
treating 117 with NaH and MOMCl did not afford the desired product.  The observations 
resulting from the isomerization of 116 suggested that the catalyst was poisoned by the substrate 
as the sulfoxide functionality could bind with the transition metal48
                                                 
47 Nelson, S. G.; Bungard, C. J.; Wang, K. J. Am. Chem. Soc. 2003, 125, 13000-13001. 
 via its electron rich oxygen 
atom shutting down the isomerization process (118). Without investigating further to improve 
48 (a) Pitchen, P.; Dunach, E.; Deshmukh, M. N.; Kagan, H. B. J. Am. Chem. Soc. 1984, 106, 8188-8193. (b) Brunel, 
J. M.; Kagan, H. B. Bull. Soc. Chim. Fr. 1996, 133, 1109-1115. 
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the isomerization reaction yield and with the low amount of material in hand, the viability of the 
cycloaddition process was assessed. tert-Butylsulfoxide protected diene precursor (112) was 
subjected to cycloaddition with allyltrimethylsilane as the dienophile using TiCl4 (1.1 equiv) at –
78 ºC, but a complete decomposition of 112 was observed (Scheme 23). The decomposition of 
112 may be attributed to the instability of the tbutyl group under the strong TiCl4 conditions.  
 
Scheme 22. Isomerization of N-allyl-tert-butanesulfinylaminal 
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Scheme 23. Cycloaddition reaction with N-allyl-tert-butanesulfinylaminal 
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 The instability of the tert-butylsulfoxide derived diene precursor 112 under the TiCl4 
reaction condition led us to construct more robust sulfinyl derived N-allylaminals.  p-
Tolylsulfinyl derived diene precursor 130 was synthesized,49
 
 but upon employing the iridium 
catalyzed isomerization condition, the catalyst was found to be completely inactive (Scheme 24). 
Chiral auxiliary based approaches for the asymmetric synthesis of piperidine derivatives were 
unsuccessful due to the inefficient isomerization techniques and incompatibility with TiCl4. We 
proceeded for a Lewis acid catalyzed approach. 
Scheme 24. Isomerization of p-tolylsulfinyl substrate 119 
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3.2 CATALYTIC AND ASYMMETRIC REACTION DEVELOPMENT WITH 
LEWIS ACID 
So far in the cycloaddition reactions with diene 56, stoichiometric amount of TiCl4 has been 
used. For any Lewis acid mediated catalytic system, regeneration of the active catalyst is 
required at the end of the catalytic cycle. In our reaction, the Lewis acid binds to the substrate 
                                                 
49 (a) Bravo, P.; Zanda, M.; Zappala, C. Tetrahedron Lett. 1996, 37, 6005-6006. (b) Cotton, H. K.; Huerta, F. F.; 
Baeckvall, J.  Eur. J. Org. Chem. 2003, 15, 2756-2763. (c) Garcia R. J. L.; Aleman J.; Parra A. J. Am. Chem. Soc. 
2005, 127, 13048-54.   
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120 in the first step providing the diene 121 and the Lewis acid-leaving group complex 122 
(Figure 19).   Next the diene would undergo a [4+2] cycloaddition with dienophile 123, resulting 
in the formation of intermediate 124. By choosing a suitable additive (in this case, excess 
allyltrimethylsilane), which will serve the purpose of both dienophile and nucleophile, the 
nucleophilic capture of tetrahydropyridinium ion intermediate (124) would produce the desired 
cycloadduct 125 and release a trimethylsilyl cation which would regenerate the active Lewis acid 
catalyst as described in the following mechanistic model. We were also aware of the fact that the 
electrophilic silicon species might activate the reaction itself, but we were hopeful that it would 
be trapped with the leaving group by forming a strong Si-O bond before it could start to behave 
as the catalyst under the reaction condition. 
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Figure 19. Mechanistic model for a Lewis acid catalyzed cycloaddition process 
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Lewis acid-substrate complexes often provide excellent stereoselectivity in presence of 
suitable chiral ligands50 and numerous chiral ligand bound metal complexes are well known in 
the literatur. 51
 
 We hypothesized that an enantiomerically enriched catalyst complex can 
effectively control cycloaddition facial selectivity exploiting fully the potential of this three-
component cycloaddition process. In order to provide an effective binding site for the Lewis acid 
during the course of the reaction, carbonyl protected enamine-aminals such as 126 or 127 were 
considered. An asymmetric variant of this methodology would now be possible (Figure 20) as 
the chiral catalyst (128) would activate 126 affording the tight ion pair 129, and the 
cycloaddition would proceed via the transition state ensemble 130. Even if significant ion pairing 
were lost due to fast ionization, the fully developed diene intermediate would be in association 
with the catalyst, and the steric barrier from the ligand backbone would prevent the free rotation 
about the N-Ccarbonyl bond. The expectation was that the metal complex-diene intermediate 
assembly would be rigid enough and would dictate the metal complex to retain in one orientation 
relative to the diene plane defined by the initial chelate conformation. This reaction design 
implicated C2-symmetric divalent metal complexes as suitable candidates. Divalent metals like 
Cu, Sn, Sc, Zn etc. would be considered due to their chelating ability. C2-symmetric ligands like 
bisoxazoline (box), salen, and bispyridine derived were chosen for enantioselective cycloaddition 
catalysis. 
                                                 
50 (a) Evans, D. A.; Wu, J. J. Am. Chem. Soc. 2005, 127, 8006-8007. (b) B. M. Trost, S. Shin, J. A. Sclafani, J. Am. 
Chem. Soc. 2005, 127, 8602-8603. (c) Evans, D. A.; Johnson, J. S. J. Am. Chem. Soc. 1998, 120, 4895-4896. 
51 (a) Evans, D. A.; Kozlowski, M. C.; Murry, J. A.; Burgey, C. S.; Campos, K. R.; Connell, B. T.; Staples, R. J. J. 
Am. Chem. Soc. 1999, 121, 669-685. (b) Walsh, P.J.; Lurain,A. E.; Balsells, J. Chem. Rev. 2003, 103, 3297-3344. (c) 
Sibi, M. P.; Manyem, S.; Zimmerman, Z. Chem. Rev. 2003, 103, 3263-3296. (d) Kobayashi, S.; Ishitani, H. Chem. 
Rev. 1999, 99, 1069-1094. 
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Figure 20. An asymmetric model for Lewis acid catalyzed cycloaddition reaction 
 
In order to find the right Lewis acid for a catalytic system, a wide variety of metal salts, 
e.g. Sn(OTf)2, Cu(OTf)2, MgBr2 etc. were screened. The tosyl protected enamine-aminal 
substrate 55 was evaluated first and subjected to 10 mol% Sn(OTf)2 and excess of 
allyltrimethylsilane (Figure 21). The progress of the reaction (in this case formation of 58 and 
132) was measured either by running 1H NMR of the reaction aliquot or performing TLC. It was 
observed that metal triflates could activate 55 and formed the respective products at ambient 
temperature. The reaction rate was slow and it took more than 12 h to complete the reaction. 
When excess of TMSCl was added as an activator at 0 °C, the reaction rate enhanced 
significantly and the reaction was completed within 2-3 h (condition A: 10 mol% metal triflate, 3 
equiv TMSCl, 0 °C). Next, the reaction temperature of the cycloaddition reaction needed to be 
lowered (−40 °C or lower), where the intermediate tetrahydropyridinium ion would be stable. 
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Instead of 55, when the more reactive substrate 131 (which had OAc as leaving group) was used, 
it was observed that catalytic InBr3 with TMSCl could activate 131 affording the desired product 
58 (condition B: 10 mol% InBr3, 3 equiv TMSCl, −40 °C). After identifying InBr3 as an effective 
catalyst, search for a chiral-ligand modified indium-complex was made and in situ generation of 
InBr3-ligand complex with ligands 133, 134, and 135 were considered. Chiral ligand 135 
modified In-complex was evaluated against substrate 131, but was found to be completely 
inactive. The carbamate protected substrates 126 and 127 were screened next. It was found that 
both 126 and 127 were completely inactive under condition B (10 mol% InBr3, 3 equiv TMSCl, 
−40 °C), but upon warming up the reaction mixture, 127 was found to react very slowly (<10% 
conversion over 24 h) at ambient temperature (condition C: 10 mol% InBr3, 3 equiv TMSCl, 0 
°C) which was not useful.  
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Figure 21. Chiral Lewis acid meditated approach towards catalytic reaction 
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3.3 CATALYTIC AND ASYMMETRIC REACTION DEVELOPMENT WITH 
BRONSTED ACIDS 
Asymmetric catalysis with chiral Bronsted acids (or chiral H-bond donors) has emerged as an 
important paradigm for enantioselective catalysis 52
3.3.1 Thiourea Catalyzed Reaction Development 
. Electrophile activation by these small-
molecule chiral hydrogen-bond (H-bond) donors has provided new applications and 
developments in organic synthesis at a rapidly increasing pace. H-bonding plays crucial role in 
the biological world either by providing stable three-dimensional structures (e.g. three-
dimensional structure of protein) or by catalyzing several transformations (e.g. Serine protease 
mediated amide hydrolysis). In trying to mimic enzyme catalyzed processes found in the 
biological world, small molecule catalysts have been designed in such a way that the new 
catalyst possesses H-bonding capability, several catalyst–substrate interactions sites, and is 
capable of simultaneous activation of nucleophile and electrophile behaving as bifunctional 
catalyst.  
Enantioselective reaction development strategies by metal-free organocatalysts have recently 
attracted much attention from organic chemists. Organocatalysts53
                                                 
52 For review see: Taylor, M. S.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2006, 45, 1520-1543 and references 
therein. 
 are environmentally benign, 
easy to handle and require low operational cost. Small organic molecules like ureas and thioureas 
are known for activating organic transformations from eighty’s, and they feature the general 
properties that may be identified to characterize them as small-molecule chiral H-bond donors. 
53 MacMillan, D. W. C.  Nature 2008, 455, 304-308. 
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Recent development in thiourea catalyzed enantioselective transformations54
 
 demonstrated well 
that the catalyst binds with substrate by H-bonding and excellent facial control is observed 
providing high enantioselectivities.  Jacobsen and co-workers showed that the thiourea catalyst 
137 forms an H-bond with the negative counterion in a zwitterionic ion pair with iminium or 
oxonium ion (Figure 22). The catalyst 137 was tuned in such a way that additional binding 
modes were possible making the catalyst bifunctional. 
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Figure 22. Chiral thiourea catalysts and their modes of binding 
                                                 
54 (a) Raheem, I. T.; Thiara, P. V.; Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 2007, 129, 13404-13405. (b) 
Reisman, S. E.; Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130, 7198-7199.  
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Encouraged by these discoveries, we sought to synthesize catalysts 137 and 138 and 
evaluate their efficiency as acid catalysts for iminium ion generation. By following literature 
methods, both of the catalysts were synthesized.13,55
 
 Test reactions were run with substrates 55 
and 131 using 10 mol% of catalyst 138 and excess allyltrimethylsilane (Figure 23). Generally 
ether (or toluene) type solvents were used considering the fact that less polar solvent would 
allow formation of a tight ion pair, which is the key to achieve high enantioselectivity. Both of 
the substrates 55 and 131 were inactive, and after extended reaction times (>24 h), only 
recovered starting material was observed. It was also known54a that additives like 
trimethylsilylchloride help in ionization and provide a relatively stabilized chloride-iminium ion 
pair. The addition of trimethylsilylchloride to the reaction mixture as an additive was also found 
to be inefficient, and most likely, an unknown complex with 131 was forming (disappearance of 
131 was observed), which did not lead to the formation of products.  
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Figure 23. Screening with racemic thiourea catalyst 138 
 
The completed studies indicated that a more effective ionizable group would be necessary 
to facilitate the formation of iminium ions under the thiourea catalyzed reaction conditions. To 
gain the full advantage of bifunctional thiourea catalyst, an enantiopure catalyst would also be 
                                                 
55 Sohtome, Y.; Tanatani, A.; Hashimoto, Y.; Nagasawa, K.Tetrahedron Lett. 2004, 45, 5589-5592. 
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necessary where something other than H-bonding activation sites are present. The catalyst 137 
was chosen (Figure 24). More reactive substrates 131 (OAc), 139 (p-nitrobenzoate), and 140 (m-
nitrobenzoate) with more ionizable leaving groups were evaluated. Instead of 
allyltrimethylsilane, the enamine 80 was used as the dienophile. Upon subjecting to the 
cycloaddition reaction with 10 mol% catalyst 137 in tert-butyl methyl ether as solvent, no 
reaction was observed (>36 h). It was concluded that the inherent acidity of thiourea catalyst 137 
was poor and not sufficient for the ionization of even the m-nitrobenzoate containing enamine 
aminal 140, which had the most ionizable group (pKa of m-nitrobenzoic acid = 2.45). These 
results further impled that either a more ionizable group than m-nitrobenzoate, or a stronger acid 
than thiourea 137 would be required.  
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Figure 24. Screening with chiral thiourea catalyst 137 
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3.3.2 Bronsted Acids Mediated Activation 
Chiral Bronsted acid mediated organic reactions56 have recently been successfully employed for 
the enantioselective preparations of many organic compounds, and this area of organocatalysis is 
progressing rapidly57
Knowing that common Bronsted acids are much stronger than the thiourea catalyst, 
various common Bronsted acids such as CSA, acetic acid and, HCl in dioxane were screened 
against substrates 127 and 131 (Figure 25). Upon treating with 10 mol% acids either at 0 ˚C or at 
ambient temperature, none of these substrates were found to be active. Substrates 127, 131, 141 
and 142 were screened with 10 mol% of phosphoric acid derived Bronsted acids 143 and 144. 
However in all cases, no cycloaddition was observed. Different solvents (CH2Cl2 and toluene) 
. It is now well known that Bronsted acids can accelerate organic reactions 
by 1) specific acid catalysis and 2) general acid catalysis. However, considering its general mode 
of catalysis, many research efforts were made to develop synthetic Bronsted acid catalysts. 
Chiral phosphoric acids derived from binapthols constitute on of the most useful classes of 
Bronsted acids within the small molecule organocatalyst paradigm. The axial chirality from the 
binapthol backbone is utilized for enantio differentiation, and by varying sterically and/or 
electronically modified substituents at the 3 and 3' positions of the catalyst framework, a tuned 
catalyst can be generated for required reactivity and high enantioselectivity. In its mode of 
activation, catalytic protonation of the electrophile forms an intermediary ion pair composed of 
activated (or protonated) electrophile and a chiral phosphate counter ion. The observed high 
degree of enentioselectivity is induced from the chiral counter ion of the ion pair association.  
                                                 
56 (a)Terada,T.; Kyoko Machioka, K.; Sorimachi, K. J. Am. Chem. Soc. 2007, 129, 10336-10337. (b) Guo, Q.; Liu, 
H.; Guo, C.; Luo, S.; Gu, Y.; Gong, L. J. Am. Chem. Soc. 2007, 129, 3790–3791. (c) Yamanaka, M.; Itoh, J.; 
Fuchibe, K.; Akiyama, T. J. Am. Chem. Soc. 2007, 129, 6756-6764. 
57 (a) Akiyama, T. Chem. Rev. 2007, 107, 5744-5758. (b) Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. 
Rev. 2007, 107, 5471-5569. 
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and temperatures (0 ˚C, 23 ˚C, 70 ˚C) were also screened, but without any reaction suggesting 
that the acidity of these phosphoric acid catalysts were not sufficient for aminal ionization.  
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Figure 25. Screening with Bronsted acids 
3.3.3 Reaction Development with N-Triflyl Phosphoramide 
In search of more acidic chiral bronsted acid catalyst, we considered N-triflyl phosphoramide. N-
Triflyl phosphoramides (145) comprise a new class of Bronsted acid catalysts capable of 
activating carbonyl compounds either in asymmetric Diels-Alder reactions 58  or in Nazarov 
reactions 59
                                                 
58 Nakashima, D.; Yamamoto, H. J. Am. Chem. Soc. 2006, 128, 9626-9627. 
 providing enantio-rich compounds (Figure 26). They possess similar structural 
features as phosphoric acid (146) but provide stronger acids in solution. Introduction of the N-Tf 
59 Rueping, M.; Ieawsuwan, W.; Antonchick, A. P.; Nachtsheim, B. J. Angew. Chem., Int. Ed. 2007, 119, 2143-
2146. 
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group make these phosphoramide catalysts highly reactive and capable of enabling 
transformations which were not achievable before with phosphoric acids. A modification in the 
diene precursor structure was further necessary as phosphoric acids were not strong enough even 
at higher temperatures (60-70 °C). In order to access more reactive diene precursors, different 
leaving groups in the order of decreasing pKa were incorporated using the standard N-allyl-
chloroaminal protocol. A series of substrates as listed in figure 27 were synthesized and it was 
found that the m-nitrobenzoate group containing precursor 140 was the optimum substrate in 
terms of its isolation and handling (Figure 27). 
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Figure 26. Phosphoric acid and N-triflyl phosphoramide 
 
N OMe
Ts
Me
N O
Ts
Me
Me
O
N O
Ts
Me
O
N O
Ts
Me
O
NO2
NO2
55 131 139 140
≈
increasing reactivity
< <
 
Figure 27. Examples of pKa modified diene precursors  
 
The modified diene precursor 140 was screened with a variety of Bronsted acids. Instead 
of allyltrimethylsilane, tertahydropyran was chosen as the dienophile partner. After few control 
reactions, it was found that when 10 mol% of the phosphoramide 147 was employed, successful 
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ionization of the aminal occurred at room temperature affording the desired cycloadduct 148 in 
51% yield (Table 28). The choice of solvent was important as the dienophile itself was reactive 
towards the acid leading to polymerization. Tetrahydrofuran was found to be the best solvent in 
balancing the catalyst’s activity towards cycloaddition over polymerization. The phosphoramide 
catalyst 147 thus provided the right acidity for the ionization of 140 whereas phosphoric acid 149 
and m-nitrobenzoic acid were ineffective under the same reaction condition. 
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Figure 28. Screening of the aminal 140 
 
Encouraged by these results, chiral phosphoramide catalysts 150 and 151 were prepared, 
and the cycloaddition process was assessed (Table 9). The reaction conversion was dependent on 
solvent, and poor conversion was obtained at low temperature (─30 °C). To fix this low 
turnover, the reactivity of 140 could be modified or the reaction could be run for a longer period. 
However, as we were more interested to see the enantioselectivity afforded in the reaction, the 
resulting products were analyzed by chiral HPLC with Chiral OD-H column (the yields were not 
determined). After extensive experimentation with varying catalysts, reaction temperatures and 
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solvents, we were unable to get any enantioselectivity. Surprisingly, even phosphoramide 151, 
which had the large 9-anthryl group, was also ineffective in controlling the facial bias of the 
incipient diene. One possible reason could be that the N-tosyl dienes used in this study were too 
reactive, forming the product quickly once generated and not allowing enough time for forming 
the tight ion pair with the chiral counterion. Lowering the temperature might form the tight ion 
pair but the acidity of the phosphoramide was not sufficient for the ionization of 140 below −30 
°C, implying that a more reactive substrate or a stronger chiral Bronsted acid was required. A 
second alternative would be to attenuate the reactivity of the N-tosyl iminium ion by replacing 
the tosyl group with carbamate protecting group. The introduction of different protecting group 
would introduce different degree of complication to the system (e.g. the aminal ionization might 
be too slow). However, to evaluate their reactivity, substrates 152 and 153 were synthesized but 
were both found to be inactive with catalyst 150 (Figure 29). 
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Table 9. Evaluation of the selectivity using chiral catalysts 
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Figure 29. Screening with substrates 152 and 153 
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3.4 CONCLUSION 
A systematic assessment of an asymmetric and catalytic cycloaddition reaction has been 
performed.  An effective diene precursor has been synthesized from intermediate N-chloroaminal 
and successfully engaged in cycloaddition reactions with mild acids, thus providing a catalytic 
method for the preparation of piperidine derivatives. Unfortuntely, no chiral induction was found 
in the cyclization reaction with chiral Bronsted acid catalysts.  
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4.0  ENAMINE-AMINAL: A USEFUL SYNTHON FOR C-C BOND FORMING 
REACTION                                      
4.1 ENAMINE-AMINAL SYNTHON 
Enamine 60 and aminal (N,O-acetal) derivatives 61 are well known chemical literature and are 
found to be useful in numerous organic transformations (Figure 30). The N,O-acetals are often 
used to generate  iminium ions and subsequently, used as electrophiles for C-C bond formation 
reactions. Enamines (or enamides) on the other hand, are often used as nucleophiles in C-C bond 
formation reactions. An enamine and an aminal together may form a highly reactive enamine-
aminal intermediate, which combines the nucleophilic nature of enamine and the electrophilic 
nature of aminal. N,O-Aminals are widely used intermediates in organic synthesis and belong to 
the class of X,Y-acetals62
                                                 
60 For recent applications: (a) Bach, T.; Schroder, J. J. Org. Chem. 1999, 64, 1265-1273. (b) Kinderman, S. S.; van 
Maarseveen, J. H.; Schoemaker, H. E.; Hiemstra, H.; Rutjes, F. P. J. T. Org. Lett. 2001, 3, 2045-2048. 
 where XR1 and YR2 are attached to a sp3 carbon atom (X = Y = N, S, P, 
O) as shown in figure 31. X,Y-acetals can be a part of acyclic or cyclic structures, and depending 
on the nature of X, Y and the types of the substituent present, the acetals can be chemoselctively 
activated by Lewis or Bronsted acids. The resulting intermediate, which is an α-heteroatom 
substituted carbocation, is then trapped with various nucleophiles forming either linear or cyclic 
structures. The reactivity of an X,Y-acetal can be tuned properly by varying the substituents on 
61 Sakai, N.; Hirasawa, M.; Hamajima, T.; Konakahara, T. J. Org. Chem. 2003, 68, 483-488 and references therein. 
62 Sugiura, M.; Hagio, H.; Hirabayashi, R.; Kobayashi, S. J. Am. Chem. Soc. 2001, 123, 12510-12517. 
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either X or Y. As an example, for a given R, 154 is much more reactive towards ionization than 
155, so a milder acid is required. But the resulting iminium ion from 155 is much less reactive 
than iminium ion from 155. 
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Figure 30. Various terminologies in enamine-aminal chemistry 
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4.2 PROPOSED ENAMINE-AMINAL SYNTHESIS 
After identifying the potential of enamine-aminal derivatives 157 towards the formation of N-
alkenyl iminium ion and subsequently towards the formation of substituted piperidine skeleton, 
we focused our attention to the synthesis of enamine-aminal derivatives (Figure 32). The limited 
development of these intermediates is likely due to the difficulty associated with preparing the 
requisite precursors. However, applying traditional protocols for synthesizing the corresponding 
enamine-aminal derivatives would suffer from aminal incompatibility during acid-catalyzed 
condensation of α-alkoxy amine 158 with an aldehyde. Limited reactivity or poor regioselectivity 
causes the poor selectivity during attempted alkylation of enamine 159 because mostly C-
alkylation would occur instead of N-alkylation. Conversely, N-allyl aminals 160 are readily 
obtained by N-alkylation of the corresponding N-allyl or N-alkyl carbamates or sulfonamides 
(161 or 162 respectively). The N-alkyl carbamates or sulfonamides can easily be prepared from 
the condensation reaction of N-allylamine and the respective chloroformate or tosyl chloride. 
Thermodynamically-driven olefin isomerization will provide the enamine-aminal from the 
readily accessed N-allyl derivatives 160. We proceeded for the synthesis of N,O-aminal 160. The 
preparation of N,O- animals are well known in the chemical literature and are synthesized mainly 
from direct alkylation of amides 63, partial reduction of acylamides 64, addition of amides to 
aldehydes65, electrochemical oxidation of amines66 and Pd-catalyzed hydroamidation.67
                                                 
63 Aurrecoechea, J. M.; Sureo, R.; Torres, E. J. Org. Chem. 2006, 71, 8767-8778. 
  On the 
other hand, several traditional methods are known for the synthesis of enamines and enamides, 
64 Suh, Y.; Shin, D.; Jung, J.; Kim, S. Chem. Commun. 2002, 1064-1065. 
65 Kamatani, A.; Overman, L. E. Org. Lett. 2001, 3, 1229-1232. 
66 Shono, T.; Matsumura, Y.; Tsubata, K. J. Am. Chem. Soc. 1981, 103, 1172-1176. 
67 Kinderman, S. S.; Wekking, M. M. T.; van Maarseveen, J. H.; Schoemaker, H. E.; Hiemstra, H.; Rutjes, F. P. J. T. 
J. Org. Chem. 2005, 70, 5519-5527. 
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such as condensation of a secondary amine with a carbonyl compound followed by β-hydrogen 
elimination 68 , copper mediated hydroamination of alkenes 69 , and base 70
 
 or transition metal 
catalyzed isomerization of N-allylamine derivatives. The first two of these approaches for 
enamine or enamide synthesis have limited substrate scope and typically require elevated 
temperatures, rigorous exclusion of water, and the use of excess base. Base (like n-BuLi, tBuLi, 
LDA, tBuOK and NaH) catalyzed isomerization techniques often suffer from low conversions 
and provide inseparable E/Z mixture of isomers. Considering all of these facts, we decided to use 
the alkylation of amides method for N,O-aminal preparation and  transition metal catalyzed 
isomerization technique for their isomerization.  
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Figure 32. Proposed route for enamine-aminal synthon synthesis 
  
                                                 
68 (a) Lenz, G. R. Synthesis, 1978, 489-502. (b) Cook, G. R.; Barta, N. S.; Stille, J. R. J. Org. Chem. 1992, 57, 461-
467. 
69 Bolshan, Y.; Batey, R. A. Angew. Chem., Int. Ed. 2008, 120, 2139-2142. 
70 (a) Ribereau, P.; Delamare, M.; Celanire, S.; Queguiner, G. Tetrahedron Lett. 2001, 42, 3571-3573. (b) Beak, P.; 
Lee, B. J. Org. Chem. 1989, 54, 458-464. (c) Tischler, A. N.; Tischler, M. H. Tetrahedron Lett. 1978, 37, 3407-
3410. (d) Bortolussi, M.; Bloch, R.; Conia, J. M. Tetrahedron Lett. 1977, 26, 2289-2292. 
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4.3 ISOMERIZATION OF N-ALLYLAMINE DERIVATIVES: SYNTHESIS OF 
ENAMINE-AMINALS 
4.3.1 Metal Catalyzed Isomerization of Allylic Double Bond 
Metal catalyzed isomerization of an N-allyl derivative to the corresponding enamine is superior 
to the base catalyzed methods due to its mildness, catalytic usage and chemoselectivity (Figure 
33).  A wide variety of transition metals have been used, such as Ir, Ru, Rh, Ni, Fe, and Co etc. 
and among these Ir, Rh and Ru were found to be the most useful. The Nelson Group71 in 2003, 
described the isomerization of diallyl ether 163 with a cationic iridium-phosphine complex 
obtained from [Ir(COE)Cl]2 with excellent E/Z selectivity (eq 4.1) (Scheme 25). Neugnot72
  
 also 
reported that N-tosyl/amide allyl derivatives 164 could be isomerized by catalytic [Ir(COD)Cl]2 
to the respective enamides 165 with 97:3 E:Z selectivity (eq 4.2). It was believed that cationic 
Ir(I) was produced from [Ir(COD)Cl]2 at elevated temperature and performed the isomerization. 
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Figure 33. Metal catalyzed isomerization strategy for enamine synthesis  
                                                 
71 Nelson, S. G.; Bungard, C. J.; Wang, K. J. Am. Chem. Soc. 2003, 125, 13000-13001. 
72 Neugnot, B.; Cintrat, J.; Rousseau, B, Tetrahedron 2004, 60, 3575-3579. 
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Scheme 25. Iridium catalyzed isomerization of allylic double bond 
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Another transition metal, Rh, is also known for olefin and N-allyl derivatives 
isomerization (Scheme 26). Grigg 73  reported in 1983 that the Wilkinson’s catalyst, 
[RhCl(PPh3)3], efficiently produced 2-aza-1,3-diene 166 with 75% yield (3:1 E:Z) at  high 
temperature (140 °C) from respective N-allyl derivative 167 (eq 4.3). Noyori74 reported that 
“cationic Rh” or “Rh-H” species could be used for N-allyl olefin isomerization to produce 
predominantly the thermodynamically favored E-isomer. Recently, Yudin75
                                                 
73 Grigg, R.; Stevenson, P. J. Synth. Commun.. 1983, 1009-1010l. 
 in 2006, utilizing 
cationic Rh(I), reported a condition to achieve the kinetically favored Z-isomer. N-allylaziridine 
derivative 168 formed the corresponding Z-enamine (169) in 100% conversion with cationic 
Rh(I) at −78 °C (eq 4.4). The higher selectivity (95:5 Z:E) was rationalized by proposing an N-
coordinated intermediate 170.  
74 Noyori, R. Angew. Chem., Int. Ed. 2002, 41, 2008-2022. 
75 Alphonse, F.; Yudin, A. K. J. Am. Chem. Soc. 2006, 128, 11754-11755.   
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Scheme 26. Rhodium catalyzed isomerization of N-allylanime derivatives 
N
N
MeRhH(CO)(Ph3)3
Ph
N
Ph
N
Me
RhCl(PPh3)3
(4.3) (4.4)
N
Rh
Ln H
H
167 166 168
170
169
100%
95:5 Z:E75%3:1 E:Z
 
Ru metal also possesses similar characteristics and under suitable reaction conditions, 
efficiently performs allylic isomerization.76 It is believed that a “Ru-H species” is responsible for 
the olefin isomerization. Among the other Ru based catalysts, Grubbs II is well known and under 
normal circumstances, Grubbs II is popular for performing ring closing metathesis (RCM), cross 
metathesis (CM), and ring opening metathesis polymerization (ROMP) reactions. It is also 
believed that under certain conditions Grubbs II may perform olefin isomerization. Hanessian77 
reported that Grubbs II was used to isomerize the homoallylic derivative 171 in presence of 
methanol as solvent at 60 ˚C to produce 172 (75%, 4:1 E:Z) (eq 4.5, Scheme 27). Arisawa78
                                                 
76 Krompiec, S.; Pigulla, M.; Szczepankiewicz, W.; Bieg, T.; Kuznik, N.; Leszcynska-Sejda, K.; Kubicki, M.; 
borowiak, T. Tetrahedron Lett. 2001, 42, 7095-7098. 
 
observed that under vinyloxytrimethylsilane (173) condition, Grubbs II preferred isomerization 
over RCM. Terminal olefin 174 produced a single product 175 (3.5: E:Z) (eq 4.6) whereas 176 
produced 177 (86%)  and 178 (14%) (eq 4.7). Arisawa observed the formation of a new “Ru-
species” under vinyloxytrimethylsilane condition and suggested formation of a Fischer type 
carbene. The new catalyst (Scheme 28, eq 4.8) then in its catalytic cycle, generated a “Ru-H” 
77  Hanessian, S.; Giroux, S.; Larson, A. Org. Lett. 2006, 8, 5481-5484. 
78 (a) Arisawa, M.; Terada, Y.; Nakagawa, M.; Nishida, A. Angew. Chem., Int. Ed. 2002, 41, 4732-4734. (b) Terada, 
Y.; Arisawa, M.; Nishida, A. Angew. Chem., Int. Ed. 2004, 43, 4063-4067. 
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species, which was believed to be the active catalyst. Grubbs I79
 
 181 can easily be converted to 
the respective Fischer type carbene (182, eq 4.9) with ethyl vinyl ether, which upon heating 
decomposes by forming a “Ru-H” species. The corresponding Ru Fischer carbene is also found 
to be a good catalyst for performing RCM under certain conditions. With the possibilities of 
having various species in the catalytic cycle, it is still unknown which species is actually 
responsible for the isomerization. 
Scheme 27. Grubbs II mediated isomerization of N-allylanime derivatives 
O
O Me
O
Me
N
Ts
OTMS
N NTs
Me
MeMe
Ts +
(4.6)
(4.7)
O
O Me
O 5 mol%
Grubbs II
OTMS
174
173
175
176 177 178
N
H
Cbz
CO2Me
N
H
Cbz
CO2Me
Me (4.5)
10 mol% 
Grubbs II
60 °C, MeOH
171 17276%
4:1 E:Z
100%
3.5:1 E:Z
5 mol%
Grubbs II
86% 14%
40 °C, CH2Cl2
 
                                                 
79 Louie, J.; Grubbs, R. H. Organometallics  2000, 21, 2153-2164. 
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Scheme 28. Formation of Fischer carbene with vinyl ether 
179 180
181
Ru
PCy3
Cl
Cl
OTMS
NNMes Mes
Ru
PCy3
Cl
Cl
Ph
NNMes Mes
Grubbs II OTMS
RuCl
Cl
PCy3
PCy3 Ph
OEt Ru
Cl
Cl
PCy3
PCy3 OEt
Grubbs I
(4.8)
(4.9)
Fischer carbeneSchrock carbene
182  
4.3.2 Cationic Ir-metal Catalyzed Isomerization: Reaction Development, Results and 
Discussions 
Recognizing the usefulness of the cationic Ir(I)-phosphine complex generated from Ir(COE)Cl]2/ 
PCy3/ NaBPh4 in the ICR reaction developed in our group, we started to explore the feasibility of 
using this complex in the isomerization of N-allylamine derivatives. Upon subjecting amine 183 
to 0.5 mol % [Ir(COE)Cl]2, PCy3 (3 equiv) and NaBPh4 (2 equiv)] at ambient temperature, partial 
conversion to the respective isomerized enamine-aminal 55 was obtained (Table 10). Upon 
increasing the reaction temperature to 40 °C, complete conversion with exclusive formation of 
the E-isomer was obtained. The enamine-aminal product was found to be stable under the given 
reaction conditions showing that the cationic Ir(I) present in the system was not Lewis acidic 
enough for the ionization of the aminal. The enamine-aminal was found to be stable to silica gel 
and was isolated in 95% yield. Only the E isomer was isolated, and this excellent selectivity can 
be accounted due to the thermodynamically biased C-H insertion by the catalyst. On the success 
of the above reaction, efforts were made to elaborate the substrate scope with different protecting 
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groups and leaving groups in the substrate. When a carbamate protected N-allylamine derivative 
184 was subjected to similar isomerization conditions (45 °C), no conversion to the product was 
obtained (Figure 34). Increasing the temperature to 80 through 110 °C led to partial conversions, 
but higher temperatures compromised the isomer selectivity providing 1:1 mixture of E:Z 
isomers. The lack of reactivity of the carbamate substrate toward isomerization at 45 °C could be 
rationalized by considering binding of the Lewis acid to the carbonyl oxygen in the protecting 
group which would diminish the catalyst’s ability toward activating the allylic C-H bond. This 
would explain why a high temperature was needed, and a poor selectivity was observed in 
comparison to the tosyl system.   
 
Table 10. Isomerization of N-tosylaminal by cationic iridium catalyst 
N
Ts
OMe
N
Ts
Me
OMe
0.5 mol% Ir2Cl2(COE)2
E isomer
isolable
PCy3 (3 equiv),
 NaBPh4 (2 equiv)
183 55
temp (°C)solvent time
1 mol% Ir+
1 mol% Ir+
50:1 
CH2Cl2/acetone
50:1 
CH2Cl2/acetone
25
40 30 min
2 h
conversion (%)
100
59
yield (100%)
-
95
catalyst
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0.5 mol% Ir2Cl2(COE)2
PCy3 (3 equiv),
 NaBPh4 (2 equiv)
N
OMe
N
Me
OMe
at 110 °C
184 59
MeO
O
MeO
O
X
45 °C
50% conversion
mixture of E:Z  
Figure 34. Isomerization of carbamate substrate 184 
 
To understand the interaction between the catalyst and carbamate protected substrate, a 
few control reactions were performed. Allylamine derivatives 185 and 186 were considered 
neither of which possessed any aminal moiety. Upon subjecting 185 to the isomerization reaction 
conditions with Ir(COE)Cl]2/ PCy3/ NaBPh4 at 40 °C, the isomerized product 80 was isolated in 
91% yield (E isomer only). Substrate 186 was subjected to Ir(COE)Cl]2/ PCy3/ NaBPh4 at 80 °C 
affording 187 in 92% yield and as a 4:1 E:Z mixture of isomer (Table 11). These results 
confirmed that the Moc group in substrate 184 was definitely involved in the catalytic cycle and 
interfering with the iridium species. Both Moc and OMe groups on the substrate made the 
carbamate protected enamine-aminal to behave as a chelating ligand. Though there was no direct 
evidence, it was speculated that the cationic Ir(I) formed a stable six-membered ring 188 with the 
carbonyl oxygen atom of the carbamate and OMe before allylic C-H bond insertion occurrred 
thus, losing its catalytic activity (Figure 35).  
  
 88 
Table 11. Isomerization of N-allyl anime substrates 
N
Z R
Me
1 mol% Ir2Cl2(COE)2
PCy3 (3 equiv), 
NaBPh4 2 equiv)
solvent
N
RZ
temp (°C) time
Ts (185)
Moc (186)
40
80 2 h
30 min
conversiona (%)
100
100
Z R
Me
H
yield (%)
a E/Z ratio was measured by comparing the proton signal of alkene CH3.
91 (80)
92 (187)
solvent
CH2Cl2
ClCH2CH2Cl
E only
4:1 E:Z
 
 
N
OMe
O
O
Me
[Ir]
N
OMe
O
O
Me
[Ir]
H 188  
Figure 35. Rationale for catalyst poisoning 
 
4.3.3 Grubbs II Catalyst: Ru-metal Catalyzed Isomerization 
The 2nd generation Grubbs II catalyst is well known for performing cross metathesis (CM), ring 
closing metathesis (RCM), and ring opening polymerization (ROMP) reactions, but recent 
literature77 reports suggest that the same catalyst can also perform isomerization of the terminal 
olefins under suitable conditions. Following Arisawa’s protocol, we observed that Grubbs II, 
with reactive vinyloxytrimethylsilane, efficiently produced isomerized products with good 
selectivities from carbamate protected allylamine derivatives. In most cases, upon subjecting 5 
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mol % Grubb II catalyst to an equimolar solution of the respective N-allylamine derivative and 
vinyloxytrimethylsilane at 45 -50 °C, a complete conversion to product was observed within 1-2 
hours. The methyl carbamate 184 was investigated first, and Grubbs II was found to produce the 
isomerized enamine-aminal 59 in 91% yield as a 10:1 mixture of E:Z isomers separable on 
column (Scheme 29). 
 
Scheme 29. Grubbs II mediated isomerization of carbamate substrate 184 
N
OMe
N
Me
OMe
5 mol% Grubb's II
CH2Cl2, 50 °C, 1hOTMS
91%
 10:1 E:Z mixture
separable on column
(1.0 equiv.)
+
184 59
MeO
O
MeO
O
 
 
N-Allylamine 189 with a nitrile leaving group, was subjected next, and after 
isomerization the desired product 190 was obtained in 83% yield and 8:1 E:Z mixture of isomer 
(Table 12). Column purification afforded the pure E isomer. Substrate 189 which was tough to 
isomerize under cationic Ir(I) condition, now could easily be isomerized with the Grubbs II 
condition. This successful application led us to utilize this protocol for the isomerization of 
different challenging substrates in good yields and selectivities (shown in table 12). The 
respective carbamate and amide protected enamine-aminal products were found to be stable and 
the E/Z mixture could be separated through column chromatography.  
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Table 12. Grubbs II mediated isomerization of N,O-aminals 
83, (190)
product
yielda(%)
protecting 
group (Z)
leaving 
group (LG)
Boc
Bz OMe 88, (126)
Cbz OMe
Moc OAc 80, (62)
90, (60)
aisolated yields of E-isomer, after column chromatography
N
Z
LG
N
Z
Me
LG
5 mol% Grubb's II
CH2Cl2, 50 °C, 2 hOTMS
(1.0 equiv.)
+
Ts
Boc
HCO
m-NO2PhCO2
"
"
Ts
Bz
Th "
"
"
92, (131)
85, (127)
87, (141)
80, (140)
94, (152)
56, (153)
CN
Ts p-NO2PhCO2 83, (139)
substrate
189
191
192
193
194
195
196
197
198
199
200
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4.3.4 Isomerization of C1-Substituted Enamine-aminal 
An effective synthetic protocol was required for the generation of C1-substituted enamine-
aminal 201 as it allowed the use of mild Lewis acidic conditions for its ionization due to 
formation of secondary carbocation intermediate. The resulting C1-substituted iminium ion 202 
would introduce a substitution in the piperidine structures 203 uopn cycloaddition and hence, 
introduce diversity in the synthesized N-heterocyclic scaffolds (Figure 36). With a limited 
choices of substrates, tosyl protected α-alkyl N,OMe-aminal 204 was subjected to the standard 
cationic Ir-catalyzed isomerization condition [Ir(COE)Cl]2/ PCy3/ NaBPh4 at 40 °C] first, but the 
catalyst system was found to be ineffective at isomerizing the double bond. When the Grubbs II 
conditions (10 mol% Grubbs II, 100 mol% vinyloxytrimethylsilane at 50 °C) was used, the 
desired product 83 was isolated with high yield and high E/Z selectivity (Table 13). In summary, 
Grubbs II derived Ru-H catalyst successfully catalyzed the isomerization reaction to the product 
which was intriguing, whereas, the iridium condition was totally ineffective. The reason behind 
this fact was not exactly clear. 
 
Me
N
Ts
R1
Me
N
Ts
R1
Me
N
Ts
R4Nu
R1
R3
C1-substituted
enamine-aminal
secondary 
carbocation
new substitution
Me
N
Ts
R1
OMe
201 202 203  
Figure 36. C1-Substituted enamie-aminal: Access to fully substituted piperidine scaffold 
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Table 13. Isomerization of C1-substituted enamie-aminal substrates 
N
Ts
OMe
R1
condition
Me
N
Ts
OMe
R1
R1 condition
Grubb's II, 50 °CEt
Ph
cationic Ir, 40 °CEt
cationic Ir, 80 °C
conversion(%) yielda(%)
-
-
0
0
100
100
94, (83)
91, (206)"
204
205
substrate
a isolated yield, only E isomer was observed  
4.4 SYNTHESIS OF N-ALLYL N,O ACETALS/ AMINALS 
4.4.1 Aminal Leaving Group: OMe  
N-Allyl N,O-aminals were synthesized by following a two step protocol starting with allylamine 
(Table 14). The protecting groups were installed first and then the leaving groups. A series of N-
protected allylamines series-A with different protecting groups were synthesized following 
common protocols with good yields. Then base mediated N-alkylations were performed with 
commercially available MOMCl. After exploring a few different bases and solvents, NaH 
mediated alkylation condition in DMF was found to be the best in terms of reactivity and isolated 
yields. N-alkylation with choloromethoxymethyl ether (MOMCl) produced compounds series-B 
with good yields, and they were found to be quite stable under silica gel purification. 
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Table 14. N-Allyl-N,OMe-aminal substrates synthesis 
a methyloxycarbonyl. b isolated yield
NH2
 Mono Protection N
Z
OMeNH
Z
NaH
DMF
MOMClCH2Cl2
0 °C − rt
B
Ts
Cbz
Moca
Bz
Z A yield(%) B yieldb(%)
A
a
d
c
b
#
90, (183)
72, (184)
87, (191)
69, (192)
96
93
97
95
 
4.4.2 Aminal Leaving Group: CN and OAc  
The nitrile group was incorporated as the leaving group via N-alkylation with commercially 
available chloroacetonitrile. Boc and Ts protected allylamines were subjected to alkylation, and 
the respective alkylated products 189 and 207 were isolated in moderate to good yields and both 
of the products were also found to be quite stable to silica gel purification (Table 15). 
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Table 15. Synthesis of N-allyl-N,CN-aminal substrates 
 a isolated yield
N
Ts
CNNH
Ts
NaH
DMF
Cl CN
yielda(%)Z
Ts
Boc
80, (207)
37, (189)
NH2
Cl CN HN CN (Boc)2O N CN
Boc
Et3NEt3N
method :1
method: 2
Method
1
2
 
 
N-Allylaminal with a better leaving group, such as OAc, was always desired. Making 
more labile aminal meant their stability during handling and silica gel purification could be an 
issue. However, heating a solution of acetic acid, acetic anhydride, paraformaldehyde, and 
protected N-allylamine produced the respective aminals series-C with moderate yields and the 
aminals were not susceptible to silica gel or to moisture (Table 16). The stability of the N-
allylamine derivatives highly depended on the electron withdrawing capability of the protecting 
group. Electron withdrawing groups like tosyl, amide and even carbamates made the nitrogen 
lone pair less available for aminal hydrolysis, and the respective N-allylamine derivatives 
became stable towards moisture and could easily be purified, isolated, and stored for long times. 
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Table 16. Acetate containing N-allyl-N,O-aminal substrates synthesis 
NH
Z CH3COOH
Ac2O
70 °C
N
Z
OAc
Z yieldb(%)
Ts
Tha
Moc
Bz
52, (194)
48, (195)
a thienylsulfone. b isolated yield
a
b
c
d
#
88, (196)
51, (193)
i) TMSCl, paraformaldehyde
ii) CH3COOH, Et3N
method 1:
method 2:
Method
1
2
1
1
C
 
 
4.4.3 Common Routes to Generate N,O-Aminals 
The most important remaining question at this point regarded the finding of common routes for 
the preparations of N,O-aminals. It was understood that more labile leaving groups could be 
incorporated as long as they were stabilized by the suitably chosen protecting groups. Labile 
leaving groups could introduce an intrinsic problem in their isomerization, they would definitely 
be beneficial in the cycloaddition process. It was known that the N-tosyl-α-chloroaminals (208) 
can be prepared from N-tosylallylamine upon treating with paraformaldehyde and 
chlorotrimethylsilane in quantitative yields.80
                                                 
80 Iley, J.; Barroso, H.; Moreira, R.; Lopes, F.; Calheiros, T. Bioorg. Med. Chem. 2000, 8, 1629-1636.   
 The resulting reactive intermediate 208 was treated 
with carboxylate salts under basic conditions and allowed us to synthesize the OAc-series, the 
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m/p-NO2PhCO2- series, and, with MeOH/Et3N condition, the OMe-series of N,O-aminals 
(Scheme 30). Among all of these substrates, m-nitrobenzoateaminals appeared to be appealing 
targets for cycloaddition due to their stability while still providing the most labile leaving group, 
which could be useful for iminium ion generation in the presence of various mild acids. 
Following the reaction protocol as described in the scheme 30, nitrobenzoate containing N,O-
aminals (197-198) were synthesized (Table 17). 
 
Scheme 30. Common routes for N,O-aminal substrates synthesis 
N
Z
OMe
N
Z
Cl
Et3N
MeOH
CO2H
NO2
Et3N Et3N
CH3COOH
N
Z
OArN
Z
OAc
Ar = m-NO2PhCOO−
           p-NO2PhCOO−
Z = Ts, Th, Bz, Cbz, HCO
Z = Ts (208)
 
Table 17. Synthesis of nitrobenzoate containing N,O-aminals  
yielda(%)
leaving 
group
protecting 
group
Ts
Ts
Boc
p-NO2PhCO2
"
m-NO2PhCO2
85, (197)
82, (198)
77, (199)
a isolated yield  
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4.4.4 C1-Substituted Aminal Synthesis 
Fully substituted piperidine derivatives could be obtained by using C1-substituted N-allylaminal 
substrates 209 as these substrates would introduce a new substitution in the final structure 
(Figure 37). Therefore, their convenient and scalable synthesis became an objective of this 
project. The preparation of C1-substituted N-allyl-N,O-aminal substrates was not straight 
forward and not known due to their instability (under work up condition). The direct N-
alkylation as before was found to be problematic because substituted N-alkylating reagents are 
not known, and their in situ preparations were substrate dependant. Some examples were known, 
however, where a cyclic amide was reduced to the corresponding alcohol and was immediately 
used for the next reaction. The same idea was followed towards the synthesis of C1-substituted 
N-allyl-N,O-aminal, and 210 was prepared following literature methods.81
N
Ts
OMe
R1
Me
N
Ts
R4Nu
R1
R3
C1-substituted
N-ally- N,O-aminal
fully substituted
piperidine
introduction of 
new substitution
209
 After reduction, the 
isolation of the final alcohol 211 was unsuccessful, and the starting material was isolated instead 
(Scheme 31). 
 
Figure 37. C1-Substituted N-allylaminal substrates towards fully substituted piperidines 
                                                 
81 Gheorghe, A.; Quiclet-Sire, B.; Vila, X.; Zard, S. Z. Tetrahedron 2007, 63, 7187-7212.   
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Scheme 31. Reduction of N-tosyl-allylamides 210 
NH
Ts
NH
Ts CH3COCl
NaH N
Ts
Me
O
DIBAL N
Ts
Me
OH
(unstable)
(isolated)
N
Ts
Me
O
H
NH
Ts
Me
O
+
210 211
 
 
The search for practical routes for the synthesis of C1-substituted N-allyl-N,O-aminal 
substrates were continued, and several different conditions were tried by keeping the Ts as 
protecting group and allyl as side chain. The use of substituted methoxychlorides could be a 
solution to this existing problem as their preparations were known82
 
 from late sixties. The same 
preparation protocol was followed for their synthesis in our studies. Starting from any 
commercially available alcohols and by treating with HCl gas in methanol/pentane mixtures, the 
corresponding substituted methoxychlorides were prepared successfully. Subsequently, they 
were used next for the N-alkylation of N-tosyl-allylamine with NaH and DMF. The end product 
was found to be stable during their work up, and column chromatography purification led the 
pure product in good yields (Scheme 32).   
                                                 
82 Warner, H. R.; Lands, W. E. M. J. Am. Chem. Soc.1963, 85, 60–64. 
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Scheme 32. Successful route to C1-substituted N-allyl-N,O-aminal substrates 
RCHO
HCl(g)
MeOH
MeO Cl
R
N
Ts
OMe
H
N
Ts
0 °C
DMF
NaH
R
R
Et
Ph
yield(%)
64, (204)
72, (205)
pentane
0 °C - rt
substituted 
methoxychloride
 
4.5 CONCLUSION 
The isomerization strategy has successfully, been applied to synthesize a wide variety of 
enamine-aminal derivatives. Various protecting and leaving groups have been incorporated to 
enamine-aminal structure, and a set of more reactive substrates has been identified. In general, it 
was concluded that Grubb II mediated isomerization protocol was found to more versatile and 
applicable to all sterically demanding and carbonyl containing substrates. A general method of 
synthesizing N-allyl amine derivatives has been developed, where different protecting and 
leaving groups can be incorporated following one reaction protocol.  
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5.0  EXPERIMENTAL 
General Information: Unless otherwise stated, all reactions were performed in dry glassware 
under an atmosphere of oxygen-free nitrogen using standard inert atmosphere techniques for the 
manipulation of solvents and reagents. Proton NMR chemical shifts are reported relative to 
residual CHCl3 (7.26 ppm) for 1H and CDCl3 (77.00 ppm) for 13C NMR spectra. Anhydrous 
solvents were obtained by passing through successive alumina and Q5 reactant-packed columns 
on a solvent purification system. [(cC8H14)2IrCl]2 was synthesized according to the literature 
procedure 83  and stored and weighed out in nitrogen-filled glove box.  N-Allyl-4- 
methylbenzenesulfonamide, 84  N-tosylindole, 85  N-methylindole, and 1-chloro-1-
methoxypropane86 and (1-methoxy-2-methylprop-1-enyloxy)trimethylsilane87 were prepared as 
described. N,N-Diisopropylethylamine and triethylamine were distilled under nitrogen from 
CaH2. Acetone was purged with nitrogen prior to use. Other commercially available reagents 
were used as received from the suppliers. Flash chromatography was performed as previously 
described on Iatrobeads or 6RS-8060 (pH 7 silica gel), purchased from Sorbent-USA, or EM 
silica gel 60 (230-240 mesh).88
                                                 
83 Onderdelinden, A. L.; van der Ent, A. Inorg. Chim. Acta 1972, 6, 420. 
 
84 Brummond, K. M.; Chen, H.; Mitasev, B.; Casarez, A. D. Org. Lett. 2004, 6, 2161-2163. 
85 (a) Merlic, C. A.; You, Y.; McInnes, D. M.; Zechman, A. L.; Miller, M. M.; Deng, Q. Tetrahedron 2001,  57,  
5199-5212. (b) Kikugawa, Y. Synthesis 1981, 460-461. 
86 Warner, H. R.; Lands, W. E. M. J. Am Chem. Soc. 1963, 85, 60-64. 
87 Dong, S.; Parker, G. D.; Tei, T.; Paquette, L. A. Org. Lett. 2006, 8, 2429-2431. 
88 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
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N
Me
D
Ts R2D R2
Me
N
Ts
OMe
TiCl4,
−78 °C
R1 R1
N
Me
D
Ts R2
R1
Nu:
 
General Procedure A. TiCl4-mediated Cycloadditions of Electron-rich Dienophiles: To a 
−78 °C solution of TiCl4 (1.1 equiv) in 20 mL of CH2Cl2 was added a solution of the dienophile 
(1-10 equiv) in 2-3 mL of CH2Cl2 dropwise over 3-4 min. A solution enamine-aminal (1.0 mmol, 
1 eq.) in CH2Cl2 (10 mL) was then added over 3-4 min. Once addition was complete, the reaction 
mixture was stirred for additional 6-8 h. A solution of the nucleophile (or Et3N, 5 equiv) in 
CH2Cl2 (5 mL) was added dropwise and the reaction was stirred for an additional 60 min. A 
saturated aqueous solution of NaHCO3 (10 mL) was added and the resulting solidified mass was 
warmed to ambient temperature (or in case of Et3N quench, after 30 min of the addition of Et3N 
the reaction mixture was warmed to ambient temperature and then saturated NaHCO3 was 
added). The resulting mixture was stirred vigorously for 20 min and the homogeneous layers 
were separated. The aqueous portion was extracted with ether (10 mL) and the combined organic 
portions were washed with brine, dried (MgSO4), and concentrated. The crude product mixture 
was purified by column chromatography on silica gel (10-25% ether in hexanes). 
 
N
Me
Ts
TMS  
2-Allyl-3-methyl-1-tosyl-4-[(trimethylsilyl)methyl]piperidine (58): General Procedure A was 
followed employing enamine 55 (1.00 mmol, 255 mg) and allyltrimethylsilane (5.00 mmol, 572 
mg) and a reaction time of 12 h. Purification by flash chromatography afforded 336 mg (89%, 
colorless oil) of the title compound as an inseparable 2:1 mixture of diastereomers (C2 epimers) 
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as determined by 1H NMR analysis of the crude product mixture. IR (thin film): 2951, 1640, 
1598, 1460, 1337, 1248, 1156, 1089, 985, 856 cm-1; 1H NMR (600 MHz, CDCl3, both 
diastereomers): δ 7.70 (d, J = 9.6 Hz, 1.3H) & 7.69 (d, J = 8.4 Hz, 0.7H), 7.28 -7.25 (m, 2H), 
5.71-5.62 (m, 1H), 5.10-4.91 (m, 2H), 4.00 (ddd, J = 15.0, 10.2, 4.8 Hz, 0.33H), 3.87 (dd, J = 
10.2, 5.4 Hz, 0.66H), 3.70 (dd, J = 15.0, 3.6 Hz, 0.33H), 3.65 (dd, J = 12.6, 6.0 Hz, 0.66H), 2.94 
(ddd, J = 27.6, 14.4, 2.4 Hz, 0.33H), 2.89 (ddd, J = 26.4, 13.2, 3.6 Hz, 0.66H), 2.41 (s, 2H) & 
2.40 (s, 1H), 2.42-2.36 (m, 0.66H), 2.27-2.08 (m, 1.33H), 1.88 (dddd, J = 17.4, 13.8, 10.2, 6.0 
Hz, 0.66H), 1.73-1.66 (m, 0.66H), 1.52 (dq, J = 13.2, 3.0 Hz, 0.33H), 1.46-1.34 (m, 1.33H), 1.28 
(dq, J = 13.2, 2.4 Hz, 0.33H), 0.99 (ddd, J = 25.2, 13.2, 4.8 Hz, 0.66H), 0.85 (d, J = 6.6 Hz, 2H) 
& 0.84 (d, J = 6.6, 1H), 0.42 (dq, J = 14.4, 6.6 Hz, 1.33H), 0.08 (dd, J = 10.2, 15.0 Hz, 0.66H), 
−0.02 (s, 6H) & −0.05 (s, 6H); 13C NMR (75 MHz, DMSO-d6 at 70 °C, major diastereomer in 
bold where resolved): δ 142.1, 138.6 + 138.1 (1C), 135.6 + 134.8 (1C), 129.1, 126.3 + 126.2 
(1C), 116.4 + 115.5 (1C), 58.7 + 57.4 (1C), 40.4 + 39.8 (1C), 33.9 + 32.0 (1C), 33.0 + 32.9 (1C), 
28.7 + 28.2 (1C), 27.8, 20.8 + 20.2 (1C), 20.4, 15.6 + 11.6 (1C), – 0.90 + −1.27 (3C); MS (EI, 70 
V): m/z 364 [(M−CH3)] •+, 338, 224, 155, 139, 110; HRMS m/z calcd. For C19H30NO2SiS 
[(M−CH3)+]: 364.1766; found: 364.1758. 
 
N
Me
N
MeTs
Ts
 
N-(2S,3S,4R,5S)-2-Allyl-3,5-dimethyl-1-tosylpiperidin-4-yl)-N-(but-3-enyl)-p-toluenesulfon-
amide (71): General Procedure A was followed employing enamine 55 (1.00 mmol, 225 mg) 
and, after an initial reaction time of 5 h, allyltrimethylsilane (5.00 mmol, 572 mg) as the 
nucleophile. Purification by flash chromatography afforded 225 mg (85%, colorless solid) of the 
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title compound as an inseparable 4:1 mixture of diastereomers (C2 epimers) as determined by 1H 
NMR analysis of the crude product mixture. Mp: 122-124 °C; IR (NaCl): 2928, 1641, 1598, 
1460, 1338, 1156, 1089, 996, 918 cm-1; 1H NMR (300 MHz, CDCl3, both diastereomers): δ 7.72-
7.63 (m, 4H), 7.32-7.22 (m, 4H), 5.79-5.46 (m, 2H), 5.14-4.92 (m, 4H), 4.14-4.07 (m, 0.2H) & 
3.87-3.54 (m, 2.8H), 3.18 (ddd, J = 14.7, 11.1, 5.4 Hz, 1H), 2.99 (ddd, J = 15.9, 11.4, 4.8 Hz, 
1H), 2.92-2.46 (m, 2H), 2.40 (s, 6H), 2.39-2.22 (m, 2H), 2.19-1.68 (m, 3H), 1.03 (d, J = 6.9 Hz, 
2.4H) & 0.69 (d, J = 6.6 Hz, 0.6H), 0.65 (d, 7.2 Hz, 0.6H) & 0.56 (d, J = 6.3 Hz, 2.4H); 13C 
NMR (75 MHz, CDCl3, major diastereomer in bold where resolved): δ 143.3, 143.2, 138.4 + 
137.9 (1C), 137.8 + 137.7 (1C), 134.8 + 134.6 (1C), 134.5 + 134.1 (1C), 129.6, 129.5 + 129.4 
(1C), 127.4 + 127.2 (1C), 127.1 + 127.0 (1C), 118.2, 117.0 + 116.9 (1C), 62.4 + 60.8 (1C), 60.2 
+ 58.2 (1C), 47.3 + 46.5 (1C), 45.1 + 42.1 (1C), 37.2 + 36.1 (1C), 35.5 + 34.8 (1C), 34.4 + 33.7 
(1C), 29.5 + 28.6 (1C), 21.5 (2C), 16.1 + 15.9 (1C), 15.8 + 14.9 (1C); MS (EI, 70 V): m/z 310, 
264, 250, 184, 155, 97, 91; HRMS (Q-TOF) m/z calcd. for C28H38N2O4S2Na [(M+Na)+]: 
553.2170; found: 553.1993. 
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N-(3S,5S)-3,5-Dimethyl-1-tosylpiperidin-4-yl)-N-(methyl)-4-dimethylbenzenesulfonamide 
(75): General Procedure A was followed employing enamine 55 (1 mmol, 255 mg), TiCl4 (1.1 
mmol, 1.1 mL), stirred for 12 hours and DIBAL-H (2.5 mmol, 5.0 mL, 0.5 M solution in 
CH2Cl2) was added and stirred for another 2 hours. Purification by flash chromatography with 
20% ether in hexane afforded 140 mg (62%) of the title compound as a foamy white solid as a 
single diastereomer. Mp: 72-75 °C; IR (thin film): 2924, 2853, 1661, 1465, 1340, 1162, 1089, 
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968 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.62 (d, J = 8.7 Hz, 2H), 7.59 (d, J = 8.4 Hz, 2H), 7.32 
(d, J = 9.0 Hz, 2H), 7.25 (d, J = 8.1 Hz, 2H), 3.74 (ddd, J = 11.4, 4.5, 2.7 Hz, 1H), 3.51 (dt, J = 
11.7, 2.4 Hz, 1H), 3.36 (dd, J = 11.7, 4.8 Hz, 1H), 2.80 (s, 3H), 2.44 (s, 3H), 2.40 (dd, J = 12.0, 
3.0 Hz, 1H), 2.39 (s, 3H), 2.26-2.08 (m, 1H), 2.08 (dq, J = 17.7, 4.8 Hz, 1H), 1.81 (t, J = 11.1 Hz, 
1H), 1.10 (d, J = 6.9 Hz, 3H), 0.43 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 143.6, 
143.2, 136.8, 133.0, 129.7, 129.5, 127.5, 126.9, 62.9, 53.1, 52.9, 35.6, 30.8, 28.3, 21.5, 21.4, 
16.0, 13.4; MS (EI, 70 V): m/z 309, 295, 267, 238, 224, 184, 155, 120, 91, 70; HRMS (Q-TOF) 
m/z calcd. for C22H30N2O4S2Na [(M+Na)+]: 473.1545; found: 473.1536. 
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R*-(4aS,9bS)-2,4a,5,9b-Tetrahydro-4-methyl-2,5-bis(p-toluenesulfonyl)-1H-pyrido[4,3-b] 
índole (82a): General Procedure A was followed employing enamine 55 (1 mmol, 255 mg), N-
tosylindole (2.00 mmol, 542 mg) as the dienophile and an initial reaction time of 12 h. 
Triethylamine (5.00 mmol, 506 mg) was used as the base. Purification by flash chromatography 
with 35% ether in hexane afforded 390 mg (79%) of the title compound as a colorless crystalline 
solid as a single diastereomer. Mp: 182-184 °C; IR (thin film): 3066, 2920, 1670, 1597, 1459, 
1350, 1244, 1089, 962, 814 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.61 (d, J = 8.1 Hz, 1H), 7.53 
(d, J = 8.1 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 7.26-7.20 (m, 3H), 7.09 (d, J = 8.1 Hz, 2H), 6.99 (t, 
J = 7.5, 1H), 6.86 (d, J = 7.5 Hz, 1H), 6.45 (s, br, 1H), 4.57 (d, J = 7.8 Hz, 1H), 4.02 (d, J = 11.4 
Hz, 1H), 2.95 (dd, J = 12.3, 3.0 Hz, 1H), 2.89-2.86 (m, 1H), 2.42 (s, 3H), 2.33 (s, 3H), 1.84 (s, 
3H); 13C NMR (75 MHz, CDCl3): δ 144.0, 143.9, 141.6, 135.3, 134.6, 133.6, 129.8, 129.6, 
128.3, 127.1, 127.0, 125.9, 123.8, 123.3, 120.2, 113.4, 62.1, 41.7, 39.9, 21.5 (2C), 17.6; MS (EI, 
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70 V): m/z 495 [(M+H)+], 475, 443, 430, 365, 339, 212, 185; HRMS (Q-TOF) m/z calcd. for 
C26H26N2O4S2Na [(M+Na)+]: 517.1232; found: 517.1248. 
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(3aS,7aS)-7-Methyl-1,5-ditosyl-2,3,3a,4,5,7a-hexahydro-1H-pyrrolo[3,2-c]pyridine (82b): 
General Procedure A was followed employing enamine 55 (0.250 mmol, 63.7 mg), TiCl4 (0.27 
mmol, 0.27 mL), 1-tosyl-2,3-dihydro-1H-pyrrole (0.500 mmol, 111 mg) as the dienophile and an 
initial reaction time of 12 h. Et3N (1.25 mmol, 0.175 mL) was added and stirred for an additional 
2 h. Purification by flash chromatography with 25% ether in hexane afforded 85 mg (76%) of the 
title compound. IR (thin film): 2923,1718, 1667, 1597, 1453, 1344, 1160, 1025, 815 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.67 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 8.4 Hz, 2H), 7.29 (t, J = 7.5 Hz, 
4H), 6.42 (d, J = 1.2 Hz, 1H), 4.12 (d, J = 6.6 Hz, 1H), 3.56 (d, J = 12 Hz, 1H), 3.39-3.21 (m, 
2H), 2.83 (dd, J = 12, 2.4 Hz, 1H), 2.42 (s, 3H), 2.41 (s, 3H), 1.87-1.72 (m, 2H), 1.76 (s, 3H), 
1.70-1.62 (m,1H); 13C NMR (75 MHz, CDCl3): δ 144, 143.6, 135.1, 134.4, 129.8, 129.7, 127.4, 
127, 121.4, 114.6, 58.5, 46.7, 43.5, 36.1, 26.4, 21.6, 21.5, 17.8; MS (EI, 70 V): m/z 446 (M+•), 
368, 291, 264, 248, 224, 155, 135, 108; HRMS m/z calcd. for C22H26N2O4S2: 446.1352; found: 
446.1331. 
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(4aR,9bS)-4-Methyl-2,5-bis(tosyl)-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (82c): 
General Procedure A was followed employing enamine 55 (1 mmol, 255 mg), N-tosylindole (2 
mmol, 542 mg) as the dienophile and an initial reaction time of 9 h. DIBAL-H (5 mmol) was 
added and stirred for another hour. Purification by flash chromatography (20% 
ethylacetate/hexane) afforded 352 mg (71%) of the title compound (colorless crystalline solid) as 
a 1:1 mixture of two diastereomers. Crystallization and re-column purification provided 
analytically pure sample of one diastereomer.  Mp: 97-99 °C; IR (thin film): 3391, 2926, 1597, 
1459, 1347, 1164, 1089, 1018, 814, 734 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.61 (d, J = 8.1 Hz, 
1H), 7.51 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.4 Hz, 2H), 7.10 (d, J = 8.1 
Hz, 2H), 6.98 (t, J = 7.5, 1H), 6.89 (d, J = 7.5 Hz, 1H), 4.33 (dd, J = 9.3, 6 Hz, 1H), 3.86 (dd, J = 
12.6, 3 Hz, 1H), 3.09 (dt, J = 12, 3.9 Hz, 2H),  2.97 (dd, J = 12, 3.6 Hz, 1H), 2.86 (dd, J = 12, 8.7 
Hz, 2H), 2.42 (s, 3H), 2.32 (s, 3H), 2.29-2.15 (m, 1H), 1.01 (d, J = 6.9 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 144.0, 143.3, 142.7, 134.9, 134.8, 134.0, 129.6, 129.5, 128.4, 127.2, 127.0, 
125.5, 123.3, 118.1, 62.6, 46.7, 41.9, 40.3, 32.4, 21.5, 14.8; MS (EI, 70 V): m/z 496 (M+•), 341, 
295, 224, 184, 158, 144, 130, 117, 91; HRMS m/z calcd. for C26H28N2O4S2 :496.1490; found: 
496.1478. 
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Methyl 3-(N,4-dimethylphenylsulfonamido)-4-(4-(N,4-dimethylphenylsulfonamido)-3,5-dim 
ethyl-1-tosylpiperidin-2-yl)-2,2-dimethylpentanoate (82d): General Procedure A was 
followed employing enamine 55 (0.500 mmol, 127 mg), (E)-N,4-dimethyl-N-(prop-1-enyl)-p-
toluenesulfonamide (2.00 mmol, 450 mg) as the dienophile and an initial reaction time of 24 h. 
(1-Methoxy-2-methylprop-1-enyloxy)trimethylsilane (2.50 mmol, 435 mg) was added as the 
nucleophile 3 h. Purification by flash chromatography (20% ether/hexane) afforded 166 (43%) of 
the title compound (colorless crystalline solid) as a single diastereomer. Mp: 94-95 °C; IR (thin 
film): 2924, 1725, 1597, 1457, 1336, 1153, 1089, 1018, 958 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.91 (d, J = 8.1 Hz, 2H), 7.69 (d, J = 8.1 Hz, 2H), 7.68 (d, J = 8.1 Hz, 2H), 7.35 (d, J = 8.1 Hz, 
2H), 7.29 (d, J = 8.1 Hz, 2H), 7.23 (d, J = 8.4 Hz, 2H), 4.43 (s, 1H), 4.06 (d, J = 10.8 Hz, 1H), 
3.81 (dd, J = 12, 4.2 Hz, 2H), 3.68 (s, 3H), 2.61 (s, 3H), 2.65 (s, 3H), 2.64-2.52 (m, 2H), 2.44 (s, 
3H), 2.41 (s, 3H), 2.39 (s, 3H), 1.88-1.71 (m, 2H), 1.47 (s, 3H), 1.23 (s, 3H), 0.85 (d, J = 6.9 Hz, 
3H), 0.80 (d, J = 6.9 Hz, 3H), 0.53 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 177.3, 
143.4, 143.1, 142.8, 138.8, 136.5, 135.6, 129.6, 129.5, 129.4, 128.7, 127.2, 127.1, 63.5, 62.4, 
60.1, 52.2, 48.0, 47.3, 36.4, 34.3, 33.5, 31.1, 27.6, 26.6, 26.2, 21.5, 21.4, 16.1, 15.0, 13.2; HRMS 
(Q-TOF) m/z calcd. for C38H53N3O8S3Na [(M+Na)+]: 798.2893; found: 798.2897. 
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(3R,4R)-2-Allyl-3-methyl-1-(thiophen-2-sulfonyl)-4-((trimethylsilyl)methyl)piperidine 
(105a): General Procedure A was followed employing enamine 102 (0.500 mmol, 124 mg), 
allyltrimethylsilane (1.00 mmol, 228 mg) and titanium tetrachloride (0.55 mmol, 0.55 mL, 1 M 
solution in CH2Cl2). Purification by flash chromatography (10% ether/hexane) afforded 144 mg 
(78%) of the title compound as a 1:1 mixture of diastereomers (C2 epimers) as determined by 1H 
NMR analysis of the crude product mixture. IR (thin film): 2950, 1641, 1407, 1342, 1248, 1151, 
1013, 918, 856, 722 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.53 (t, J = 5.1 Hz, 2H), 7.04 (dd, J = 
5.1, 3.9 Hz, 1H), 5.99-5.58 (m, 1H), 4.99 (dd, J = 13.2, 13.2 Hz, 2H ), 4.09-3.86 (m, 1H), 3.74 
(dt, J = 18.9, 4.2 Hz, 1H), 2.96 (dq, J = 17.7, 3 Hz, 1H), 2.52-2.36 (m, 1H), 2.30-2.08 (m, 2H), 
2.01-1.84 (m, 1H), 1.79-1.65 (m, 1H), 1.51-1.28 (m, 2H), 0.87 (t, 6.9 Hz, 3H), 0.46 (t, J = 6.3 
Hz, 1H), -0.01 & -0.03 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 143.1 & 142.5, 135.2 & 134.8, 
131.3, 131.0 & 130.9, 127.1 & 127.0, 117.4 & 116.6, 59.8 & 58.5, 41.2, 41.0 & 40.7, 34.5 & 
33.6, 33.4 & 32.9, 28.8 & 28.6, 21.5 & 20.8, 16.5 & 12.2, -(0.47 & 0.78); HRMS (Q-TOF) m/z 
calcd. for C17H29NO2S2SiNa [(M+Na)+]: 394.1307; found: 394.1274. 
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Methyl-2-allyl-3-methyl-4-[(trimethylsilyl)methyl]piperidine-1-carboxylate (61): To a stirred 
solution of TiCl4 (0.55 mmol, 0.55 mL, 1M solution in CH2Cl2) in 1 mL CH2Cl2 at −78 °C a 
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solution of (E)-methyl methoxymethyl(prop-1-enyl)carbamate 59 (0.500 mmol, 79.5 mg) in 1 
mL CH2Cl2 and allyTMS (2.00 mmol, 228 mg) were added. The reaction temperature was raised 
to ambient temperature over 3-4 hours and stirred for additional 3-4 hours. The reaction mixture 
was diluted with saturated NaHCO3 (10 mL) and organic layer was separated. The organic phase 
was washed with water, dried (MgSO4) and concentrated. Purification by column 
chromatography with 15% ether in hexane afforded 50 mg (37%) of the title compound as 
colorless oil as an inseparable 1:1 mixture of diastereomers (C2 epimers) as determined by 1H 
NMR analysis of the crude product mixture. IR (thin film): 2952, 1701, 1641, 1448, 1248, 89 
cm-1; 1H NMR (300 MHz, CDCl3, both diastereomers): δ 5.82-5.58 (m, 1H), 5.05-4.94 (m, 2H), 
4.35-3.80 (m, 2H), 3.65 & 3.64 (s, 3H), 2.84-2.81 (m, 1H), 2.44-2.23 (m, 2H), 2.01-1.87 (m, 
1H), 1.74-1.56 (m, 1H), 1.51-1.21 (m, 1H), 1.20-1.10 (m, 1H), 0.87 (dd, J = 6.3, 4.8 Hz, 3H), 
0.45 (dd, J = 7.2, 6.9 Hz, 1H), 0.15 (dd, J = 9.9, 9.9 Hz, 0.5H), -0.002 & -0.008 (s, 9H); 13C 
NMR (75 MHz, CDCl3, for one diastereomer): δ  156.1, 135.2, 116.4, 57.5, 52.4, 39.4, 34.7, 
33.2, 29.4, 21.6, 16.5, 12.2,  −0.76; MS (EI, 70 eV): m/z 283 (M+•), 268, 242, 168, 154, 138, 128, 
110, 95, 89; HRMS m/z calcd. for C15H29NO2Si: 283.1967; found: 283.1973. 
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 Methyl-3,5-dimethyl-4-phenyl-3,4-dihydropyridine-1(2H)-carboxylate (64): To an ice-cold 
solution of (E)-methylmethoxymethyl(prop-1-enyl)carbamate, 59 (0.33 mmol, 53 mg ) and β-
methylstyrene (0.500 mmol, 58.4 mg) in 3 mL CH2Cl2 was added a solution of SnCl4 (0.400 
mmol, 104 mg) in 0.5 mL CH2Cl2. After 2 hours, the reaction mixture was diluted with saturated 
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bicarbonate solution and organic layer was separated. The organic phase was washed with water, 
dried (MgSO4) and concentrated. Purification by flash chromatography with 20% ether in hexane 
afforded 55 mg (67%) of the title compound as a colorless oil in 4.4:1 diastereomeric ratio. IR 
(thin film): 2957, 1709, 1674, 1444, 1394, 1207, 1191 cm-1; 1H NMR (300 MHz, CDCl3, minor 
diastereomer in bold where resolved): δ  7.28-7.13 (m, 5H), 6.95 & 6.81 (s, 1H), 6.90 & 6.77 (s, 
0.2H), 3.80 & 3.77 (s, 3H), 3.65 & 3.61 (s, 0.7H),  3.13 (d, J = 5.1 Hz, 1H), 2.86 (t, J = 12 Hz, 
1H), 2.25-2.12 (m, 1H), 1.58 &1.57 (s, 3H), 1.49 &1.47 (s, 0.7H), 1.28-1.21 (m, 1H), 0.96 & 
0.94 (s, 0.7H), 0.69 & 0.67 (s, 3H); 13C NMR (75 MHz, CDCl3, for both diastereomers): δ 154.1 
+ 153.6 (1C), 139.5, 129.7, 127.9, 126.6, 120.9 + 120.5 (1C), 116.2 + 115.9 (1C), 52.9 + 52.8 
(1C), 48.5 + 48.3 (1C), 43.6 + 43.4 (1C), 31.1, 19.8 + 19.7 (1C), 16.2 + 16.1 (1C); MS (EI, 70 
eV): m/z 245 (M+•), 230, 199, 183, 168, 155, 131, 109; HRMS m/z calcd. for C15H19NO2: 
245.1415; found: 245.1421. 
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(2S,3S,4R)-2-Ethyl-1,2,3,4-tetrahydro-N,3,5-trimethyl-N,N'-bis(p-toluenesulfonyl)pyridine-
4-amine (86): To a −78 °C solution of TiCl 4 (1.1 equiv, 0.55 mL) in 10 mL of CH2Cl2 was 
added a solution of enamine 83 (0.500 mmol, 141 mg) in CH2Cl2 (3 mL) and the reaction was 
stirred for 90 min. (E)-N,4-dimethyl-N-(prop-1-enyl)benzenesulfonamide 80 (0.600 mmol, 135 
mg) was added and the reaction was stirred for 3 h at –78 °C prior to adding Et3N (2.50 mmol, 
250 mg). Once addition was complete, the reaction was warmed to ambient temperature 
whereupon a saturated aqueous solution of NaHCO3 (5 mL) was added and resulting mixture 
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was stirred vigorously for 20 min. The resulting homogeneous layers were separated and the 
aqueous portion was extracted with ether (5 mL) and the combined organic portions were 
washed with brine, dried (MgSO4), and concentrated. The crude product mixture was purified by 
flash chromatography on silica gel (25% ether in hexanes) affording 105 mg (44%) of the title 
compound as a white crystalline solid (single diastereomer). Mp: 176-178 °C; IR (thin film): 
2969, 2932, 1659, 1597, 1453, 1339, 1219, 1187, 1163, 1084, 970, 947 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.62 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 8.4 Hz, 2H), 7.24 
(d, J = 8.1 Hz, 2H), 6.41 (dd, J = 2.4, 1.2 Hz, 1H), 4.06 (d, J = 10.8 Hz, 1H), 3.67 (dt, J = 11.4, 
2.7 Hz, 1H), 2.39 (s, 3H), 1.99 (s, 3H), 1.50 (ddd, J = 13.8, 7.5, 3.0 Hz, 1H), 1.41-1.32 (m, 1H), 
1.30 (s, 3H), 1.03 (t, J = 7.2 Hz, 3H), 0.70 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
143.6, 143.1, 137.3, 136.0, 129.6, 129.4, 127.1, 126.9, 123.3, 119.4, 60.9, 58.7, 31.6, 27.1, 21.5, 
21.4, 18.7, 17.8, 15.8, 11.1; MS (EI, 70 V): m/z 476 (M•+), 447; HRMS (Q-TOF) m/z calcd. for 
C24H32N2O4S2Na [(M+Na)+]: 499.1701; found: 499.1713. 
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6-Ethyl-3-methyl-1-tosyl-4-((trimethylsilyl)methyl)-2-vinylpiperidine (87): To a −78 °C 
solution of TiCl4 (1.1 equiv, 0.59 mL) in 10 mL of CH2Cl2 was added a solution of enamine 83 
(0.540 mmol, 152 mg)  and allyltrimetylsilane (2.15 mmol, 246 mg) in CH2Cl2 (3 mL) and the 
reaction was stirred for 3 hours. The reaction was quenched by addition of a saturated aqueous 
solution of NaHCO3 (5 mL) and the resulting residue was warmed to ambient temperature. The 
resulting homogeneous layers were separated and the aqueous portion was extracted with ether 
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(5 mL) and the combined organic portions were washed with brine, dried (MgSO4), and 
concentrated. Purification by flash chromatography with 10% ether in hexane afforded 134 mg 
(61%) of the title compound in the form of a colorless oil as a 10:18 mixture of non-separable 
diastereomers as determined by 1H NMR analysis of the crude product mixture. IR (thin film): 
2957, 1640, 1460, 1340, 1248, 1162, 1088, 840 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.71 (dd, J 
= 8.1, 6 Hz, 2H), 7.26 (t, J = 6.9 Hz, 2H), 5.83 (ddd, J = 24.3, 14.1, 7.5 Hz, 1H), 5.05 (dd, J = 
14.1, 3.9 Hz, 2H), 3.84-3.64 (m, 1.3 H), 3.63-3.42 (m, 0.7 H), 2.52-2.40 (m, 1H),  2.39 (s, 3H), 
2.36-2.24 (m, 1H), 2.08-1.96 (m, 1H), 1.85 (ddd, J = 13.5, 10.5, 2.4 Hz, 1H),  1.75-1.59 (m, 1H), 
1.58-1.42 (m, 1H), 1.39-1.14 (m, 1H), 1.05-0.94 (m,1H), 0.91 (t, J = 7.5 Hz, 3H), 0.86-0.74 (m, 
1H),  0.68 (d, J = 6.9 Hz, 2H), 0.56 (dd, J = 14.7, 2.1 Hz, 1H), 0.46 (d, J = 9 Hz, 1H), 0.41-0.39 
(m, 1H), 0.07 (dd. J = 14.4, 10.2, 1H) -0.17 & -0.15 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 
142.8 & 142.5, 139.0 & 138.4, 136.2 & 135.5, 129.4 & 129.3, 127.3 & 127.0, 117.1& 117.0, 
60.3 & 59.4, 56.7 & 55.4, 44.9, 43.7 & 40.3, 36.1 & 34.4, 33.9 & 29.3, 33.0 & 28.9, 23.5, 21.5 & 
21.4, 20.55 & 20.51, 12.1 & 10.8, - (0.79 & 1.01); HRMS (Q-TOF) m/z calcd. for 
C22H37NO2SSiNa [(M+Na)+]: 430.2212; found: 430.2172. 
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1,2,3,4-Tetrahydro-5-methyl-4-((trimethylsilyl)methyl)-1-tosylpyridine (132): General 
Procedure A was followed employing enamine 55 (0.500 mmol, 128 mg) and 
allyltrimethylsilane (2.50 mmol, 286 mg) in toluene and a reaction time of 12 h. Purification by 
flash chromatography afforded the title compound (13.5 mg, 8%) as minor product (along with 
the major product). IR (thin film): 2951, 1663, 1442, 1351, 1249, 1164, 1093, 859 cm-1; 1H NMR 
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(300 MHz, CDCl3): δ 7.65 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 6.33 (s, 1 H), 3.40 (ddd, 
J = 9.6, 6, 3.3 Hz, 1H), 3.19 (ddd, J = 12.9, 10.2, 3.3 Hz, 1H), 2.42 (s, 3H), 1.91-1.87 (m, 1H), 
1.62 (s, 3H), 1.48-1.32 (m, 2H), 0.76 (dd, J = 15, 2.7 Hz, 1H), 0.16 (dd, J = 15.3, 11.1 Hz, 1H), -
0.04 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 143.3, 135.1, 129.6, 127.1, 122.9, 118.4, 40.3, 31.4, 
28.3, 21.5, 21.1, 19.3, -0.87; MS (EI, 70 V): m/z 337 (M•+), 309, 249, 182, 155, 149, 139, 108, 
91, 86; HRMS m/z calcd. For C17H27NO2SSi: 337.1531; found: 337.1528. 
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General Procedure B. TiCl4-mediated Cycloadditions of Neutral Alkene Dienophiles: To a −78 
°C solution of TiCl4 (1.1 equiv) in 25 mL of CH2Cl2 was added a solution of the alkene 
dienophile (1-10 equiv) in 2-3 mL of CH2Cl2 dropwise over 3-4 min. A solution enamine- aminal 
(1.0 mmol, 1 eq.) in CH2Cl2 (10 mL) was then added over 3 h via syringe pump. Once addition 
was complete, the reaction mixture was warmed to −50 °C and stirred for additional 6-8 h. A 
solution of the nucleophile (or Et3N, 5 equiv) in CH2Cl2 (5 mL) was added dropwise and the 
reaction was stirred for an additional 60 min. A saturated aqueous solution of NaHCO3 (10 mL) 
was added and the resulting solidified mass was warmed to ambient temperature (or in case of 
Et3N quench, after 30 min of the addition of Et3N the reaction mixture was warmed to ambient 
temperature and then saturated NaHCO3 was added). The resulting mixture was stirred 
vigorously for 20 min and the homogeneous layers were separated. The aqueous portion was 
extracted with ether (10 mL) and the combined organic portions were washed with brine, dried 
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(MgSO4), and concentrated. The crude product mixture was purified by column chromatography 
on silica gel (10-25% ether in hexanes). 
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3-Allyl-4-methyl-2-tosyl-decahydroisoquinoline (88): General Procedure B was followed 
employing enamine 55 (1.00 mmol, 255 mg), cyclohexene (10.0 mmol, 820 mg) as the 
dienophile, and allyltrimethylsilane (5.00 mmol, 572 mg) as the nucleophile. Purification by 
flash chromatography afforded 203 mg (59%) of the title compound as a viscous oil that 
solidified upon standing (diastereomer ratio major:Σothers = 97:3 as determined by 1H NMR 
analysis of the crude product mixture). Mp: 55-57 °C; IR (NaCl): 2929, 1640, 1448, 1333, 1153, 
1089, 1005, 915 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 8.1 Hz, 2H), 7.24 (d, J = 8.1 
Hz, 2H), 5.37 (dddd, J = 17.0, 10.0, 7.5, 7.2 Hz, 1H), 4.85 (dd, J = 17.1, 1.2 Hz, 1H), 4.70 (dd, J 
= 10.2, 1.2 Hz, 1H), 3.96 (dd, J = 13.2, 5.7 Hz, 1H), 3.50 (d, J = 13.8 Hz, 1H), 3.12 (dd, J = 13.5, 
2.7 Hz, 1H), 2.40 (s, 3H), 2.25 (dddd, J = 18.6, 13.8, 11.7, 6.9 Hz, 1H), 2.18-2.13 (m, 2H), 1.81-
1.48 (m, 5H), 1.41-1.18 (m, 5H), 0.83 (d, J = 6.9, 3H); 13C NMR (75 MHz, CDCl3): δ 142.5, 
139.0, 135.8, 129.2, 127.2, 116.2, 58.4, 46.1, 36.6, 34.7, 30.6, 29.6, 27.6, 26.2, 25.6, 21.5, 19.7, 
16.1; MS (EI, 70 V): m/z 306 [(M−41)•+], 231, 215, 177, 155, 117, 97, 91; HRMS m/z calcd. For 
C17H24NO2S [(M−C3H5)•+]: 306.1527; found: 306.1534. 
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R*-(4aS,8aR)-1,2,4a,5,6,7,8,8a-Octahydro-4-methyl-2-(p-toluenesulfonyl)isoquinoline (90): 
General Procedure B was followed employing enamine 55 (1.00 mmol, 255 mg), cyclohexene 
(10.0 mmol, 820 mg) as the dienophile, and Et3N (5.00 mmol, 506 mg) as the base. Purification 
by flash chromatography (15% ether/hexane) afforded 162 mg (53%) of the title compound as a 
viscous oil (single diastereomer as determined by 1H NMR analysis of the crude product 
mixture). IR (thin film): 2924, 2854, 1662, 1597, 1450, 1346, 1162, 1091, 1055, 948, 812 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 7.8 Hz, 2H), 6.37 (s, 1H), 
3.25-3.19 (m, 2H), 2.42 (s, 3H), 1.89-1.79 (m, 2H), 1.62 (s, 3H), 1.55-1.15 (m, 8H); 13C NMR 
(75 MHz, CDCl3): δ 143.2, 135.4, 129.6, 127.0, 119.5, 118.8, 45.3, 37.1, 31.9, 27.9, 27.6, 24.5, 
22.7, 21.5, 18.7; MS (EI, 70 V): m/z 305 (M•+), 290, 276, 224, 155, 123, 91, 81, 67; HRMS m/z 
calcd. for C17H23NO2S: 305.1449; found: 305.1438. 
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(3S,4R,4aS,8aR)-4-Methyl-2-tosyl-(3-nitrile)decahydroisoquinoline (91a): General Procedure 
B was followed employing enamine 55 (0.500 mmol, 127 mg), cyclohexene (5.00 mmol, 410 
mg) as dienophile, and trimethylsilylnitrile (2.50 mmol, 248 mg) as the nucleophile. Purification 
by flash chromatography (10% ether/hexane) afforded 88 mg (53%) of the title compound as a 
single diastereomer. IR (thin film): 2930, 2861, 1597, 1451, 1350, 1163, 1026, 931, 813, 667 cm-
1; 1H NMR (300 MHz, CDCl3): δ 7.69 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 4.82 (d, J = 
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3.9 Hz, 1H), 3.54 (d, J = 12.6 Hz, 1H), 2.88 (dd, J = 12.3, 2.1 Hz, 1H), 2.43 (s, 3H), 2.41-2.31 
(m, 1H), 1.92-1.71 (m, 4H), 1.66-1.59 (m, 1H), 1.51-1.12 (m, 5H), 1.02 (d, J = 6.9 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 144.4, 133.6, 129.8, 127.7, 113.8, 52.5, 48.8, 36.6, 35.5, 30.2, 27.0, 
25.8, 25.3, 21.6, 19.6, 15.0; HRMS (Q-TOF) m/z calcd. for C18H24N2O2SNa [(M+Na)+]: 
355.1456; found: 355.1443. 
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R*-(3'S,4'R,4a'S,8a'R)-Methyl 2-(decahydro-4'-methyl-2'-(p-toluenesulfonyl)isoquinolin-3'-
yl)-2,2-dimethylpropanoate (91b): General Procedure B was followed employing enamine 55 
(1.00 mmol, 255 mg), cyclohexene (10.0 mmol, 820 mg) as dienophile, and (1-methoxy-2- 
methylprop-1-enyloxy)trimethylsilane (5.00 mmol, 870 mg) as the nucleophile. Purification by 
flash chromatography (15% ether/hexane) afforded 232 mg (57%) of the title compound as a 
single diastereomer as determined by 1H NMR analysis of the crude product mixture. IR (thin 
film): 2926, 2855, 1728, 1597, 1450, 1339, 1257, 1158, 11116, 1022, 810 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.74 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 7.8 Hz, 2H), 3.93 (dd, J = 7.5, 1.5 Hz, 1H), 
3.81 (ddd, J = 15.6, 9.3, 1.5 Hz, 1H), 3.66 (s, 3H), 2.74 (dd, J = 15.6, 8.7 Hz, 1H), 2.41 (s, 3H), 
1.82 (ddd, J = 16.8, 13.2, 6.0 Hz, 1H), 1.68-1.64 (m, 2H), 1.53-1.52 (m, 1H), 1.33 (s, 3H), 1.31-
1.27 (m, 3H), 1.25 (s, 3H), 1.11-1.05 (m, 3H), 0.93-0.89 (m, 1H), 0.83 (d, J = 6.6 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 177.5, 143.0, 138.0, 129.4, 127.5, 67.4, 51.8, 48.0, 47.6, 36.0, 32.2, 
28.4, 27.4, 26.4 (2C), 24.8, 23.0, 21.5, 21.1, 19.6; MS (EI, 70 V): m/z 408 [(M+H)•+], 306; 
HRMS (Q-TOF) m/z calcd. for C22H33NO4SNa [(M+Na)+]: 430.2028; found: 430.2035. 
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R*-(3S,4R,4aS,8aR)-Decahydro-4-methyl-3-(N-methyl-1H-indol-3-yl)-2-(p-toluenesulfonyl) 
isoquinoline (91c): General Procedure B was followed employing enamine 55 (1.00 mmol, 255 
mg), cyclohexene (10.0 mmol, 820 mg) as the dienophile, and N-methylindole (1.300 mmol, 
170.5 mg) as the nucleophile. Purification by flash chromatography (15% ether/hexane) afforded 
230 mg (53%) of the title compound as a colorless crystalline solid (single diastereomer as 
determined by 1H NMR analysis of the crude product mixture). Mp: 73-75 °C; IR (thin film): 
3051, 2926, 1597, 1466, 1374, 1331, 1159, 1022, 969, 950, 912, 808, 736 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.76 (d, J = 7.5 Hz, 1H), 7.25-7.14 (m, 3H), 6.89 (d, J = 8.1, 2H), 6.62-6.60 (m, 
3H), 5.55 (d, J = 5.1 Hz, 1H), 3. 57 (dd, J = 24.3, 12.0 Hz, 1H), 3.50 (s, 3H), 3.12 (dd, J = 12, 3.3 
Hz, 1H), 2.62 (septet, J = 6.3 Hz, 1H), 2.18 (s, 3H), 2.11-2.03 (m, 1H), 1.87-1.77 (m, 4H), 1.57-
1.50 (m, 1H), 1.43-1.32 (m, 4H), 0.58 (d, J = 6.6, 3H); 13C NMR (75 MHz, CDCl3): δ 141.4, 
136.0, 135.2, 130.0, 127.9, 126.9, 125.8, 121.8, 119.4, 119.3, 109.5, 108.5, 53.7, 48.0, 36.5, 34.5, 
32.4, 30.9, 27.5, 26.2, 25.5, 21.2, 19.7, 15.4; MS (EI, 70 V): m/z 436 (M•+), 305, 281, 265, 198, 
171, 157, 144, 131, 91; HRMS m/z calcd. for C26H32N2O2S: 436.2184; found: 436.2185. 
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R*-(4aS,10aR)-1,2,4a,5,6,7,8,9,10,10a-Decahydro-4-methyl-2-(p-toluenesulfonyl)cycloocta 
[c]pyridine (94): General Procedure B was followed employing enamine 55 (1.00 mmol, 255 
mg), cyclooctene (10 mmol, 1.1 g) as the dienophile, and Et3N (5.00 mmol, 506 mg) as the base. 
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Purification by flash chromatography (15% ether/hexane) afforded 230 mg (69%) of the title 
compound as viscous oil (single diastereomer as determined by 1H NMR analysis of the crude 
product mixture. IR (thin film): 2920, 1671, 1597, 1468, 1342, 1186, 1163, 1092, 1044, 980, 813 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.67 (d, J = 7.5 Hz, 2H), 7.33 (d, J = 7.8 Hz, 2H), 6.38 (s, 
1H), 3.43 (d, J = 11.4 Hz, 1H), 2.56 (t, J = 11.8 Hz, 1H), 2.45 (s, 3H), 2.10-1.95 (m, 1H), 1.71 (s, 
3H), 1.65-1.60 (m, 6H), 1.42-1.32 (m, 6H), 1.15-1.10 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 
143.1, 134.8, 129.4, 126.7, 121.3, 117.5, 45.2, 37.9, 35.8, 29.6, 28.5, 26.8, 26.7, 26.0, 25.3, 21.3, 
19.4; MS (EI, 70 V): m/z 333 (M•+), 318, 248, 236, 178, 155, 91, 80, 68; HRMS m/z calcd. for 
C19H27NO2S: 333.1762; found: 333.1758. 
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(3S,4R,4aS,8aR)-N-Benzyl-4-methyl-2-tosyl-decahydroisoquinoline-3-carboxamide (96b): 
General Procedure B was followed employing enamine 55 (0.500 mmol, 128 mg), cyclohexene 
(5.00 mmol, 410 mg) as dienophile, and benzylisonitrile (1.500 mmol, 175.5 mg) as the 
nucleophile. Purification by flash chromatography (25% ether/hexane) afforded 80 mg (36%) of 
the title compound (white solid) as a single diastereomer. MP: 160-161 °C; IR (thin film): 3398, 
2924, 1656, 1576, 1498, 1450, 1334, 1159, 1027, 698 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.63 
(d, J = 8.4 Hz, 2H), 7.38-7.21 (m, 7H), 6.15 (t, J = 6.3 Hz, 1H), 4.38 (dd, J = 14.7, 6.3 Hz, 1H), 
4.25 (d, J = 4.8 Hz, 1H), 4.09 (dd, J = 9.9, 4.8 Hz, 1H), 3.66 (dd, J = 12.6, 3.6 Hz, 1H), 3.37 (d, J 
= 13.8 Hz, 1H), 2.41 (s, 3H), 2.33-2.15 (m, 2H), 1.84-1.61 (m, 3H), 1.38-1.14 (m, 6H),  0.96 (d, 
J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 168.7, 143.2, 137.7, 136.5, 129.5, 128.7, 127.8, 
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127.5, 127.0, 59.7, 48.3, 43.2, 35.9, 33.4, 29.3, 27.3, 26.0, 25.1, 21.5, 19.3, 15.2; HRMS (Q-
TOF) m/z calcd. for C25H32N2O3SNa [(M+Na)+]: 463.2031; found: 463.1991. 
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 (S)-Methyl 3-methyl-2-((3S,4R,4aS,8aR)-4-methyl-2-tosyl-decahydroisoquinoline-3-carbox 
amido)butanoate (96c): General Procedure B was followed employing enamine 55 (0.500 
mmol, 128 mg), cyclohexene (5.00 mmol, 410 mg) as dienophile, and (S)-methyl 2-isocyano-3-
methylbutanoate (1.60 mmol, 225 mg) as the nucleophile. Purification by flash chromatography 
(25% ether/hexane) afforded 116 mg (50%) of the title compound as an oil (diastereomeric ratio 
= 1:1 as determined by 1H NMR analysis of the crude product mixture). IR (thin film): 3373, 
2930, 1743, 1679, 1522, 1450, 1450, 1333, 1156, 1027, 814 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.67 (d, J = 8.4 Hz, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.26 (d, J = 7.8 Hz, 1H), 7.20 (d, J = 8.1 Hz, 
1H), 6.50 (d, J = 7.8 Hz, 0.5H), 6.42 (d, J = 8.1 Hz, 0.5H), 4.33 (dt, J = 7.8, 4.8 Hz, 1.5H), 4.22 
(dd, J = 8.1, 4.5 Hz, 0.5H), 3.79 (s, 1.5 H), 3.72 (s, 1.5 H), 3.68 (t J = 3.3 Hz, 0.5H), 3.64 (d, J = 
3.6 Hz, 0.5H), 3.42 (d, J = 12.3 Hz, 0.5H), 3.34 (d, J = 12.6 Hz, 0.5H),  2.41 (s, 1.5H),  2.39 (s, 
1.5H), 2.28-2.02 (m, 3H), 1.82-1.61 (m, 4H), 1.41-1.05 (m, 4H),  0.97 (t, J = 7.2 Hz, 3H), 0.91 
(d, J = 6.9 Hz, 3H), 0.86 (dd, J = 6.9, 3.3 Hz, 3H); 13C NMR (75 MHz, CDCl3, for both 
diastereomer): δ 171.9 & 171.8, 169.2 & 168.8, 143.1 & 143.0, 137.0 & 136.5, 129.4 & 129.3, 
127.1 & 127.0, 59.6 & 59.2, 57.1 & 56.9, 52.0 & 51.9, 48.2 & 48.16, 35.9 & 35.8, 33.6 & 33.4, 
31.2 & 30.8, 29.36 & 29.33, 27.32 & 27.26, 25.9, 25.2 & 25.1, 21.4, 19.3 & 19.2, 18.9 & 18.8, 
17.88 & 17.82, 15.4 & 14.9; HRMS (Q-TOF) m/z calcd. for C24H36N2O5SNa [(M+Na)+]: 
487.2243; found: 487.2213. 
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R*-(4aS,8aR)-1,2,4a,5,6,7,8,8a-Octahydro-2-(p-toluenesulfonyl) isoquinoline (99): General 
Procedure B was followed employing enamine N-(methoxymethyl)-N-vinyl-p-
toluenesulfonamide 212 (1.00 mmol, 241 mg), cyclohexene (10.0 mmol, 820 mg) as the 
dienophile, and Et3N (5 mmol, 506 mg) as the base. Purification by flash chromatography (10% 
ether/hexane) afforded 52 mg (18%) of the title compound as viscous oil (single diastereomer as 
determined by 1H NMR analysis of the crude product mixture). IR (thin film): 2928, 1686, 1597, 
1449, 1378, 1165, 1092, 935, 815, 709 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.66 (d, J = 8.4 Hz, 
2H), 7.30 (d, J = 8.4 Hz, 2H), 6.59 (dd, J = 8.4, 2.4 Hz, 1H), 4.23 (dd, J = 8.4, 3 Hz, 1H), 3.39 
(dd, J = 11.4, 6 Hz, 1H), 3.14 (dd, J = 11.7, 3.3 Hz, 1H), 2.42 (s, 3H), 2.27-2.18 (m, 1H), 190-
1.78 (m, 1H), 1.52-1.44 (m, 4H), 1.43-1.25 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 143.5, 
135.2, 129.6, 127.0, 124.0, 111.5, 47.4, 31.9, 31.8, 30.8, 29.7, 26.4, 24.0, 21.5; MS (EI, 70 V): 
m/z 291 (M•+), 278, 264, 184, 155, 150, 136, 124, 111, 95, 91; HRMS m/z calcd. for 
C16H21NO2S: 291.1293; found: 291.1285. 
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3-Allyl-4-ethyl-2-tosyl-decahydro-isoquinoline (101): General Procedure B was followed 
employing (E)-N-(but-1-enyl)-N-(methoxymethyl)-p-toluenesulfonamide 213 (0.250 mmol, 67.3 
mg), cyclohexene (2.50 mmol, 205 mg) as the dienophile, and allyltrimethylsilane (1.25 mmol, 
143 mg) as the nucleophile. Purification by flash chromatography afforded 49 mg (56%) of the 
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title compound as viscous oil (single diastereomer as determined by 1H NMR analysis of the 
crude product mixture). IR (NaCl): 2926, 1640, 1455, 1332, 1153, 1090, 1024, 949 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.66 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 5.41 (dddd, J = 
14.1, 9.9, 9.9, 6.6 Hz, 1H), 4.87 (dd, J = 17.1, 1.8 Hz, 1H), 4.71 (dd, J = 9.9, 1.2 Hz, 1H), 3.48 
(d, J = 13.8 Hz, 1H), 3.15 (dd, J = 13.8, 3.8 Hz, 1H),  2.41 (s, 3H), 2.32-2.17 (m, 1H), 2.09-1.87 
(m, 2H), 1.83 (d, J = 12.3 Hz, 1H), 1.75-1.57 (m, 3H), 1.43 (dd, J = 13.2, 3.9 Hz, 1H), 1.42-1.08 
(m, 7H), 0.94 (d, J = 4.8, 3H); 13C NMR (75 MHz, CDCl3): δ 142.4, 139.0, 135.6, 129.1, 127.1, 
116.2, 54.8, 45.8, 36.9, 33.8, 29, 27.6, 26.1, 25.7, 21.5, 21.4, 19.7, 11.4; HRMS(Q-Tof) m/z 
calcd. For C21H31NO2SNa [(M+ Na)+]: 384.1973; found: 384.1940. 
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(3R,4R,4aS,8aR)-3-Allyl-4-methyl-2-(thiophen-2-ylsulfonyl)-decahydroisoquinoline (105b): 
General Procedure B was followed employing enamine 102 (0.250 mmol, 61.8 mg), cyclohexene 
(2.50 mmol, 205 mg) as dienophile, and allyltrimethylsilane (1.40 mmol, 159 mg) as the 
nucleophile. Purification by flash chromatography (10% ether/hexane) afforded 41 mg (49%) of 
the title compound as a single diastereomer as determined by 1H NMR analysis of the crude 
product mixture. IR (thin film): 2928, 1642, 1450, 1337, 1149, 1029, 915 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.50 (s, 1H), 7.49 (d, J = 1.2 Hz, 1H), 7.02 (dd, J = 4.5, 3.6 Hz, 1H), 5.50 (dddd, 
J = 16.8, 9.9, 6.9, 6.9 Hz, 1H ), 4.89 (dd, J = 16.8, 1.5 Hz, 1H), 4.77 (d, J = 10.5 Hz, 1H), 4.04 
(q, J = 5.7 Hz, 1H), 3.53 (d, J = 13.8 Hz, 1H), 3.15 (dd, J 13.8, 3.3 Hz, 1H), 2.33-2.14 (m, 2H), 
1.79 ()d, J = 11.1 Hz, 1H), 1.74-1.57 (m, 3H), 1.46 (dd, J = 12.6, 3.6 Hz, 1H), 1.41-1.12 (m, 6H), 
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0.85 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 143.1, 135.3, 131.2, 130.6, 126.8, 116.3, 
58.6, 46.2, 36.5, 34.5, 30.5, 29.5, 27.5, 26.1, 25.4, 19.6, 16.0; HRMS (Q-TOF) m/z calcd. for 
C17H25NO2S2Na [(M+Na)+]: 362.1224; found: 362.1213. 
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(3S,4R,4aS,8aR)-3-(1-Benzyl-1H-indol-3-yl)-4-methyl-2-(thiophen-2-ylsulfonyl) decahydro 
isoquinoline (105c): General Procedure B was followed employing enamine 102 (0.500 mmol, 
124 mg), cyclohexene (5.00 mmol, 410 mg) as dienophile, and N-benzylindole (1.30 mmol, 135 
mg) as the nucleophile. Purification by flash chromatography (15% ether/hexane) afforded 131 
mg (52%) of the title compound as a single diastereomer as determined by 1H NMR analysis of 
the crude product mixture. Mp: 165-166 °C; IR (thin film): 2924, 1609, 1466, 1451, 1334, 1143, 
1018, 915 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.91-7.86 (m, 1H),  7.31-7.24 (m, 3H), 7.22-7.14 
(0m, 3H), 7.05 (dd, J = 5.1, 1.5 Hz, 1H), 6.94 (s, 1H), 6.91 (dd, J = 7.2, 3.9 Hz, 2H), 6.60 (dd, J = 
3.6, 1.2 Hz, 1H), 6.39 (dd, J = 5.1, 3.9 Hz, 1H),  3.52 (d, J = 12.3 Hz, 1H), 3.17 (dd, J = 12.3, 3 
Hz, 1H),  2.66 (sep, J = 6.6 Hz, 1H), 2.17-1.95 (m, 1H), 1.92-1.78 (m, 4H), 1.52 (d, J = 13.2 Hz, 
1H), 1.45-1.27 (m, 4H), 0.62 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ139.8, 137.3, 
134.9, 131.4, 130.22, 130.2, 128.7, 127.6, 126.5, 122.2, 119.74, 119.7, 109.7, 109.2, 53.6, 49.9, 
47.5, 36.3, 34.9, 31.1, 27.5, 26.2, 25.4, 19.7, 15.5; MS (EI, 70 V): m/z 504 [(M)•+], 357, 304, 
256, 247, 220, 123, 95, 91, 81, 69; HRMS  m/z calcd. for C29H32N2O2S2: 504.1905; found: 
504.1892. 
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(3R,4R)-2-Allyl-3-methyl-4-((trimethylsilyl)methyl)piperidine (106a): Piperidine 105a (78 
mg, 0.21 mmol) was added to a stirred solution of magnesium (25.0 mg, 1.05 mmol) and 
methanol (3 mL) at room temperature. The resulting solution was stirred vigorously until 
completion (~2 h, monitored by TLC). The solvent was removed and the resulting solid residue 
was suspended in water. The resulting slurry was extracted with ether (3 ×). The combined 
organic phase was dried (MgSO4), and concentrated affording 43 mg (91%) of the title 
compound as an yellowish oil with > 90% purity.   IR (thin film): 3336, 2951, 1640, 1439, 1334, 
1248, 1140, 913, 859, 836 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.85-5.69 (m, 1H), 5.15-5.05 (m, 
2H), 3.74 (q, J = 7.2 Hz, 1H), 2.94-2.76 (m, 2H), 2.54 (dt, J = 8.4, 3.9 Hz, 0.4H) & 2.41-2.26 (m, 
0.6H), 2.26-1.98 (m, 1H), 1.96-1.81 (m, 1H), 1.59-1.41 (m, 2H), 1.31-1.12 (m, 2H), 0.96 & 0.87 
(d, J = 6.9 Hz, 3H), 0.82-0.55 (m, 1H), 0.54-0.50 (m, 1H), -0.017 (s, 9H); 13C NMR (75 MHz, 
CDCl3): δ 136.2 &135.8, 117.5 & 117.0, 55.5 & 53.8, 41.0 & 39.2, 40.6 & 39.4, 37.6 & 34.8, 
33.4 & 32.0, 29.6, 20.7 & 15.6, 14.5 & 14.2, -(0.79 & 0.87, 3C); HRMS (Q-TOF) m/z calcd. for 
C13H28NSi [(M+H)+]: 226.1991; found: 226.1988. 
 
HN
H
H
MeBnN  
(3S,4R,4aS,8aR)-3-(1-Benzyl-1H-indol-3-yl)-4-methyldecahydroisoquinoline (106b): Piperi-
dine 105c (130 mg, 0.250 mmol) was added to a stirred solution of magnesium (60 mg, 2.5 
mmol, added 3 ×) and methanol/ THF (10 : 2 mL) at room temperature. The resulting solution 
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was stirred vigorously until completion. The solvent was removed and the resulting solid residue 
was suspended in water. The resulting slurry was extracted with ether (3 ×). The combined 
organic phase was dried (MgSO4), and concentrated.  Purification by flash chromatography (5% 
methanol/dichloromethane) afforded 87 mg (94.5%) of the title compound as an yellowish oil.  
IR (thin film): 3332, 2924, 2854, 1611, 1466, 1377, 1176, 1075, 1015 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.57 (d, J = 7.5 Hz, 1H), 7.31-7.22 (m, 5H), 7.18 (dd, J = 6.9, 1.2 Hz, 1H), 7.1 (dd, J = 
6, 1.2 Hz, 1H), 7.11-7.05 (m, 2H), 5.23 (s, 2H), 4.60 (, J = 3.3 Hz, 1H), 3.17 (t, J = 12.3 Hz, 1H), 
2.87 (dd, J = 12, 4.2 Hz, 1H), 2.33-2.21 (m, 1H), 2.09-1.91 (m, 2H),1.87-1.43 (m, 4H), 1.38-1.23 
(m, 4H), 0.90 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 137.5, 136.4, 128.6, 127.4, 
126.6, 126.4, 125.3, 121.7, 119.0, 118.9, 116.1, 109.8, 51.9, 50.0, 46.4, 41.2, 38.3, 29.7 & 29.6 
(1C), 29.3, 27.1, 26.7, 21.7, 14.2; MS (EI, 70 V): m/z 358 [(M+H)•+], 287, 275, 261, 247, 234, 
220, 157, 91, 65; HRMS m/z calcd. for C25H30N2: 358.2408; found: 358.2392. 
 
N
H
H
Me
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1-((3S,4R,4aS,8aR)-3-(1-Benzyl-1H-indol-3-yl)-octahydro-4-methylisoquinolin-2(1H)-yl)-2-
chloroethanone (107): To a stirred solution of amine 106b (60.0 mg, 1.67 mmmol) and Et3N 
(203 mg, 2.01 mmol) in 8 mL CH2Cl2 at 0 °C was added chloroacetyl chloride (208 mg, 1.84 
mmol). The resulting dark colored solution was stirred for 2 h after which the reaction was 
quenched with a saturated aqueous solution of ammonium chloride. The organic layer was 
separated, washed with water and brine, dried (MgSO4) and concentrated. Purification by flash 
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chromatography (50% ether/hexane) afforded 61 mg (83%) of the title compound as yellow oil. 
IR (thin film): 3058, 2926, 2241, 1639, 1465, 1449, 1370, 1017, 910, 735, 693 cm-1; 1H NMR 
(300 MHz, CDCl3, mixture of rotamers were obtained): δ 7.92 (dd, J = 6.6, 1.5 Hz, 1H) & 7.66 
(dd, J = 11.4, 7.2 Hz, 0.4H), 7.36-7.24 (m, 5H), 7.22-7.16 (m, 1H), 7.16 (dd, J = 7.5, 2.4 Hz, 
1H), 7.07 (d, J = 6.3 Hz, 2H), 6.34 (d, J = 5.4 Hz, 1H), & 5.51 (d, J = 5.4 Hz, 0.3H), 5.34 (s, 3H)  
5.29 (s, 0.2H), 4.44 (d, J = 9.9 Hz, 0.3H), 4.33 (d, J = 13.8 Hz, 0.3H), 4.15-3.97 (m, 1H), 4.09 (d, 
J = 3 Hz, 3H), 3.49 (dd, J = 14.1, 3.3 Hz, 1H), 3.26 (d, J = 13.8 Hz, 1H) & 3.18 (dd, J = 14.1, 3.9 
Hz, 0.5H), 2.69-2.58 (m, 0.3H), 2.57-2.44 (m, 1H), 2.31-2.15 (m, 1H), 2.05-1.91 (m, 1H), 1.90-
1.21 (m, 8H), 0.94 (d, J = 6.9 Hz, 3H) & 0.74 (d, J = 6.6 Hz, 1H); 13C NMR (75 MHz, CDCl3, 
for major roramer): δ 164.5, 137.5, 135.8, 129.2, 128.8, 127.5, 127.2, 126.4, 122.3, 120.5, 119.8, 
110.9, 109.2, 50.4, 50.0, 47.4, 41.7, 37.4, 36.3, 30.0, 27.5, 26.0, 25.3, 19.3, 16.1; MS (EI, 70 V): 
m/z 434 [(M)•+], 399, 357, 307, 274, 247, 220, 152, 91; HRMS (Q-TOF) m/z calcd. for 
C27H31N2OCl: 434.2129; found: 434.2119. 
 
NPh
O
Me
TMS
 
5-Methyl-4-((trimethylsilyl)methyl)-3,4-dihydropyridin-1(2H)-yl)(phenyl)methanone (136): 
To a 0 °C stirred solution of indium bromide  (0.250 mmol, 88.5 mg) ) in 1.5 mL CH2Cl2, a 
mixture of enamine 127 (0.25 mmol, 58 mg) and allyltrimethylsilane (0.50 mmol, 72 mg) in 1 
mL CH2Cl2 was added dropwise.  After stirring for 16 h at ambient temperature, the reaction was 
diluted with brine and the layers were separated. The organics were washed with brine and dried 
over MgSO4. The crude product mixture was purified by column chromatography on silica gel 
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using 15% ether/hexanes as eluent affording 22 mg (32%) of the title compound as yellow oil. IR 
(thin film): 2950, 1712, 1638, 1405, 1248, 1134, 840 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.53-
7.28 (m, 5H), 7.02 (s, 0.3 H) & 6.15 (s, 0.7 H), 3.90 (ddd, J = 10.2, 6.3, 3.6 Hz, 0.7H), 3.65 (ddd, 
J = 12.9, 9.6, 3.3 Hz, 0.7H), 3.49 (dd, J = 8.1, 3.3 Hz, 0.6H), 2.22-2.11 (m, 1H), 2.07-1.92 (m, 
1H), 1.76 (s, 1H) & 1.56 (s, 2H), 1.74-1.66 (m, 1H), 0.91 (dd, J = 15, 2.4 Hz, 1H),  0.48 (dd, J =  
15, 11.1 Hz, 1H), 0.6(s, 6H) & 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 135.4, 129.7, 128.3, 
128.1, 127.4, 124.8+121.6 (1C),121.1+118.7 (1C), 37.9, 32.5, 29.9+29.0 (1C), 20.8, 19.2, -0.76; 
MS (EI, 70 V): m/z 287 (M•+), 272, 214, 200, 105, 73; HRMS m/z calcd. For C17H25NOSi: 
287.1705; found: 287.1715. 
 
N
O
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3,4,4a,5,6,8a-Hexahydro-8-methyl-6-tosyl-2H-pyrano[3,2-c]pyridine (148): To a stirred 
solution of pyran (0.50 mmol, 42 mg) and 140 (0.10 mmol, 39 mg) in 1 mL THF, rac-1,1'-
binaphthyl-2,2'-diyl-N-triflylphosphoramidates (0.010 mmol, 4.8 mg) was added.  After stirring 
for 1 hour, the reaction was diluted with a saturated aqueous solution of NaHCO3 and extracted 
with ether. The organics were combined, dried (MgSO4) and concentrated. The crude product 
mixture was purified by column chromatography on silica gel (15% ether/hexanes) affording 16 
mg (51%) of the title compound as oil. IR (thin film): 2929, 1726, 1668, 1454, 1349, 1164, 1052, 
949, 812 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 
6.54 (s, 1 H), 3.79 (d, J = 11.4 Hz, 2H), 3.60 (d, J = 2.1 Hz, 1H), 3.43 (dt, J = 11.1, 2.4 Hz, 2H), 
3.17 (t, J = 11.1 Hz, 1H), 2.42 (s, 3H), 1.92-1.31 (m, 4H), 1.72 (s, 3H); 13C NMR (75 MHz, 
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CDCl3): δ 143.7, 135.2, 129.8, 127, 122.7, 115.2, 72.4, 67.4, 43.3, 31.9, 25.1, 22.3, 21.5, 18; 
HRMS (Q-TOF) m/z calcd. For C167H22NO3S [(M+H)+]: 308.1320; found: 308.1329. 
 
N
Ts R
N
Ts R
Me
1 mol % Ir(PCy3)3+
30:1 CH2Cl2/acetone
35 °C, 20-30 min
 
General Procedure C. Iridium(I)-catalyzed isomerization of N-alkyl-N-tosylallylamines:89
 
 
A solution of [(cC8H14)2IrCl]2 (0.5 mol%, 0.01 equiv Ir, 4.5 mg) and PCy3 (1.5 mol%, 0.03 equiv, 
8.5 mg), and NaBPh4 (0.01 mol%, 0.01 equiv, 3.4 mg, 0.01 mmol) were dissolved in 3.1 mL of 
CH2Cl2/acetone (30:1). The resulting mixture was stirred at ambient temperature until a clear 
yellow solution resulted (~30 min). The reaction flask was placed in a 35 °C oil bath and stirred 
an additional 10 min, whereupon the allylic sulfonamides (1 mmol) were added via syringe. The 
reaction was stirred 30 min then cooled to ambient temperature and concentrated. The resulting 
residue was purified by flash chromatography on silica gel (10% ether in hexanes eluent). 
N OMe
Me
Ts
 
(E)-N-(Methoxymethyl)-N-(prop-1-enyl)-p-toluenesulfonamide (55): General Procedure C 
was followed employing N-allyl-N-(methoxymethyl)-4-methylbenzenesulfonamide 183 (5.60 
mmol, 1.43 g). Purification by column chromatography afforded 1.33 g (93%) of the title 
                                                 
89 Nelson, S. G.; Bungard, C. J.; Wang, K. J. Am. Chem. Soc. 2003, 125, 13000-13001. Slightly modified procedure 
was followed. Tosyl protected allylamine derivatives are especially good substrate for Ir(I)-catalyzed isomerization. 
Small to large scale (3 g of substrate loading) can be performed with as low as 1 mol % to Ir(I) catalyst loading. 
Reaction is sluggish at room temperature but proceeds to completion at slightly elevated temperature (35-40 °C). 
Typical ratio of Ir+:NaBPh4:PCy3 is 1:2:3 and CH2Cl2: CH3COCH3  is 30:1. 
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compound as a viscous oil that solidified upon storage at 4 °C. Mp: 29-32 °C; IR (thin film): 
2936, 2887, 1662, 1453, 1399, 1290, 1058, 912 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.68 (d, J = 
8.1 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 6.39 (dd, J = 14.1, 1.6 Hz, 1H), 5.28 (ddd, J = 20.7, 13.5, 
6.7 Hz, 1H), 4.85 (s, 2H), 3.31 (s, 3H), 2.41 (s, 3H), 1.64 (dd, J = 6.6, 1.5 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 143.6, 137.0, 129.7, 126.9, 125.9, 110.8, 79.0, 55.7, 21.5, 15.3; MS (EI, 70 V): 
m/z 255 (M•+), 224, 155, 119, 91, 68; HRMS: m/z calcd. for C12H17NO3S: 255.0929; found: 
255.0940. 
 
N
Me
Me
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(E)-N,4-Dimethyl-N-(prop-1-enyl)-p-toluenesulfonamide (80): General Procedure C was 
followed employing N-allyl-N,4-dimethylbenzenesulfonamide 185 (2.0 mmol, 0.45 g).  
Purification by column chromatography afforded 0.41 g (91%) of the title compound as a 
colorless solid. Mp: 47-50 °C; IR (thin film): 2922, 2866, 1658, 1597, 1453, 1382, 1198, 992 cm-
1; 1H NMR (300 MHz, CDCl3): δ 7.62 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 7.8 Hz, 2H), 6.70 (dd, J = 
14.1, 1.2 Hz, 1H), 4.73 (ddd, J = 20.4, 13.2, 6.6 Hz, 1H), 2.82 (s, 3H), 2.42 (s, 3H), 1.67 (dd, J = 
6.6, 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 143.5, 134.6, 129.6, 128.2, 127.0, 106.3, 32.2, 
21.5, 15.1; MS (EI, 70 V): m/z 225 (M•+), 161, 155, 139, 120, 105, 91, 89; HRMS m/z calcd. for 
C11H15NO2S: 225.0823; found: 225.0823. 
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(E)-N-(Methoxymethyl)-N-(prop-1-enyl)-thiophene-2-sulfonamide (102): General Procedure 
C was followed employing N-allyl-N-(methoxymethyl)-thiophene-2-sulfonamide 214 (1.00 
mmol, 247 mg). Purification by column chromatography afforded 230 mg (93%) of the title 
compound as a viscous oil. IR (thin film): 3107, 2939, 1662, 1403, 1359, 1227, 1174, 1058, 912 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.64-7.53 (m, 2H), 7.08 (t, J = 4.2 Hz, 1H), 6.39 (dd, J = 
13.8, 1.5 Hz, 1H), 5.36 (dq, J = 13.5, 6.6 Hz, 1H), 4.88 (s, 2H), 3.34 (s, 3H), 1.68 (dd, J = 6.6, 
1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 140.4, 132.2, 132.1, 127.3, 125.5, 112.6, 79.4, 55.9, 
15.4; MS (EI, 70 V): m/z 247 (M•+), 216, 156, 147, 131, 111, 99, 83, 68, 57; HRMS: m/z calcd. 
for C9H13NO3S2: 247.0337; found: 247.0332. 
 
N OMe
Ts
Me  
(E)-N-(but-1-enyl)-N-(methoxymethyl)-p-toluenesulfonamide (213): General Procedure C 
was followed employing (E)-N-(but-2-enyl)-N-(methoxymethyl)-p-toluenesulfonamide 215 (2.00 
mmol, 538 mg). The conversion was found to be poor (~16% after 3h). Purification by column 
chromatography afforded 80 mg (94%, brsm) of the title compound as a viscous oil. IR (thin 
film): 2961, 1658, 1458, 1351, 1173, 1062, 949, 812 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.68 
(d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 6.38 (d, J = 14.1 Hz, 1H), 5.28 (ddd, J = 13.8, 6.9, 
69 Hz, 1H), 4.85 (s, 2H), 3.30 (s, 3H), 2.40 (s, 3H), 2.00 (dpent, J = 7.2, 1.2 Hz, 2H), 0.95 (t, J =  
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7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 143.6, 136.9, 129.6, 126.9, 124.5, 117.4, 78.8, 55.7, 
23.4, 21.5, 14.1; HRMS (Q-Tof): m/z calcd. for C13H19NO3SNa [(M + Na)+]: 292.0983; found: 
292.0963. 
 
NH
Me
O
MeO
 
 (E)-Methyl prop-1-enylcarbamate (187): [(cC8H14)2IrCl]2 (0.28 mol%×3, 8.8 mg), PCy3 (0.84 
mol%×3, 0.03 equiv, 14.28 mg), and NaBPh4 (0.56 mol%×3, 5.7 mg) were dissolved in 9 mL of 
BTF/acetone (30:1). The resulting mixture was stirred at ambient temperature until a clear 
yellow solution resulted (~10 min). The reaction flask was placed in a 80 °C oil bath and stirred 
an addition 10 min, whereupon methyl N-allylcarbamate 186 (3.5 mmol, 0.42 g) was added. The 
reaction was stirred for 60 min then cooled to ambient temperature and concentrated. The 
resulting residue was purified by flash chromatography on silica gel (10% ether in hexanes 
eluent) which afforded 0.36 g (91%) of the title compound (colorless solid) as a non separable 
4:1 mixture of E/Z isomers. Mp: 47-49 °C; IR (thin film): 3294, 2958, 1704, 1528, 1242, 1041, 
952 cm-1; 1H NMR (300 MHz, CDCl3, for major isomer): δ 6.55-6.34 (m, 1H), 5.00 (dq, J = 
13.2, 6.6 Hz, 1H), 3.67 (s, 3H), 1.62 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3, for major 
isomer): δ 154.2, 124.1, 105.5, 52.3, 14.6; MS (EI, 70 V): m/z 115 (M•+), 100, 86, 84, 70, 59, 56; 
HRMS m/z calcd. for C5H9NO2: 115.0633; found: 115.0637. 
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General Procedure D. Ru(II)-catalyzed Isomerization of Allylamine Derivatives:90
 
 A two-
necked roundbottomed flask was fitted with a condenser and charged with N-(1-methoxypropyl)-
N-tosylprop-2-en-1-amine (1 equiv), vinyloxytrimethylsilane (1 equiv), and 12 mL of CH2Cl2. 
The resulting solution was placed in a preheated 50 °C oil bath and a solution of the Grubbs 2nd 
generation catalyst (Grubbs II, 5 mol%, 0.05 equiv) in 2 mL CH2Cl2 was added and the resulting 
solution was stirred at 45-50 °C until the reaction was complete (determined by 1H NMR 
analysis of reaction aliquots). The reaction was cooled to ambient temperature, the reaction 
mixture was concentrated and purified by column chromatography (10-20% ether in hexanes 
eluents). 
N OMeMeO
O
Me  
(E)-Methyl methoxymethyl(prop-1-enyl)carbamate (59): General Procedure D was followed 
employing methyl allyl(methoxymethyl)carbamate 184 (2.80 mmol, 0.445 g), vinyloxytrimethyl 
-silane (2.8 mmol, 0.33 g) and Grubbs II (0.056 mmol, 47.5 mg) in 10 mL CH2Cl2. Purification 
                                                 
90 (a) Arisawa, M.; Terada, Y.; Nakagawa, M.; Nishida, A. Angew. Chem., Int. Ed. 2002, 41, 4732-4734. (b) Terada, 
Y.; Arisawa, M.; Nishida, A. Angew. Chem., Int. Ed. 2004, 43, 4063-4067. Benzylidene[1,3-bis(12,4,6 
trimethylphenyl)-2-imidazolidinylidene]dichloro(tricyclohexylphosphine)ruthenium [CAS 246047-72-3]. The 
isomerization can be performed in small to large scale (1 g of substrate loading) using as low as 1.6 mol % catalyst 
loading at 45-50 °C for 2 h in CH2Cl2. A complete conversion was obtained and longer time enhanced the E/Z ratio 
(typical E/Z ratio was 8 to 1).  
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by flash chromatography afforded 0.4 g (91%) of the title compound as a yellowish oil. IR (thin 
film): 2956, 1720, 1666, 1444, 1394, 1282, 1146, 1083 cm-1; 1H NMR (300 MHz, CDCl3): δ  
6.71 (m, 1H), 5.31-5.19 (m, 1H), 4.96 (br s, 2H), 3.78 (s, 3H), 3.31 (s, 3H), 1.68 (d, J = 6.6 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ  154.7, 127.0, 107.3, 76.8, 53.5, 53.1, 15.3; MS (EI, 70 eV): 
m/z 159 (M•+), 144, 128, 97, 84, 69, 57; HRMS m/z calcd. for C7H13NO3: 159.0895; found: 
159.0891. 
 
N OMeBnO
O
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(E)-Benzylmethoxymethyl(prop-1-enyl)carbamate (60): General Procedure D was followed 
employing benzyl allyl(methoxymethyl)carbamate 192 (1.00 mmol, 0.235 g ), 
vinyloxytrimethylsilane (1.00 mmol, 0.116 g) and Grubbs II (5 mol %, 0.050 mmol, 42 mg) in 3 
mL CH2Cl2. Purification by flash chromatography afforded 0.21 g (90%) of the title compound 
as a yellowish liquid. IR (thin film): 2936, 1983, 1718, 1667, 1456, 1278, 1140, 946 cm-1; 1H 
NMR (300 MHz, CDCl3): δ  7.39-7.30 (m, 5H), 6.77 (d, J= 13.2 Hz, 1H), 5.29 (dq, J = 13.2, 6.6 
Hz, 1H), 5.22 (s, 2H), 5.0 (s, 2H), 3.31 (s, 3H), 1.68 (dd, J = 6.6, 0.9 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ  154.2, 136.0, 128.6, 128.3, 128.1, 126.9, 107.5, 77.2, 67.9, 55.7, 15.6; MS (EI, 
70 eV): m/z 235 (M•+), 204, 160, 144, 107; HRMS m/z calcd. for C13H17NO3: 235.1208; found: 
235.1206. 
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(E)-Methyl acetoxymethyl(prop-1-enyl)carbamate (62): General Procedure D was followed 
employing methyl allyl(acetyloxymethyl)carbamate 193 (2.00 mmol, 0.375 g), vinyloxytrimethyl 
-silane (2.00 mmol, 0.232 g) and Grubbs II (0.04 mmol, 34 mg) in 12 mL CH2Cl2. Purification 
by flash chromatography afforded 0.3 g (80%) of the title compound as a yellowish liquid. IR 
(thin film): 2959, 1742, 1726, 1669, 1445, 1373, 1221, 950 cm-1; 1H NMR (300 MHz, CDCl3): δ  
6.68-6.58 (m, 1H), 5.58 (br s, 2H), 5.13 (dq, J = 13.3, 6.6 Hz, 1H), 3.76 (s, 3H), 2.07 (s, 3H), 
1.69 (dd, J = 6.6, 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ  170.4, 154.2, 126.7, 107.4, 70.1, 
53.5, 20.8, 15.2; MS (EI, 70 eV): m/z 187 (M•+), 128, 115, 100, 83, 68, 59; HRMS m/z calcd. for 
C8H13NO4: 187.0844; found: 187.0847. 
 
N OMe
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(+/−)-N-(1-Methoxypropyl)-N-(prop-1-enyl)-p-toluenesulfonamide (83): General procedure 
D was followed employing N-(1-methoxypropyl)-N-tosylprop-2-en-1-amine 204 (4.00 mmol, 
1.13 g), vinyloxytrimethylsilane (4.00 mmol, 0.465 g), and 50 mL of CH2Cl2. A solution of the 
Grubbs 2nd generation catalyst (Grubbs II) (0.200 mmol, 170 mg) was added. After completion 
(determined by 1H NMR analysis of reaction aliquots), the reaction was cooled to ambient 
temperature, the reaction mixture was concentrated and purified by column chromatography 
(SiO2, 10% ether in hexanes) to afford the title compound as a brown oil (94% yield). IR (thin 
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film): 3033, 2937, 1659, 1597, 1494, 1460, 1345, 1165, 1081, 989, 814 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.70 (d, J = 8.1 Hz, 2H), 7.28 (d, J = 10.2 Hz, 2H), 5.80 (dd, J = 14.0, 0.9 Hz, 
1H), 5.65 (dq, J = 14.1, 6.6 Hz, 1H), 5.04 (t, J = 6.6 Hz, 1H), 3.23 (s, 3H), 2.42 (s, 3H), 1.73 
(ddq, J = 21.3, 14.4, 7.5 Hz, 1H), 1.67 (dd, J = 6.6, 1.2 Hz, 3H), 1.50 (ddq, J = 21.3, 14.4, 7.2 Hz, 
1H), 0.83 (d, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 143.3, 137.8, 129.4, 127.4, 124.9, 
121.5, 91.7, 56.0, 26.1, 21.5, 15.8, 9.5; MS (EI, 70 V): m/z 283 (M•+), 252, 211, 155, 147, 120, 
96, 91, 73; HRMS m/z calcd. for C14H21NO3S: 283.1242; found: 283.1236. 
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(E)-N-(Methoxymethyl)-N-(prop-1-enyl)benzamide (126): General Procedure D was followed 
employing N-allyl-N-(methoxymethyl)benzamide 191 (1.00 mmol, 0.205 g), 
vinyloxytrimethylsilane (1.00 mmol, 0.116 g) and Grubbs II (1.8 mol %, 0.018 mmol, 15 mg) in 
3 mL CH2Cl2. Purification by flash chromatography afforded 0.18 g (88%) of the title compound 
as a pale yellowish liquid. IR (thin film): 3418, 2254, 2128, 1652, 1026, 825 cm-1; 1H NMR (300 
MHz, DMSO-d6, calibrated at 2.49 ppm at 65 °C): δ  7.50-7.47 (m, 5H), 6.63 (d, J = 13.8 Hz, 
1H), 5.39 (dq, J = 14.1, 7.2 Hz, 1H), 4.93 (s, 2H), 3.22 (s, 3H), 1.63 (d, J = 6.9 Hz, 3H); 13C 
NMR (75 MHz, DMSO-d6, calibrated at 39.5 ppm at room temperature): δ 169.8, 135.2, 130.5, 
128.5, 127.8, 127.5, 108.9, 76.8, 55.1, 15.3; MS (EI, 70 eV): m/z 205 (M•+), 175, 173, 164, 105; 
HRMS m/z calcd. for C12H15NO2: 205.1103; found: 205.1098. 
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(E)-(N-(Prop-1-enyl)methylacetate)benzamide (127): General Procedure D was followed 
employing N-allyl-N-(methoxyacetate)benzamide 195 (5.58 mmol, 1.30 g). Purification by flash 
chromatography afforded 1.12g (85%) of the title compound as a pale yellowish liquid. IR (thin 
film): 2922, 1744, 1685, 1446, 1396, 1369, 1219, 1020, 951 cm-1; 1H NMR (300 MHz, CDCl3): 
δ  7.55-7.48 (m, 2H), 7.46-7.37 (m, 3H), 6.71 (s, br, 1H), 5.64 (s, br, 2H), 5.26 (dq, J = 13.5, 6.6 
Hz, 1H), 2.10 (s, 3H), 1.63 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 170.4, 170.3, 
134.4, 130.8, 128.4, 127.8, 109.4, 20.8, 15.3; MS (EI, 70 eV): m/z 233 (M•+), 174, 161, 106, 78, 
56; HRMS m/z calcd. for C13H15NO3: 233.1052; found: 233.1058. 
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(E)-N-Methylacetate-N-(prop-1-enyl)-p-toluenesulfonamide (131): General Procedure D was 
followed employing N-allyl-N-(methylacetate)-p- toluenesulfonamide 194 (2.47 mmol, 700 mg). 
Purification by flash chromatography (20% ether in hexanes) afforded 645 mg (92%) of the title 
compound as a yellowish oil that solidified upon storage at 4 °C. Mp: 43-44 °C. IR (thin film): 
3036, 2923, 1745, 1664, 1453, 1361, 1216, 1171, 1090, 1018, 994, 811 cm-1; 1H NMR (300 
MHz, CDCl3): δ  7.71 (d, J = 8.1 Hz, 2H), 7.30 ( dd, J =  8.4, 0.6 Hz, 2H), 6.42 (dq, J = 13.8, 1.5 
Hz, 1H), 5.60 (s, 2H), 5.18 (dq, J = 13.5, 6.6 Hz, 1H), 1.86 (s, 3H), 1.66 (dd, J = 6.9, 1.5 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ  169.9, 144, 136.4, 129.5, 127.3, 125.5, 111.8, 71.3, 21.5, 
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20.5, 15.2; MS (EI, 70 eV): m/z 283 (M•+), 225, 219, 211, 184, 156, 146, 140, 132, 105, 90, 88, 
63; HRMS m/z calcd. for C13H17NO4S:  283.0878; found: 283.0879. 
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(E)-N-4-Nitrobenzylmethyl-N-(prop-1-enyl)-p-toluenesulfonamide (139): General Procedure 
D was followed employing N-allyl-N-(4-nitrobenzoatemethyl)-p-toluenesulfonamide 197 (0.660 
mmol, 310 mg). Purification by flash chromatography (20% ether in hexanes) afforded 260 mg 
(83%) of the title compound as a brownish oil that solidified upon storage at 4 °C. Mp: 90-91 °C. 
IR (thin film): 2922, 1728, 1528, 1357, 1270, 1171, 1089, 996, 718 cm-1; 1H NMR (300 MHz, 
CDCl3): δ  8.16 (d, J = 9 Hz, 2H), 7.75 (d, J = 9.3, 2H),  7.72 (d, J =  9 Hz, 2H), 7.25 (d, J = 8.4 
Hz, 2H), 6.56 (dd, J = 14.1, 1.8 Hz, 1H), 5.88 (s, 2H), 5.25 (dq, J = 14.1, 6.9 Hz, 1H), 2.38 (s, 
3H), 1.70 (dd, J = 3.6, 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 163.4, 150.6, 144.2, 136.7, 
134.4, 130.7, 129.7, 127.3, 125.7, 123.3, 112.3, 72.8, 21.5, 15.3; MS (EI, 70 eV): m/z 390 (M•+), 
326, 269, 235, 224, 205, 171, 155, 150, 119, 92, 84, 68, 65; HRMS m/z calcd. for C18H18N2O6S:  
390.0885; found: 390.0874. 
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(E)-N-3-Nitrobenzylmethyl-N-(prop-1-enyl)-p-toluenesulfonamide (140): General Procedure 
D was followed employing N-allyl-N-(3-nitrobenzoatemethyl)-p-toluenesulfonamide 198 (5.00 
mmol, 1.95 g). Purification by flash chromatography (20% ether in hexanes) afforded 1.56 g 
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(80%) of the title compound as a brownish oil that solidified upon storage at 4 °C. Mp: 93-95 °C. 
IR (thin film): 3086, 2922, 1728, 1534, 1352, 1228, 1172, 1122, 995, 717 cm-1; 1H NMR (300 
MHz, CDCl3): δ  8.39 (ddd, J = 8.1, 2.1, 0.9 Hz, 1H), 8.33 (t, J = 1.8, 1H), 8.04 (dt, J = 7.8, 1.2 
Hz, 1H), 7.74 (d, J =  8.1 Hz, 2H), 7.58 (t, J = 8.1 Hz, 1H), 7.26 (d, J = 7.5 Hz, 2H), 6.56 (dq, J = 
14.1, 1.5 Hz, 1H), 5.92 (s, 2H), 5.25 (dq, J = 13.5, 6.6 Hz, 1H), 2.36 (s, 3H), 1.69 (dd, J = 6.9, 
1.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ  163.3, 148.1, 144.4, 136.4, 135.3, 130.8, 129.8, 
129.6, 127.7, 127.2, 125.6, 124.2, 112.2, 72.9, 21.5, 15.3; MS (EI, 70 eV): m/z 390 (M•+), 326, 
235, 224, 205, 151, 139, 88, 75, 63; HRMS m/z calcd. for C18H18N2O6S:  390.0886; found: 
390.0894. 
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(E)-N-Methylacetate-N-(prop-1-enyl)-thiophene-2-sulfonamide (141): General Procedure D 
was followed employing N-allyl-N-(methylacetate)-thiophene-2-sulfonamide 196 (1.00 mmol, 
275 mg). Purification by flash chromatography (25% ether in hexanes) afforded 240 mg (87%) 
of the title compound as a yellowish oil. IR (thin film): 3100, 2921, 1744, 1664, 1365, 1213, 
1167, 1018, 993, 949 cm-1; 1H NMR (300 MHz, CDCl3): δ  7.62 (dt, J = 3.9, 1.2 Hz, 2H), 7.10 ( 
dt, J = 4.8, 0.9 Hz, 1H), 6.40 (dd, J = 14.1, 1.5 Hz, 1H), 5.62 (s, 1H), 5.30 (dq, J = 13.5, 6.9 Hz, 
1H), 1.93 (s, 3H), 1.70 (dd, J = 6.9, 1.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ  169.8, 139.8, 
133.0, 132.7, 127.2, 125.1, 113.7, 71.6, 20.6, 15.2; MS (EI, 70 eV): m/z 275 (M•+), 223, 203, 
155, 147, 139, 112, 91, 65; HRMS m/z calcd. for C10H13NO4S2:  275.0286; found: 275. 0279. 
 
 138 
Boc
N
Me
O
O
NO2  
(E)-N-(3-Nitrobenzylmethyl)-N-(prop-1-enyl)-tert-butoxycarbmide (152): General Procedure 
D was followed employing N-allyl-N-(3-nitrobenzoatemethyl)-tert-butyloxy carbamide 199 
(0.660 mmol, 224 mg). Purification by flash chromatography (15% ether in hexanes) afforded 
211 mg (94%) of the title compound as a brownish oil. IR (thin film): 2977, 1720, 1670, 1533, 
1395, 1253, 1124, 947 cm-1; 1H NMR (300 MHz, CDCl3): δ  8.84 (t, J = 1.8 Hz, 1H), 8.43 (ddd, 
J = 8.1, 2.1, 0.9, 1H),  8.35 (d, J =  7.8 Hz, 1H), 7.66 (t, J = 7.8 Hz, 1H), 6.75 (d, J = 12.6 Hz, 
1H), 5.87 (s, 2H), 5.16 (dd, J = 14.1, 6.9 Hz, 1H),  1.71 (dd, J = 6.6, 1.5 Hz, 3H), 1.52 (s, 9H); 
13C NMR (75 MHz, CDCl3): δ  163.9, 152.2, 148.3, 135.4, 131.5, 129.7, 127.6, 127.0, 124.7, 
106.5, 82.5, 71.3, 28.1, 15.3; MS (EI, 70 eV): m/z 336 (M•+), 236, 219, 170, 151, 104, 76, 70, 57; 
HRMS m/z calcd. for C16H20N2O6:  336.1321; found: 336.1337. 
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(E)-N-(Prop-1-enyl)-N-(3-nitrobenzylmethyl)-formamide (153): General Procedure D was 
followed employing N-allyl-N-(3-nitrobenzylmethyl)-formamide 200 (3.59 mmol, 940 mg). 
Purification by flash chromatography (40% ether in hexanes) afforded 526 mg (56%, 80% brsm) 
of the title compound (2:1 mixture of non convertible rotamers) as a brownish oil. IR (thin film): 
3087, 2922, 1730, 1697, 1670, 1533, 1397, 1352, 1258, 1122, 951, 774 cm-1; 1H NMR (300 
MHz, CDCl3, for both of the rotamers): δ  8.80 (t, J = 2.1 Hz, 1.5H), 8.47-8.28 (m, 4.5H), 7.68 (t, 
J = 8.1 Hz, 1H) &7.65 (t, J = 8.1 Hz, 0.5H), 6.90 (dd, J = 14.7, 1.5 1H) & 6.37 (dd, J = 14.7, 1.5 
 139 
Hz, 0.5H), 5.85 (s, 2H) & 5.76 (s, 1H), 5.57 (dq, J = 14.4, 6.9 Hz, 1H) & 5.43 (dq, J = 14.4, 6.9 
Hz, 0.5H), 1.76 (dd, J = 6.9, 1.8 Hz, 3H) & 1.74 (dd, J = 6, 1.5 Hz, 1.5H); 13C NMR (75 MHz, 
CDCl3): δ  164 & 163.7, 162.1 & 161.6, 148.3, 135.4 & 135.3, 131 & 130.8, 129.9 & 127.7, 128 
& 127.8, 126.4, 124.7 & 123.1, 111.1 & 109.9, 71.7 & 66.6, 15.4 & 15.1; MS (EI, 70 eV): m/z 
264 (M•+), 236, 206, 167, 150, 134, 121, 104, 97, 92, 77, 74, 65; HRMS m/z calcd. for 
C12H12N2O5:  264.0746; found: 264.0750. 
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(E)-tert-Butyl cyanomethyl(prop-1-enyl)carbamate (190): General Procedure D was followed 
employing tert-butyl allyl(cyanomethyl)carbamate 189 (0.51 mmol, 0.10 g), 
vinyloxytrimethylsilane (0.51 mmol, 60 mg) and Grubbs II (0.024 mmol, 20 mg) in 3 mL 
CH2Cl2. Purification by flash chromatography afforded 83 mg (83%) of the title compound  as a 
pale yellowish liquid. IR (thin film): 2979, 2934, 2246, 1711, 1667, 1397, 1373, 1163, 969 cm-1; 
1H NMR (300 MHz, CDCl3): δ  6.82-6.66 (m, 1H), 4.95 (dq, J = 13.1, 9 Hz, 1H), 4.44+4.34 (2 S, 
2H), 1.74 (dd, J = 6.6, 1.5 Hz, 3H), 1.51 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 151.8, 126.4, 
115.1, 105.5, 83.0, 32.0, 28.1, 15.2; MS (EI, 70 eV): m/z 196 (M•+), 181, 140, 123, 96, 84; 
HRMS m/z calcd. for C10H16N2O2: 196.1211; found: 196.1209. 
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(+/−)-N-(1-Methoxyphenyl)-N-(prop-1-enyl)-p-toluenesulfonamide (206): General procedure 
D was followed employing N-(1-methoxybenzyl)-N-tosylprop-2-en-1-amine 205 (0.500 mmol, 
165 mg), vinyloxytrimethylsilane (0.50 mmol, 58 mg), and 5 mL of CH2Cl2. A solution of the 
Grubbs 2nd generation catalyst (Grubbs II) (0.025 mmol, 21 mg) was added. After completion 
(determined by 1H NMR analysis of reaction aliquots), the reaction was cooled to ambient 
temperature, the reaction mixture was concentrated and purified by column chromatography 
(SiO2, 10% ether in hexanes) to afford 150 mg (91%) of the title compound as a brown oil. IR 
(thin film): 2924, 1597, 1451, 1340, 1165, 1096, 1005, 814, 666 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.76 (d, J = 8.1 Hz, 2H), 7.32 - 7.26 (m, 7H), 6.28 (s, 1H), 5.66 (dq, J =  13.8, 1.5 Hz, 
1H), 5.45 (dq, J =  13.8, 6.6 Hz, 1H), 3.39 (s, 3H), 2.44 (s, 3H), 1.49 (dd, J =  6.9, 1.5 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 143.6, 137.2, 137.1, 129.5, 128.1, 128.0, 127.5, 126.7, 124.1, 
121.5, 89.6, 56.3, 21.6, 15.7; MS (EI, 70 V): m/z 331 (M•+), 300, 224, 155, 147, 121, 105, 91, 77; 
HRMS m/z calcd. for C18H21NO3S: 331.1242; found: 331.1239. 
 
N
Z
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N
Z
OR
ROH, Et3N
CH2Cl2
 0 °C - rt
NH
Z paraformaldehyde
TMSCl
rt -  45 °C
N-ChloromethylamineN-allylamine  
General Procedure E. N-(Methyl)-benzoate preparation via N-Chloromethylation of N-
allylamine: To a mixture of paraformaldehyde (2 equiv) and N-allylamine (1 mmol, 1 equiv) 
was added 0.5 mL of TMSCl and the resulting mixture was stirred at room temperature (or 
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warmed to 45 °C) until completed (determined by 1H NMR analysis of reaction aliquots). The 
reaction was diluted with CH2Cl2 and the resulting mixture was passed through celite. Combined 
organics were concentrated and used for the next reaction.91
To a 0 °C solution of triethylamine (3 equiv) and ROH (1 mmol, 1 equiv) in 5 mL 
CH2Cl2, N-(chloromethyl)-allylamine was added (in 1 mL CH2Cl2).  The resulting mixture was 
stirred at room temperature until completion (~ 1h). The reaction was diluted with a saturated 
aqueous solution of NaHCO3 and the layers were separated. The organics were combined and 
washed with water, dried over MgSO4 and concentrated. The resulting residue was purified by 
flash chromatography on silica gel (15-25% ether in hexanes eluent). 
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N-Allyl-N-(chloromethyl)-p-toluenesulfonamide (208): General Procedure E was followed 
employing N-allyl-N,4-methylbenzenesulfonamide (23.7 mmol, 5.00 g) and paraformaldehyde 
(47.4 mmol, 1.33 g) in 12 mL TMSCl under nitrogen atmosphere at room temperature. The 
resulting heterogeneous mixture was stirred vigorously for 2 h. Filtration and removal of the 
solvent afforded the title compound (quantitative) as yellow oil. 1H NMR (300 MHz, CDCl3): δ 
7.79 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 5.76 (dddd, J = 16.8, 10.2, 6.6, 6.6 1H), 5.44 
(s, 2H), 5.33 (ddd, J = 9, 2.4, 0.6 Hz, 2H), 3.80 (d, J = 6.3 Hz, 2H), 2.44 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ 144.4, 135.2, 131, 129.7, 128.3, 121, 59.5, 48.1, 21.6. 
 
                                                 
91 The products contained small amount of  paraformaldehyde.  
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N-Allyl-N-(chloromethyl)-thiophene-2-sulfonamide: General Procedure E was followed 
employing N-allyl-N,thiophene-2-sulfonamide (2.46 mmol, 0.500 g) and paraformaldehyde (3.0 
mmol, 90 mg) in 2 mL TMSCl. Filtration and removal of the solvent afforded the title compound 
(0.59 g, 95 %) as yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.71 (dd, J = 3.9, 1.5 Hz, 1H), 7.67 
(dd, J = 5.9, 1.5 Hz, 1H), 7.13 (dd, J = 5.1, 3.9 Hz, 1H), 5.79 (dddd, J = 16.5, 10.8, 6.6, 6.6 Hz, 
1H), 5.42 (s, 2H), 5.38 (dd, J = 13.8, 1.2 Hz, 1H), 5.34 (dd, J =  6.9, 1.2 Hz, 1H),  3.90 (d, J =  
6.6 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 138.4, 133.8, 133.3, 130.8, 127.6, 121.2, 59.2, 48.3.  
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N-Allyl-N-(methylacetate)-thiophene-2-sulfonamide (196): General Procedure E was followed 
employing N-allyl-N-(chloromethyl)-thiophene-2-sulfonamide (0.50 mmol, 0.13 g), acetic acid 
(0.60 mmol, 36 mg), and triethylamine (2.0 mmol, 0.28 mL) in 5 mL CH2Cl2. Purification by 
flash chromatography (15% ether/hexanes) afforded the title compound (0.44 g, 88%) as 
colorless oil. IR (thin film): 3097, 2983, 1745, 1403, 1345, 1232, 1157, 1016, 945 cm-1;  1H 
NMR (300 MHz, CDCl3): δ 7.64 (d, J = 1.8 Hz, 1H), 7.63 (d, J = 1.8 Hz, 1H), 7.10 (dd, J = 4.8, 
3.9 Hz, 1H), 5.74 (dddd, J = 12.6, 9.9, 6.3, 6.3 Hz,  1H), 5.28 (dd, J = 11.21, 1.2 Hz, 1H), 5.24 
(dd, J = 3.9, 1.2 Hz, 1H), 3.88 (d, J = 6.3, 2H), 1.93 (s, 3H), 1.88 (s, 3H); 13C NMR (75 MHz, 
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CDCl3): δ 169.9, 140.1, 132.8, 132.5, 131.6, 127.1, 119.7, 70.9, 49.4, 20.4; HRMS (QTof): m/z 
calcd. for C10H13NO4S2Na ; [(M+Na)+],: 298.0184; found: 298.0180. 
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N-Allyl-N-(4-nitrobenzoatemethyl) )-p-toluenesulfonamide (197): General Procedure E was 
followed employing N-allyl-N-(chloromethyl)-p- toluenesulfonamide (4.81 mmol, 1.25 g), p-
nitrobenzoic acid (5.77 mmol, 0.800 g), and triethylamine (7.11 mmol, 0.990 mL) in 15 mL 
CH2Cl2. Purification by flash chromatography (25% ether/hexanes) afforded 1.6 g (85%) of the 
title compound as oil which solidified upon standing. Mp: 84-85 °C; IR (thin film): 3112, 2981, 
1727, 1604, 1528, 1348, 1266, 1162, 1082, 900, 718 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.18 
(d, J = 9.3 Hz, 2H), 7.73 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.84(d, J = 9.3 Hz, 2H),  
5.76 (dddd, J = 16.5, 10.2, 6.3, 6.3 Hz, 1H), 5,41 (s, 2H), 5.22 (ddq, J = 9.3, 9.3, 1.2 Hz, 2H), 
3.89 (d, J = 6.6 Hz, 2H), 2.46 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 161.4, 144, 142, 136.4, 
131.7, 129.6, 127.7, 125.9, 120.1, 115.1, 75.4, 49.0, 21.5; HRMS (Q-Tof): m/z calcd. for 
C18H18N2O6SNa [(M+Na)+]: 390.0783; found: 390.0797. 
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N-Allyl-N-(3-nitrobenzoatemethyl)-p-toluenesulfonamide (198): General Procedure E was 
followed employing N-allyl-N-(chloromethyl)-p- toluenesulfonamide (10.0 mmol, 2.95 g), m-
nitrobenzoic acid (15 mmol, 1.7 g), and triethylamine (20 mmol, 2.8 mL) in 30 mL CH2Cl2. 
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Purification by column chromatography (20% ether/hexanes) afforded 3.2 g (82%)  of the title 
compound as oil which solidified upon standing. Mp: 64-65 °C; IR (thin film): 3088, 2925, 1727, 
1616, 1534, 1351, 1258, 1163, 1120, 904 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.44-8.38 (m, 
2H), 8.12 (dt, J = 7.8, 1.2 Hz, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.60 (dd, J = 9, 7.8 Hz, 1H), 7.30 (d, 
J = 8.1 Hz, 2H), 5.80 (dddd, J = 16.5, 10.2, 6.6, 6.6 Hz, 1H) 3.95 (d, J = 6.3 Hz, 2H), 2.38 (s, 
3H); 13C NMR (75 MHz, CDCl3): δ 163.5, 148.1, 144.2, 136.9, 135.3, 131.8, 131.0, 129.8, 
129.6, 127.7, 127.4, 124.2, 120.1, 72.8, 49.7, 21.4; MS (EI, 70 V): m/z 390 (M•+), 235, 226, 139, 
134, 121, 107, 90, 77, 69, 64; HRMS: m/z calcd. for C18H18N2O6S: 390.0886; found: 390.0868. 
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N-Allyl-N-(3-nitrobenzoatemethyl)-tert- butyloxycarbamide (199): General Procedure E was 
followed employing N-allyl-N-(chloromethyl)-tert- butyloxycarbamide92
                                                 
92 N-Allyl-N-(chloromethyl)-tert- butyloxycarbamide was prepared from N-allyl-tert-butyloxycarbamide, 
paraformaldehyde and TMSCl. 
 (4.25 mmol, 0.875 g), 
m-nitrobenzoic acid (5.32 mmol, 0.890 g), and triethylamine (8.5 mmol, 1.9 mL) in 20 mL 
CH2Cl2. Purification by flash chromatography (20% ether in hexanes) afforded 1.1 g (77%) of 
the title compound as oil. IR (thin film): 3084, 2978, 1700, 1535, 1350, 1160, 921, 847 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 8.85 (t, J = 1.8 Hz, 1H), 8.43 (d, J = 8.1 Hz, 1H), 8.35 (d, J = 7.5 Hz, 
1H), 7.66 (t, J = 7.8 Hz, 1H), 5.85 (dddd, J = 16.2, 11.1, 5.7, 5.7 Hz, 1H), 5.64 (s, br, 2H), 5.27-
5.06 (m, 2H), 4.03 (s, br, 2H), 1.49 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 165.5, 148.2, 135.2, 
131.7, 129.6, 127.5, 124.6, 117.5, 81.4, 73.5, 55.8, 28.2; HRMS (Q-Tof): m/z calcd. for 
C16H20N2O6Na [(M+Na)+]: 359.1219; found: 359.1206. 
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General Procedure F. N-Acetoxymethylation of N-(p-toluenesulfonyl)-1-amino-2-propene: 
To a mixture of paraformaldehyde (5 equiv) and N-allylamine (1 mmol, 1 equiv) was added 1 
mL of (CH3O)2O and 1 mL of acetic acid. The resulting mixture was stirred at 70-80 °C for 3-4 
hours. The reaction was cooled to room temperature; the reaction mixture was diluted with 
CH2Cl2 and washed with water. Column purification afforded the desired product as colorless oil. 
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Methyl-N-allyl(acetyloxymethyl)carbamate (193): 93
                                                 
93 Oleksyszyn, J.; Subotkowska, L. Synthesis 1980, 906.  
 General Procedure F was followed 
employing paraformaldehyde (4.34 mmol, 0.130 g) and  methyl N-allylcarbamate (4.34 mmol, 
0.500 g) in a 1: 1 v/v mixture of acetic anhydride and acetic acid (2 mL). The resulting mixture 
was stirred at 70 °C for 2 h. Purification by flash chromatography (20% ether in hexane) 
afforded 0.42 g (51%) of the title compound as a colorless oil. IR (thin film): 2988, 2959, 1746, 
1721, 1645, 1476, 1214, 1205, 1017, 944 cm-1;  1H NMR (300 MHz, CDCl3): δ  5.77-5.64 (m, 
1H), 5.26 (br s, 2H), 5.11-5.05 (m, 2H), 3.89 (br s, 2H), 3.67 (s, 3H), 1.96 (s, 3H); 13C NMR (75 
MHz, CDCl3, for two rotamers): δ  170.5, 156.4 + 155.8 (1C), 133.1, 117.1 + 116.6 (1C), 71.9 + 
77.2 (1C), 52.9, 49.5, 20.7;  MS (EI, 70 eV): m/z  187 (M•+), 160, 144, 129, 144, 114, 73, 57, 54; 
HRMS: m/z calcd. for C8H13NO4: 187.0844; found: 187.0851. 
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N-Allyl-N-(methylacetate)-p-toluenesulfonamide (194): General Procedure F was followed 
employing N-allyl-4-methylbenzenesulfonamide (2.46 mmol, 0.520 g) and paraformaldehyde 
(12.3 mmol, 0.370 g) in 2 mL of a 1:1 v/v mixture of (CH3O)2O  and acetic acid. Column 
purification (15% ethyl acetate/hexanes) afforded 0.36 g (52%) of the title compound as a pale 
yellow oil. IR (thin film): 2982, 1745, 1597, 1495, 1347, 1233, 1161, 1016, 943, 816, 758 cm-1;  
1H NMR (300 MHz, CDCl3): δ 7.75 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 5.72 (dddd, J = 
16.5, 9, 6, 6 Hz,  1H), 5.42 (s, 2H), 5.22 (ddd, J = 18, 18, 9 Hz, 2H), 3.81 (d, J = 6.3, 2H), 2.44 
(s, 3H), 1.88 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 170.2, 143.8, 137, 132.1, 129.5, 127.6, 
119.6, 71.1, 49.5, 21.5, 20.6; MS (EI, 70 V): m/z 224 [(M-C2H3O2)•+], 155, 91, 68; HRMS: m/z 
calcd. for C10H14NO2S: 224.0740; found: 224.0741. 
 
O
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Phenyl-N-allyl(acetyloxymethyl)carbamate (195): General Procedure F was followed 
employing N-allyl-N-benzamide (21.4 mmol, 3.45 g) and paraformaldehyde (36.7 mmol, 1.10 g) 
in a 1: 1 v/v mixture of acetic anhydride and acetic acid (12 mL). The resulting mixture was 
stirred at 95 °C. Purification by flash chromatography (20% ether/hexanes) afforded 2.4 g (48%) 
of the title compound as colorless oil. IR (thin film): 2984, 1743, 1658, 1443, 1409, 1238, 1202, 
1018, 947 cm-1;  1H NMR (300 MHz, CDCl3): δ  7.52-7.46 (m, 2H), 7.45-7.36 (m, 3H), 5.86 (s, 
br, 1H), 5.38-5.18 (m, 4H), 4.17 (s, br, 2H), 2.09 (s, 3H); 13C NMR (75 MHz, CDCl3, for two 
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rotamers): δ  172.3, 170.4 + 170.2 (1C), 134.9, 132.6, 130.3, 128.5, 127.1, 118, 86.8, 48.8, 21;  
MS (EI, 70 eV): m/z  233 (M•+), 190, 173, 150, 106, 103, 77, 73, 68; HRMS: m/z calcd. for 
C13H15NO3: 233.1052; found: 233.1053. 
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General Procedure G. N-Alkylation of N-(p-toluenesulfonyl)-1-amino-2-propene: To a 0 °C 
suspension of NaH (60% in mineral oil, 1.2 equiv) in 5 mL of DMF was added a solution of N-
tosylallylamine (1 mmol, 1 equiv) in 1 mL of DMF (CAUTION: H2 gas evolution). Once 
addition was complete, the resulting thick mixture was warmed to ambient temperature and 
stirred for 30 min. The reaction mixture was cooled to 0 °C and a solution of 
chloro(methoxy)methane or iodomethane (1.5 equiv) in 1 mL DMF was added dropwise by 
syringe. After warming to ambient temperature, the reaction was stirred until complete as 
monitored by TLC (~1-2 h). The reaction was quenched by adding a saturated aqueous solution 
of NaHCO3 and the resulting mixture was extracted with ether (3×). The combined organic 
extracts were washed with brine, dried over MgSO4, and concentrated. The crude product 
mixture was purified by column chromatography on silica gel using 10-15% ether/hexanes as 
eluent. 
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N-Allyl-N-(methoxymethyl)-2-methylpropane-2-sulfinamide (116): General Procedure G was 
followed employing NaH (7.44 mmol, 0.300 g), N-allyl-2-methylpropane-2-sulfinamide 115 (6.2 
mmol, 1.0 g) and chloro(methoxy)methane (8.68 mmol, 0.700 g) in 30 mL DMF.  Purification 
by flash  chromatography (15% ether/hexanes as eluent) afforded 0.89g (70%) of the title 
compound as yellow oil. IR (thin film): 3486, 2953, 1455, 1361, 1077, 902 cm-1; 1H NMR (300 
MHz, CDCl3): δ 5.76 (dddd, J = 15.6, 10.2, 6.9, 5.4 Hz, 1H), 4.48 (d, J = 10.8 Hz, 1H), 4.40 (dd, 
J = 10.5, 0.6 Hz, 1H), 3.86 (dd, J = 5.4, 0.9 Hz, 1H), 3.47 (dd, J = 6.9, 0.9 Hz, 2H), 3.28 (s, 3H), 
1.15 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 133.6, 118.3, 80.7, 58, 55.4, 45, 22.7 (3C); MS (EI, 
70 V): m/z 205 (M•+), 191, 174, 149, 119, 99, 84, 69, 55; HRMS m/z calcd. for C9H19NO2S: 
205.1136; found: 205.1130. 
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N-Allyl-N-(methoxymethyl)-4-methylbenzenesulfinamide (119): General Procedure G was 
followed employing NaH (11.7 mmol, 0.468 g), N-allyl-4-methylbenzenesulfinamide (9.74 
mmol, 1.90 g) and chloro(methoxy)methane (14.6 mmol, 1.18 g) in 50 mL DMF.  Purification 
by flash  chromatography (20% ether/hexanes as eluent) afforded 1.9 g (82%) of the title 
compound as yellow oil. IR (thin film): 3488, 2924, 1491, 1449, 1210, 1156, 1090, 1068, 925, 
897 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.56 ( d, J = 8.1 Hz, 2H), 7.30 ( d, J = 8.4 Hz, 2H), 
5.52 (dddd, J = 16.5, 9.9, 6.6, 6.6 Hz, 1H), 5.14-5.05 (m, 2H), 4.73 (d, J = 10.5 Hz, 1H), 4.63 (d, 
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J = 10.8 Hz, 1H), 3.52 (d, J = 6.3Hz, 2H), 3.38 (s, 3H), 2.41 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 141.4, 140.6, 133.4, 129.5, 126.0, 118.8, 82.2, 55.8, 45.4, 21.3; HRMS (Q-TOF) m/z 
calcd. for C12H17NO2SNa [(M+Na)+]: 262.0878; found: 262.0888. 
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N-Allyl-N-(methoxymethyl)-p-toluenesulfonamide (183): General Procedure G was followed 
employing NaH (2.85 mmol, 0.113 g), N-allyl-4-methylbenzenesulfonamide (2.36 mmol, 0.500 
g) and chloro(methoxy)methane (3.54 mmol, 0.284 g) in 12 mL DMF.  Purification by flash  
chromatography afforded 0.54 g (90%) of the title compound as viscous oil.  IR (thin film): 
2928, 1678, 1455, 1344, 1161 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.72 (d, J = 8.4 Hz, 2H), 7.28 
(d, J = 7.8 Hz, 2H), 5.63 (dddd, J = 16.9, 10.2, 6.41, 6.4 Hz, 1H), 5.17 (dd, J = 13.6, 1.4 Hz, 1H), 
5.13 (dd, 5.2, 1.4 Hz, 1H), 4.69 (s, 2H), 3.80 (d, J = 6.3 Hz, 2H), 3.27 (s, 3H), 2.41 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 143.4, 137.5, 132.4, 129.6, 127.3, 119.1, 78.4, 55.7, 48.6, 21.5; MS 
(EI, 70 eV): m/z 255 (M•+), 224, 184, 155, 100, 91, 68; HRMS m/z calcd. for C12H17NO3S: 
255.0929; found: 255.0938. 
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Methylallyl(methoxymethyl)carbamate (184): General Procedure G was followed employing 
NaH (5.22 mmol, 0.200 g), N-allylmethylcarbamate (4.35 mmol, 0.500 g) and 
chloro(methoxy)methane (6.52 mmol, 0.523 g) in 15 mL DMF. Purification by flash 
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chromatography afforded 0.498 g (72%) of the title compound as yellow viscous oil. IR (thin 
film): 2954, 2821, 1717, 1644, 1473, 1258, 1085, 980 cm-1; 1H NMR (300 MHz, CDCl3): δ  
5.73-5.71 (m, 1H), 5.07-5.04 (m, 2H), 4.65-4.63 (m, 2H), 3.83-3.81 (m, 2H), 3.21 (s, 3H), 3.65 
(m, 3H); 13C NMR (75 MHz, CDCl3, for two rotamers): δ  156.9 + 156.2 (1C), 133.3, 116.9 + 
116.4 (1C), 77.9 + 77.6 (1C), 55.3, 53.3 + 52.6 (1C), 48.2 + 47.6 (1C); MS (EI, 70 eV): m/z 159 
(M•+), 144, 128, 100, 84, 59; HRMS m/z calcd for C7H13NO3: 159.0895; found: 159.0901. 
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N-Allyl-N-methyl-p-toluenesulfonamide (185): General Procedure G was followed employing 
NaH (5.68 mmol, 0.227 g), N-allyl-4-methylbenzenesulfonamide (4.73 mmol, 1.00 g), and 
methyl iodide (7.10 mmol, 1.01 g) in 25 mL DMF. Purification by flash chromatography 
afforded 1.0 g (94%) of the title compound as viscous oil. IR (thin film): 2978, 1644, 1597, 
1454, 1381, 1184, 985 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.66 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 
8.1 Hz, 2H), 5.70 (ddt, J = 17.1, 9.9, 6.3 Hz, 1H), 5.20 (dq, J = 3.9, 1.5 Hz, 1H), 5.15 ( dt, J = 
3.6, 1.5 Hz, 1H), 3.61 (d, J = 6.3 Hz, 2H), 2.65 (s, 3H), 2.42 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 143.3, 134.4, 132.5, 129.6, 127.4, 119.0, 53.0, 34.1, 21.4; MS (EI, 70 V): m/z 225 
(M•+), 198, 155, 91; HRMS m/z calcd. for C11H15NO2S: 225.0823; found: 225.0825. 
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N-Allyl-N-(methoxymethyl)benzamide (191): General Procedure G was followed employing 
NaH (8.06 mmol, 0.322 g), N-allylbenzamide (6.2 mmol, 1.0 g) and chloro(methoxy)methane 
(9.3 mmol, 0.749 g) in 15 mL DMF. Purification by flash chromatography afforded 1.11 g (87%) 
of the title compound as viscous yellow oil. IR (thin film): 3081, 2985, 2933, 1652, 1602, 1446, 
1412, 1266, 1086, 916 cm-1; 1H NMR (300 MHz, DMSO-d6, calibrated at 2.49 ppm at 70 °C): δ 
7.44-7.42 (m, 5H), 5.93-5.80 (m, 1H), 5.22-5.14 (m, 2H), 4.61 (s, 2H), 4.04 (d, J = 5.7 Hz, 2H), 
3.17 (s, 3H); 13C NMR (75 MHz, DMSO-d6, calibrated at 39.5 ppm at 70 °C): δ 171.0, 135.5, 
133.3, 129.2, 127.8, 126.3, 116.4, 78.4, 54.7, 47.3. MS (EI, 70 eV): m/z 205 (M•+), 175, 164, 
105; HRMS m/z calcd. for C12H15NO2: 205.1102; found: 205.1094. 
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Benzylallyl(methoxymethyl)carbamate (192): General Procedure G was followed employing 
NaH (6.28 mmol, 0.252 g), N-allylbenzylcarbamate (5.23 mmol, 1.00 g) and 
chloro(methoxy)methane (7.85 mmol, 0.632 g) in 10 mL DMF. Purification by flash 
chromatography afforded 0.85 g (69%) of the title compound as colorless oil. IR (thin film): 
3066, 2942, 1709, 1645, 1455, 1414, 1283, 1256, 1229, 915 cm-1; 1H NMR (300 MHz, DMSO-
d6, calibrated at 2.49 ppm at 70 °C): δ  7.43-7.27 (m, 5H), 5.88-5.72 (m, 1H), 5.20-5.06 (m, 4H), 
4.66 (s, 2H), 3.90 (d, J = 5.7 Hz, 2H), 3.20 (s, 3H); 13C NMR (75 MHz, DMSO-d6, calibrated at 
39.5 ppm at 70 °C): δ  155.0, 136.3, 133.6, 127.8, 127.3, 127.0, 116.0, 78.0, 66.2, 54.7, 47.8; MS 
 152 
(EI, 70 eV): m/z 235 (M•+), 203, 160, 144, 130, 121, 113, 107, 104; HRMS m/z calcd. for 
C13H17NO3: 235.1208; found: 235.1210. 
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(+/−)-N-Allyl-N-(1-methoxypropyl)-p-toluenesulfonamide (204): General Procedure G was 
followed employing NaH (6.00 mmol, 240 mg), N-allyl-N,4-methylbenzenesulfonamide (5.00 
mmol, 1.05 g) in 25 mL DMF at 0°C. The resulting slurry was stirred vigorously for 20-30 min 
at ambient temperature. The reaction mixture was cooled to 0 °C and 1-chloro-1-
methoxypropane (12.5 mmol, 1.35 g)94
 
 was added slowly. The resulting mixture was stirred at 
ambient temperature for additional 1 hour (complete by TLC). Purification by flash 
chromatography (10% ether/hexanes) afforded 0.91 g (64%) of the title compound as colorless 
oil. IR (thin film): 2935, 1598, 1495, 1464, 1339, 1170, 1149, 1069, 925, 873 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.72 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 9.0 Hz, 2H), 5.74 (dddd, J = 16.9, 
10.3, 6.6, 6.4 1H), 5.15 (dd, J = 17.4, 1.5 Hz, 1H), 5.03 (dd, J = 9.9, 0.9 Hz, 1H), 4.91 (dd, J = 
7.2, 6.0 Hz, 1H), 3.78 (ddd, J = 5.5, 3.3, 1.5 Hz, 2H), 3.20 (s, 3H), 2.42 (s, 3H), 1.70 (ddq, J = 
21.6, 14.7, 7.5 Hz, 1H), 1.43 (ddq, J = 21.0, 13.8, 7.5 Hz, 1H), 0.84 (t, J = 7.5 Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ 143.2, 138.3, 135.5, 129.5, 127.3, 117.1, 91.1, 56.0, 44.4, 27.4, 21.5, 10.0; 
MS (EI, 70 V): m/z 252, 155, 91; Q-TOF m/z calcd. for C14H21NO3SNa [(M+Na)+]: 306.1140; 
found: 306.1145. 
                                                 
94 1-Chloro-1-methoxypropane was freshly prepared as a solution in pentane and used directly in the reaction, see: 
Berliner, M. A.; Belecki, K. J. Org. Chem. 2005, 70, 9618-9621. 
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 (+/−)-N-Allyl-N-(1-methoxybenzyl)-p-toluenesulfonamide (205): General Procedure G was 
followed employing NaH (2.84 mmol, 113 mg.), N-allyl-N,4-methylbenzenesulfonamide (2.37 
mmol, 0.5 g) in 10 mL DMF under nitrogen atmosphere at 0°C a slurry was obtained and stirred 
vigorously for 20-30 min. The reaction mixture was cooled down to 0 °C and 1-
(chloro(methoxy)methyl)benzene (5.92 mmol, 927 mg) 95
 
 was added slowly. The resulting 
mixture was stirred at ambient temperature for additional 1 hour (complete by TLC). Purification 
by flash chromatography (10% ether/hexanes) afforded 0.57 g (72%) of the title compound as 
colorless oil. IR (thin film): 3065, 2932, 1597, 1493, 1452, 1342, 1096, 1028, 923, 889, 814, 745 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.81 (d, J = 8.4 Hz, 2H), 7.25 - 7.26 (m, 7H), 6.15 (s, 1H), 
5.43 (dddd, J = 16.5, 10.2, 6.6, 6.6 Hz, 1H), 4.85 (ddq, J = 17.4, 14.1, 1.2 Hz, 2H), 3.75 (dt, J = 
16.5, 1.5 Hz, 1H), 3.50 (dt, J = 16.2, 1.2 Hz, 1H), 3.38 (s, 3H), 2.44 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 143.4, 138.0, 137.4, 134.7, 129.5, 128.3, 128.2, 127.6, 126.7, 116.9, 89.1, 56.1, 45.5, 
21.5; MS (EI, 70 V): m/z 331, 300, 224, 176, 155, 144, 122, 104, 89, 78; Q-TOF m/z calcd. for 
C18H21NO3S [(M+Na)+]: 331.1142; found: 331.12409. 
 
 
                                                 
95 1-(Chloro(methoxy)methyl)benzene was freshly prepared as a solution in pentane and used directly in the 
reaction, see: Berliner, M. A.; Belecki, K. J. Org. Chem. 2005, 70, 9618-9621. 
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N-Allyl-N-(cyanomethyl)-p-toluenesulfonamide (207): General Procedure G was followed 
employing NaH (5.67 mmol, 0.227 g), chloroacetonitrile (7.10 mmol, 0.535 g) and N-allyl-4-
methylbenzenesulfonamide (4.73 mmol, 1.00 g) in 15 mL DMF. Purification by flash 
chromatography afforded 0.96 g (80%) of the title compound as viscous oil. IR (thin film): 2986, 
2249, 1644, 1597, 1353, 1186, 1092 cm-1; 1H NMR (300 MHz, CDCl3): δ  7.73 (d, J = 8.4 Hz, 
2H), 7.37 (d, J = 8.1 Hz, 2H), 5.79-5.66 (m, 1H), 5.39-5.29 (m, 2H), 4.21 (s, 2H), 3.82 (d, J = 6.6 
Hz, 2H), 2.45 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 144.8, 134.3, 130.7, 130.1, 127.6, 121.8, 
113.4, 50.2, 34.4, 21.6; MS (EI, 70 eV): m/z 250 (M•+), 155, 91; HRMS m/z calcd. for 
C12H14N2O2S: 250.0776; found: 250.0767. 
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N-Allyl-N-(methoxymethyl)-thiophene-2-sulfonamide (214): General Procedure G was 
followed employing NaH (2.95 mmol, 0.12 g), N-allyl-2-thiophenesulfonamide (2.46 mmol, 0.50 
g) and chloro(methoxy)methane (3.69 mmol, 0.296 g) in 12 mL DMF.  Purification by flash  
chromatography afforded 0.44 g (72%) of the title compound as viscous oil.  IR (thin film): 
3093, 2934, 1446, 1404, 1348, 1156, 1080, 915 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.61 (d, J = 
3.6 Hz, 1H), 7.58 (d, J = 5.1 Hz, 1H), 7.07 (t, J = 4.5 Hz, 1H), 5.70 (dddd, J = 16.8, 12.9, 6.6, 6.6 
Hz, 1H), 5.19 (dd, J = 12.9, 4.2, 2H), 4.71 (s, 2H), 3.88 (d, J = 6.3 Hz, 2H), 3.30 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 141.3, 132.3, 132.2, 131.8, 127.2, 119.3, 78.8, 55.9, 48.9; MS (EI, 70 
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eV): m/z 247 (M•+), 216, 147, 100, 68; HRMS m/z calcd. for [C9H13NO3S2 – CH3O]: 216.0147; 
found: 216.0151. 
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(E)-N-(But-2-enyl)-N-(methoxymethyl)-p-toluenesulfonamide (215): General Procedure G 
was followed employing NaH (2.60 mmol, 0.106 g), N-(but-2-enyl)-p-toluenesulfonamide (2.22 
mmol, 0.500 g) and chloro(methoxy)methane (3.33 mmol, 0.268 g) in 10 mL DMF. Purification 
by flash chromatography afforded 0.57 g (96%) of the title compound as colorless oil. IR (thin 
film): 2934, 1598, 1449, 1340, 1164, 1076, 929, 815, 748 cm-1;  1H NMR (300 MHz, CDCl3): δ 
7.70 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 7.8 Hz, 2H), 5.30-5.17 (m, 2H), 4.67 & 4.66 (s, 2H), 3.72 
(d, J = 6.9 Hz, 2H), 3.27 & 3.25 (s, 2H), 2,40 (s, 3H), 1.61 (dd, J = 6.3, 1.5 Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ 143.2, 137.6, 130.8, 129.5, 127.2, 124.8, 77.9, 55.5, 47.7, 21.4, 17.6; MS 
(EI, 70 V): m/z 269 (M•+), 254, 238, 224, 184, 155, 139, 114, 91; HRMS m/z calcd. for 
C13H19NO3S: 269.1089; found: 269.1093. 
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tert-Butyl-allyl(cyanomethyl)carbamate (189):96
                                                 
96 Gensini, M.; Kozhushkov, S. I.; Yufit, D. S.;Howard, J. A. K.; Es-Sayed, M.; Meijere, A. D. Eur. J. Org. Chem. 
2002, 2499-2507. 
 To a suspension of allylamine (24.9 mmol, 
1.42 g), K2CO3 (51 mmol, 7.1 g), NaI (50 mmol, 7.5 g) and Et3N (100 mmol, 10.2 g) in 
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anhydrous DMF (50 mL) was added chloromethylnitrile (25.1 mmol, 1.90 g) and the resulting 
mixture was stirred for 24 h. The mixture was filtered through celite and the solid filter cake was 
washed with ether (30 mL). The filtrates were combined and washed with water (30 mL) and 
brine (30 mL). The aqueous portions were combined and extracted with EtOAc (3 ×). The 
organic extracts were combined, dried (MgSO4) and concentrated to afford a brown oil of (N-
allylamino)acetonitrile (confirmed by NMR) and used directly for the next reaction. 
To an ice cold solution of (Boc)2O (27.5 mmol, 6.00 g) in 50 mL MeOH and Et3N (36.0 
mmol, 3.64 g) was added a solution of (N-allylamino)acetonitrile (prepared above) in MeOH (50 
mL) and the resulting mixture was stirred at 60 °C for 3 h. The solvent was evaporated and the 
resulting mixture was dissolved in water (60 mL). The aqueous phase was extracted with CH2Cl2 
(3 ×) and the combined organic extracts were dried (MgSO4) and concentrated. Purification by 
flash chromatography (1:2 ether in hexane) afforded 1.8 g (37% overall yield) the title compound 
as a colorless oil. IR (thin film): 2981, 2249, 1703, 1645, 1456, 1402, 1369, 1250, 1072, 928 cm-
1; 1H NMR (300 MHz, CDCl3): δ  5.82-5.69 (m, 1H), 5.26-5.20 (m, 2H), 4.11 (m, 2H), 3.94-3.92 
(m, 2H), 1.47 (s, 9H); 13C NMR (75 MHz, CDCl3): δ  146.7, 132.1, 118.8, 115.9, 81.8, 49.7, 
34.4, 28.1;  MS (EI, 70 eV): m/z  196 (M•+), 181, 140, 123, 114, 95, 86, 69,  58,56; HRMS: m/z 
calcd. for C10H16N2O2: 196.1211; found: 196.1209. 
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N-(2-(Dimethylamino)ethyl)-p-toluenesulfonamide: To a 0 °C solution of tosylchloride (0.95 
equiv, 10.5 mmol, 2.00 g) and Et3N (3 equiv, 33.2 mmol, 4.60 mL) in 30 mL of CH2Cl2 was 
added N,N-dimethylethane-1,2-diamine (1 equiv, 11.1 mmol, 1.20 mL) in 3 mL of CH2Cl2 
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dropwise over 3-4 min. The reaction mixture was brought to ambient temperature and stirred for 
additional 30 min. The reaction was diluted with CH2Cl2 and a saturated aqueous solution of 
NaHCO3 was added. The organic extract was washed with water and brine, dried over MgSO4, 
and concentrated. Removal of the solvent afforded 2.44 g (96%) of the title compound as yellow 
oil. IR (thin film): 3566, 3275, 2948, 1598, 1457, 1331, 1160, 1096, 816, 661 cm-1;  1H NMR 
(300 MHz, CDCl3): δ 7.76 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 7.8 Hz, 2H), 5.22 (t, J = 3.6 Hz,  NH), 
2.97 (dd, J = 6.9, 5.7 Hz, 2H), 2.43 (s, 3H), 2.34 (dd, J = 6, 4.5 Hz, 2H), 2.09 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ 143.1, 136.4, 129.4, 126.9, 56.8, 44.5, 39.9, 21.3; MS (EI, 70 V): m/z 242 
(M•+), 213, 155, 105, 91, 65, 59; HRMS: m/z calcd. for C11H18N2O2S: 242.1089; found: 
242.1085. 
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N-Vinyl-N-(methoxymethyl)-p-toluenesulfonamide (212): To a 0 °C solution of NaH (65%, 
9.07 mmol, 0.360 g) in 55 mL of THF was added N-(2-(dimethylamino)ethyl)-p- 
toluenesulfonamide (1 equiv, 7.56 mmol, 1.83 g) in 3 mL of THF dropwise over 3 min. The 
reaction mixture was brought to ambient temperature and stirred for one hour. The reaction 
mixture was cooled to 0 °C and MOMCl (18.9 mmmol, 1.43 mL) in 2 mL THF was added. The 
reaction temperature was raised to ambient temperature and stirred for additional 2 h. The 
reaction was quenched by adding 10M NaOH solution (caution: caustic!) and the resulting 
mixture was stirred for 14 h, then diluted with ether. The organic part was separated, washed 
with water and brine, dried over MgSO4, and concentrated. Column purification afforded 1.34 g 
(95%) of the title compound as yellow oil. IR (thin film): 2946, 1630, 1597, 1449, 1354, 1172, 
1089, 941, 661 cm-1;  1H NMR (300 MHz, CDCl3): δ 7.69 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 
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Hz, 2H), 6.75 (dd, J = 15.6, 9.3 Hz,  1H), 4.92 (s, 2H), 4.65 (dd, J = 15.9, 1.2, 1H), 4.42 (dd, J = 
9.3, 1.2, 1H), 3.32 (s, 3H), 2.43 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 143.9, 136.9, 131.6, 
129.8, 126.8, 95.7, 77.7, 55.8, 21.5; MS (EI, 70 V): m/z 241 (M•+), 210, 155, 145, 105, 91, 65, 
58; HRMS: m/z calcd. for C11H15NO3S: 241.0773; found: 241.0780. 
 
S
O
NH
 
N-Allyl-2-methylpropane-2-sulfinamide (115): To a stirred solution of allylamine (0.1779 mol, 
10.14 g) in 30 mL CH2Cl2 at 0 °C was added 2-methylpropane-2-sulfinic chloride (114)97
 
 (35.6 
mmol, 5.00 g) slowly over 10 minutes. The resulting mixture was stirred at room temperature for 
1 h. The reaction was diluted with brine and the layers were separated. The organics were 
combined and washed with water, and dried over MgSO4. Upon concentration and passing 
through silica gel with ether as eluent, the title compound (5.27 g, 92%) was isolated as yellow 
oil. IR (thin film): 3479, 2978, 1640, 1476, 1418, 1361, 1078, 922 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 5.87 (dddd, J = 15.9, 10.2, 5.7, 5.7 Hz, 1H), 5.23 (dq, J = 17.1, 1.5 Hz, 1H), 5.12 (dq, J 
= 10.2, 1.2 Hz, 1H), 3.83-3.61 (m, 2H), 3.26 (t, J = 5.7 Hz, NH), 1.19 (s, 9H); 13C NMR (75 
MHz, CDCl3): δ 135.2, 117, 55.6, 48.1, 22.5 (3C); MS (EI, 70 V): m/z 162 [(M+H)•+], 145, 105, 
86, 56; HRMS m/z calcd. for C7H16NOS (M+H): 162.0953; found: 162.0954. 
                                                 
97 (a) Weix, D.J.; Ellman, J. A.;Wang, X.; Curran, D.P. Org. Synth. 2005, 82, 157-162. (b) Gontcharov, A. V.; Liu, 
H.; Sharpless, K. B. Org. Lett. 1999, 1, 783-786. (c) Netscher, T.; Prinzbach, H. Synthesis 1987, 683-688. 
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 N-Allyl-p-toluenesulfonamide (186):84 4-Methylbenzenesulfonyl chloride (26.2 mmol, 5.00 g) 
was dissolved in 100 mL dry CH2Cl2 at 0°C and allylamine (92.8 mmol, 7.00 mL) was 
introduced. The resulting mixture was stirred at ambient temperature for 1 h. The solvent was 
removed and the residue was dissolved in ether. The organic layer was washed with water (2 ×), 
brine and dried (MgSO4). Purification by flash chromatography with ether as eluent afforded 
5.32 g (96%) of the title compound as a white crystalline solid. 1H NMR (300 MHz, CDCl3): δ  
7.75 (d, J = 8.7 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 5.76-5.64 (m, 2H), 5.18-5.04 (m, 2H), 4.89 (br 
s, NH), 3.58-3.53 (m, 2H), 2.41 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 143.4, 136.9, 132.9, 
129.6, 127.1, 117.5, 45.6, 21.4. 
 
S S
NH
O
O
 
N-Allylthiophene-2-sulfonamide: Thiophene-2-sulfonyl chloride (5.47 mmol, 1.00 g) was 
dissolved in 10 mL dry CH2Cl2 at 0°C and allylamine (27.3 mmol, 1.56 g) was added. The 
resulting mixture was stirred at ambient temperature for 1 h. The solvent was removed and the 
residue was purified by flash chromatography with ether as eluent affording 1.0 g (90%) of the 
title compound as a white crystalline solid. IR (thin film): 3286, 3094, 1646, 1405, 1327, 1156, 
925, 855 cm-1; 1H NMR (300 MHz, CDCl3): δ  7.62 (dd, J = 3.9, 1.5 Hz, 1H), 7.59 (dd, J = 5.1, 
1.2 Hz, 1H), 7.09 (dd, J = 4.8, 3.6 Hz, 1H), 5.75 (dddd, J = 16.2, 10.5, 5.7, 5.7 Hz, 1H), 5.20 (dd, 
17.1, 1.2 Hz, 1H), 5.13 (dt, J = 10.2, 0.9 Hz, 1H),  4.8 (br s, NH), 3.68 (t, J =  5.7 Hz, 2H); 13C 
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NMR (75 MHz, CDCl3): δ 140.9, 132.6, 132.2, 131.9, 127.4, 117.9, 45.9; MS (EI, 70 eV): m/z 
225 (M+ + Na),; HRMS m/z calcd. for C7H9NO2S2Na: 225.9972; found: 225.9961. 
 
NHMeO
O
 
Methyl N-allylcarbamate:98
 
 Methylchloroformate (40.0 mmol, 3.78 g) was added over 5 min to 
an ice cold solution of allylamine (88 mmol, 5.0 g) in 60 mL CH2Cl2. After addition was 
complete, the reaction mixture was allowed to warm to ambient temperature and stirred for 
additional 2 h. The reaction mixture was diluted with 2 M HCl solution (25 mL) and the organic 
layer was separated. The organic layer was washed with saturated NaHCO3, brine, dried 
(MgSO4) and concentrated to afford 4.3 g (93%) of the title compound as a colorless oil. 1H 
NMR (300 MHz, CDCl3): δ 5.78-5.65 (m, 1H), 5.26-5.15 (m, 1H, NH), 5.09-4.96 (m,2H), 3.66-
3.60 (m, 2H), 3.59 (br s, 3H); 13C NMR (75 MHz, CDCl3): δ 156.8, 134.4, 115.4, 51.7, 43.1. 
NHBnO
O
 
Benzyl allylcarbamate:99
                                                 
98 Kozmin, S. A.; Iwama, T.; Huang, Y.; Rawal, V. H. J. Am. Chem. Soc. 2002, 124, 4628 -4641. 
 Benzylchloroformate (42.2 mmol, 7.20 g, 95%) was added over 30 
min to a 1:1 mixture of water and EtOAc (75 mL each), K2CO3 (130 mmol, 18.0 g) and 
allylamine (38.0 mmol, 2.17 g) at 0 °C with vigorous stirring. After addition, the reaction 
99 Bischofberger, N.; Waldmann, H.; Saito, T.; Simon, E. S.; Lees, W.; Bednarski, M. D.; Whitesides, G. M. J. Org. 
Chem. 1988, 53, 3457-3465.  
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mixture was brought to ambient temperature and stirred for additional 2 h. Upon completion, the 
reaction mixture was diluted with 2 M HCl solution (40 mL) and the organic layer was 
separated. The organic layer was washed with brine, dried (MgSO4) and concentrated to afford 
7.0 g (97%) of the title compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ  7.37-7.34 
(m, 5H), 5.87-5.78 (m, 1H), 5.22-5.11 (m, 4H), 4.58 (br s, 1H, NH), 3.80 (br s, 2H); 13C NMR 
(75 MHz, CDCl3): δ 156.2, 136.4, 134.3, 128.2, 127.8, 115.6, 66.4, 43.3. 
 
NHPh
O
 
N-Allylbenzamide: 100
 
 To a stirred solution of allylamine (86.16 mmol, 4.920 g) in 50 mL 
CH2Cl2 at 0°C, benzoyl chloride (17.2 mmol, 2.42 g) was added over 30 min. After addition, the 
resulting solution was stirred at ambient temperature for additional 2 h and diluted with saturated 
NaHCO3 solution. The organic layer was separated and washed with brine, dried (MgSO4) and 
concentrated to afford 2.64 g (95%) of the title compound. 1H NMR (300 MHz, CDCl3): δ 7.8-
7.76 (m, 2H), 7.51-7.37 (m, 3H), 6.39 (br s, 1H, NH), 5.99-5.86 (m, 1H), 5.27-5.14 (m, 2H), 
4.09-4.03 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 167.3, 134.1, 131.4, 128.5, 126.9, 116.6, 42.4. 
 
 
                                                 
100 Castagnolo, D.; Armaroli, S.; Corelli, F.; Botta, M. Tetrahedron: Asymmetry 2004, 15, 941-949. 
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N-(But-2-enyl)-p-toluenesulfonamide:101
 
 To a stirred solution of tosylamine (6.92 mmol, 1.18 
g) and K2CO3 (14.8 mmol, 2.04 g) in 20 mL CH3CN, crotyl bromide (85%, 7.4 mmol, 1.0 g) was 
added and the resulting mixture was refluxed for 5-6 hours. The reaction was cooled down to 
ambient temperature and diluted with water. Excess of ether was added to the reaction mixture 
and extracted. The organic layer was separated and washed with brine, dried (MgSO4) and 
concentrated. Column purification afforded 1.1 g (71%) of the title compound. 1H NMR (300 
MHz, CDCl3): δ 7.75 (d, J = 6.6 Hz, 2H), 7.30 (d, J = 7.8 Hz, 2H), 5.67- 5.52 (m, 1H), 5.35-5.27 
(m, 1H), 4.52 (s, br, 1H, NH),  3.52- 3.47 (m, 2H), 2.43 (s, 3H), 1.59 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ 143.3, 129.7, 129.6, 127.1, 125.6, 45.3, 21.4, 17.5. 
S
O
NH
Me
 
N-Allyl-4-methylbenzenesulfinamide:102
                                                 
101 Aggarwal, V. K.; Fang, G. Y.; Charmant, J. P. H.; Meek, G. Org. Lett. 2003, 5, 1757-1760. 
 To a 0 °C solution of p-toluenesulfinic acid sodium 
salt (16.8 mmol, 3.00 g) in 15 mL toluene, oxalyl chloride (17.9 mmol, 2.26 g) was added 
dropwise.  After stirring the reaction for 1 h at room temperature, allylamine (84.18 mmol, 6.3 
mL) was added and the reaction was stirred for another hour. The reaction mixture was diluted 
with brine and the layers were separated. The aqueous layer was extracted with ether. The 
combined organics were washed with brine and dried over MgSO4. The crude product mixture 
102  (a) Savilea, C. K.; Kazlauskas, R. J. Adv. Synth. Catal. 2006, 348, 1183-1192. (b) Ruano, J.L. G.; Parra, A.; 
Yuste, F.; Mastranzo, V. M. Synthesis 2008, 2, 311-319. 
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was purified by column chromatography on silica gel using 20% ether/hexanes as eluent 
affording 2.25 g (69%) of the title compound as yellow oil.  
 164 
APPENDIX A 
X-RAY DATA 
Table 18. Crystal data for 71 
N
Me
Me
N
Ts
Ts  
  
Identification code  nihar6 
Empirical formula  C28 H38 N2 O4 S2 
Formula weight  530.72 
Temperature  150(2) K 
Wavelength  0.71073 Å 
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Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 10.186(3) Å α= 90°. 
 b = 7.968(2) Å β= 97.626(5)°. 
 c = 16.756(4) Å γ = 90°. 
Volume 1347.9(6) Å3 
Z 2 
Density (calculated) 1.308 Mg/m3 
Absorption coefficient 0.234 mm-1 
F(000) 568 
Crystal size ,0.18 x 0.23 x 0.26 mm3 
Theta range for data collection 2.02 to 24.99°. 
Index ranges -12<=h<=12, -9<=k<=9, -19<=l<=19 
Reflections collected 10604 
Independent reflections 4720 [R(int) = 0.1187] 
Completeness to theta = 24.99° 100.0 %  
Absorption correction multi-scan 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4720 / 1 / 327 
Goodness-of-fit on F2 0.794 
Final R indices [I>2sigma(I)] R1 = 0.0653, wR2 = 0.1304 
R indices (all data) R1 = 0.1339, wR2 = 0.1590 
Absolute structure parameter 0.23(14) 
Extinction coefficient 0.0000(15) 
Largest diff. peak and hole 0.274 and -0.257 e.Å-3 
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Table 19. Crystal data 75 
N
Me
Me
N
Ts
Ts
Me
 
  
Identification code  ns112006 
Empirical formula  C22 H30 N2 O4 S2 
Formula weight  450.60 
Temperature  373(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 16.5309(11) Å α= 90°. 
 b = 8.3946(5) Å β= 95.5840(10)°. 
 c = 33.062(2) Å γ = 90°. 
Volume 4566.2(5) Å3 
Z 8 
Density (calculated) 1.311 Mg/m3 
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Absorption coefficient 0.264 mm-1 
F(000) 1920 
Crystal size 0.28 x 0.23 x 0.22 mm3 
Theta range for data collection 1.66 to 25.00°. 
Index ranges -19<=h<=19, -9<=k<=9, -39<=l<=39 
Reflections collected 35433 
Independent reflections 8018 [R(int) = 0.0495] 
Completeness to theta = 25.00° 99.9 %  
Absorption correction None 
Max. and min. transmission 0.9443 and 0.9298 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8018 / 0 / 551 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0620, wR2 = 0.1549 
R indices (all data) R1 = 0.0869, wR2 = 0.1664 
Largest diff. peak and hole 0.690 and -0.556 e.Å-3 
 
 
 
Table 20. Crystal data for 88 
N
Me
H
H
Ts
 
 
 
Identification code  ns92906s 
Empirical formula  C20 H29 N O2 S 
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Formula weight  347.50 
Temperature  473(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 7.6629(8) Å α= 90°. 
 b = 10.9011(11) Å β= 90.215(2)°. 
 c = 22.370(2) Å γ = 90°. 
Volume 1868.7(3) Å3 
Z 4 
Density (calculated) 1.235 Mg/m3 
Absorption coefficient 0.185 mm-1 
F(000) 752 
Crystal size 0.27 x 0.22 x 0.21 mm3 
Theta range for data collection 1.82 to 27.50°. 
Index ranges -9<=h<=9, -14<=k<=14, -29<=l<=28 
Reflections collected 17888 
Independent reflections 4286 [R(int) = 0.0643] 
Completeness to theta = 27.50° 100.0 %  
Absorption correction multi-scan (Sadabs) 
Max. and min. transmission 0.9622 and 0.9517 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4286 / 0 / 217 
Goodness-of-fit on F2 0.955 
Final R indices [I>2sigma(I)] R1 = 0.0562, wR2 = 0.1287 
R indices (all data) R1 = 0.0954, wR2 = 0.1454 
Largest diff. peak and hole 0.385 and -0.228 e.Å-3 
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Table 21. Crystal data for 91c 
N
H
H
Me
Ts
N
Me  
 
Identification code  ns1206 
Empirical formula  C26 H32 N2 O2 S 
Formula weight  436.60 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 16.566(11) Å α= 90°. 
 b = 14.871(12) Å β= 106.885(14)°. 
 c = 10.019(8) Å γ = 90°. 
Volume 2362(3) Å3 
Z 4 
Density (calculated) 1.228 Mg/m3 
Absorption coefficient 0.162 mm-1 
F(000) 936 
Crystal size 0.28 x 0.14 x 0.08 mm3 
Theta range for data collection 1.28 to 24.99°. 
Index ranges -19<=h<=19, -17<=k<=17, -11<=l<=11 
Reflections collected 16172 
Independent reflections 4156 [R(int) = 0.1503] 
Completeness to theta = 24.99° 100.0 %  
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Absorption correction Multi-scan 
Max. and min. transmission 0.9872 and 0.9561 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4156 / 0 / 280 
Goodness-of-fit on F2 0.846 
Final R indices [I>2sigma(I)] R1 = 0.0657, wR2 = 0.1425 
R indices (all data) R1 = 0.1994, wR2 = 0.2018 
Largest diff. peak and hole 0.203 and -0.195 e.Å-3 
 
 
Table 22. Crystal data for 105c 
N
Me
H
H
S
N
Bn
S
O
O
 
 
Identification code  ns825s 
Empirical formula  C29 H32 N2 O2 S2 
Formula weight  504.69 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 12.8077(13) Å α= 90°. 
 b = 9.9740(10) Å β= 96.093(2)°. 
 c = 19.981(2) Å γ = 90°. 
Volume 2538.1(4) Å3 
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Z 4 
Density (calculated) 1.321 Mg/m3 
Absorption coefficient 0.240 mm-1 
F(000) 1072 
Crystal size 0.38 x 0.36 x 0.23 mm3 
Theta range for data collection 1.60 to 32.34°. 
Index ranges -18<=h<=19, -14<=k<=14, -29<=l<=29 
Reflections collected 30858 
Independent reflections 8517 [R(int) = 0.0346] 
Completeness to theta = 32.34° 94.0 %  
Absorption correction None 
Max. and min. transmission 0.9469 and 0.9144 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8517 / 0 / 316 
Goodness-of-fit on F2 1.539 
Final R indices [I>2sigma(I)] R1 = 0.0698, wR2 = 0.1895 
R indices (all data) R1 = 0.0935, wR2 = 0.2018 
Largest diff. peak and hole 1.027 and -0.698 e.Å-3 
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